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A B S T R A C T 
As part of a currently intense research effort into the development of novel 
potent macromolecular pharmaceuticals, diagnostic tools and carriers for targeted 
drug delivery, this project involved the synthesis of glycopoljoners. Polymethacrylate 
derivatives carrying carbohydrate residues were efficiently prepared in a stereo-
controlled manner, following two different routes. As revealed by a thorough 
characterisation of the materials obtained, the synthetic procedure strongly affected 
the polymers' composition and, in turn, their properties, such as their self-association 
in aqueous media and the interaction of the compounds bearing D-galactose units with 
a specific lectin. 
Polymers containing peracetylated saccharide residues were shown to be 
surface-active, forming stable spread Langmuir films. These monolayers acted as 
effective dl-aspartic acid nucleation promoters, whilst the soluble analogues (for 
which the sugars are deacetylated) seemed to possess a certain activity as dl-aspartic 
acid growth inhibitors. 
The behaviour of the deprotected polymers in aqueous solution was 
thoroughly investigated, prior to testing whether the materials carrying galactosyl 
units on the side chains could be recognised by a galactose-specific protein. For the 
first time for polymeric glycoconjugates, thermodynamic binding parameters relative 
to this protein-carbohydrate interaction were directly evaluated using isothermal 
titration microcalorimetry. 
Moira Ambrosi, Durham, September 2002 
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V I I I 
INTRODUCTION 
L l L E C T I N S 
Lectins'^'' exist in most living organisms, ranging from viruses and bacteria to 
plants and animals. They were first identified before the turn of last century as plant 
proteins capable of agglutination of red blood cells^^'^l Despite this early discovery, it 
was only in the 1960s that their study started to attract great attention'^^'^l Their 
involvement in diverse biological processes'^\ such as clearance of glycoproteins 
from the circulatory system, trafficking, adhesion of infectious agents to host cells, 
recruitment of leukocytes to inflammatory sites, cell interactions in the immune 
system, in malignancy and metastasis, was then shown. At present they are the focus 
of intense research. The investigation of their role in cell recognition, as well as their 
employment as invaluable tools for the study of complex carbohydrates in solution 
and on the cell surface, is contributing markedly to the advancement in glycobiology. 
Like enzymes and antibodies, lectins interact with carbohydrates non-
covalently; however, unlike these biomolecules, they do not present any catalytic 
activity and they are not products of an immune response. The interaction with sugars 
is usually reversible and highly specific''''^l Each lectin contains typically two or more 
carbohydrate-binding sites; therefore, their interaction with sugars on the surface of 
erythrocytes results in the cross-linking of several blood cells and their subsequent 
precipitation. This phenomenon, known as cell agglutination, is a major attribute of 
lectins' activity and is used routinely for their detection and characterisation. Both the 
agglutination and precipitation processes are inhibited by the carbohydrate for which 
the lecfin is specific. 
Lectins represent a heterogeneous group of oligomeric proteins, widely 
varying in size and structure. Nonetheless, many of them can be grouped in families 
characterised by similar sequences and s tructural organisation. S equence similarity 
with known lectins provides a novel guideline for the identification of new ones. 
According to the monosaccharide toward which they exhibit the highest 
affinity, lectins can be classified into five groups: mannose, galactose/A^-
acetylgalactosamine, A'^-acetylglucosamine, fucose and A^-acetylneuraminic acid'^'l 
With the exception of fiicose, all the sugars are in the D configuration. Despite the 
weak intrinsic protein-ligand affinity, with typical association constants in the 
millimolar range for monosaccharides, lectin selectivity is usually high^'^l Therefore, 
apart from few exceptions, neither do lectins specific for galactose bind glucose, nor 
those specific for mannose bind galactose. However, variations at the C-2 position of 
the pyranose ring may be tolerated, so that most lectins that bind galactose also 
interact with A^-acetylgalactosamine. Certain lectins combine preferentially with either 
the a- or the /?-anomer, whereas others lack anomeric specificity. The properties of 
the aglycon can influence markedly the lectin recognition activity. For instance, 
aromatic glycosides bind to many lectins much more strongly than aliphatic ones, 
indicating the presence of a hydrophobic region in the proximity of the carbohydrate-
binding site '"I 
Besides that based on carbohydrate specificity, other classifications of lectins 
have been drawn. The determination of the amino acid sequences of several hundreds 
of lectins, together with the elucidation of about thirty 3D-structures, allowed the 
replacement of the traditional division according to the lectin origin - i.e. plant, 
animals and microorganisms - by a classification based on common structural 
features''^ Most' lectins belong to three classes: (1) simple, (2) mosaic (or 
multidomain) and (3) macromolecular assemblies. Simple lectins consist of a small 
number of subunits, not necessarily identical, each of molecular weight usually below 
40 kDa. Each monomeric unit contains a carbohydrate-binding site. This class 
comprises practically all known plant lectins '^^ ^ and the galectins (formerly known as 
S-lectins), a family of galactose specific animal lectins^'^'l Mosaic lectins are 
composite molecules consisting of several kinds of protein domains, only one of 
which possesses a carbohydrate-binding site. This class includes diverse proteins from 
different sources: viral hemagglutinins^'''^ and animal lectins of C-, P- and I-types''^l 
Macromolecular assemblies are common in bacteria. They are filamentous organelles 
consisting of helically arranged subunits (pilins) assembled in a well-defined order''^l 
Within each class, proteins can be grouped into families, with similar sequences and 
structural properties. 
In this study we wil l concenfrate our attention on legume lectins, a family of 
simple plant proteins, including the lectin from Arachis Hypogaea (peanut agglutinin, 
PNA), used here as a galactose-specific protein to test the lectin-ligand affinity of our 
glycopolymers. 
1.1.1 L E G U M E L E C T I N S 
Legume lectins represent the largest and most thoroughly studied family o f 
simple lectins. Around 100 members have been characterised, almost all isolated from 
the seeds of the plants from which they come''^''^l Concanavalin A (Con A ) , the 
lectin from the jack bean, is the prototype member of the family. Firstly isolated in 
1919 by Sumner, it was only in 1936 that Sumner and Howell showed its specificity 
toward mannose and glucose^'^l The relative abundance of this protein in jack bean, 
the ease of its preparation and the large number of saccharides with which it can 
interact, led to numerous studies on Con A, markedly accelerated by the discovery 
that cells transformed by DNA tumour viruses or carcinogens were agglutinated by 
the lectin more readily than normal cells. About 85% of the binding sites for Con A, 
which are in a cryptic form on normal cells, were found to be exposed on the surface 
membrane of transformed cells. It was therefore hypothesised that the change in 
structure of the surface membrane, resulting in the exposure of the sites, could 
produce the change in cellular regulatory mechanisms associated with 
transformation''^l 
1.1.1.1 S T R U C T U R A L F E A T U R E S 
Typically, legume lectins consist of two or four identical or almost identical 
subunits (protomers) of 2 5-30 kDa each, in turn commonly constituted by a single 
polypeptide chain of about 2 50 amino acids that may present one or two //-linked 
oligosaccharides. Each protomer contains a carbohydrate-combining site, a tightly 
bound Ca^^ and a transition metal ion, usually Mn^^. 20% of the amino acid residues 
are invariant in all legume lectins and another 20% are similar in all proteins. The 
conserved amino acids include several of those involved in the interaction with the 
saccharide and almost all the residues that coordinate the metal ions. The resolution of 
3D-structures of about ten legume lectins has shown that each subunit is constituted 
largely - nearly 60% - of y5-strands mutually connected by loops. For all legume 
lectins known so far, the tertiary structure is made up of two anti-parallel y5-sheets, a 
six-stranded flat "back" and a seven-stranded curved "front", connected by a five-
stranded y^sheet, giving the well known "jellyroU" motif, also referred to as the 
"lectin fold"f^''^ (Figure la) . 
Figure 1 a), Tertiary structure of a legume lectin monomer; b), dimerisation in Con A; c), 
tetramerisation in Con A. 
The subunit structures o f different lectins can be nearly superimposed, irrespective o f 
the protein specificity. Despite their similarities at the primary, secondary and tertiary 
structural monomeric level, legume lectins exhibit considerable variation in their 
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quaternary structure: small differences in the amino acid sequences at the monomer-
monomer interfaces and the presence/absence of glycosylation affect the monomers' 
association mode. In the case of lectins with "canonical" quaternary structure, such as 
Con A, dimerisation involves anti-parallel side-by-side alignment of the flat six-
stranded /9-sheets of the two monomers, resulting in the formation of a continuous 12-
stranded sheet that extends across the dimer interface. A considerable portion of the 
surface area is buried in the process: ca. 1000 per monomer (Figure lb). Further 
association of two dimers gives the tetrameric assembly of Con A observed in 
physiological conditions'^'^ (Figure Ic). 
1.1.1.2 CARBOHYDRATE-BINDING S I T E 
During the past 15 years there has been significant progress in elucidating the 
features of lectins involved in carbohydrate binding. Mainly X-ray crystallography of 
the proteins complexed with their ligands, site-directed mutagenesis experiments and 
molecular modelling have allowed the identification of the chemical groups belonging 
to both interacting species involved in the binding and of the types of bond formed. 
Studies of lectin-oligosaccharide complexes are especially interesting, providing the 
basis for the understanding of the proteins' interaction with natural ligands. Generally, 
lecfins show exquisite specificity for di-, tri- and tetrasaccharides, with association 
constants significantly higher compared to the corresponding monosaccharides. 
The carbohydrate-binding site is represented by a shallow depression on the 
surface of the protein, located at the top right of each protomer. In all cases the 
combining site appears to be preformed'^^^, since few conformational changes occur 
upon binding. The Ca^ "^  and Mn^"^ are situated around 4 A apart and in close proximity 
to the sugar-combining pocket. Although not always directly involved in the 
carbohydrate binding, the cations help the positioning of the amino acid residues 
interacting with the glycoside. 
Lectins bind carbohydrates through a network of hydrogen bonds and 
hydrophobic interactions. A schematic representation of the T-antigenic disaccharide, 
Gal/^l->3)GalNAc (Tant), in the binding site of PNA is reported in Figure 2. 
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Figure 2 Schematic representation of protein-carbohydrate interactions in the PNA-Tant complex. 
Van der Waals forces, although rather weak (usually a fraction of 4.2 kJ mol' 
for each pair of atoms), are frequently numerous, contributing significantly to the 
overall binding^'l The steric disposition of hydroxyl groups creates hydrophobic 
patches'^ ^^ -' on the sugar surface that can interact with hydrophobic regions of the 
protein. A common type of interaction is the stacking of the sugar on the side chain of 
aromatic amino acids such as phenylalanine, tyrosine or tryptophan^^'^l Contacts 
between the ligand and the protein are often mediated by water molecules. Water acts 
as a molecular "mortar"'^^^; its small size and its ability to behave as both hydrogen 
donor and acceptor make it ideal to exploit this function. Tightly bound water 
molecules can be considered as structural, i.e. an extension of the protein surface. 
Thus, water plays a significant role in carbohydrate recognition, imparting in some 
cases exquisite specificity*. 
In all legume lectins, irrespective of their specificity, four invariant amino acid 
residues participate in the ligand binding: an aspartic acid, an asparagine, a glycine 
(conserved in all the lectins of the family apart from Con A) and an aromatic amino 
acid'^ ^^ or leucine^^^l Replacement of the aspartic acid or asparagine by site-directed 
mutagenesis results in several cases in the loss of the lectin sugar-binding ability. The 
aspartic acid and asparagine residues also participate in coordinating Ca^^ (Figure 3). 
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Figure 3 Methyl-a-mannoside in the combining site of concanavalin A. 
A rare c/i'-peptide bond between the critical asparagine and the preceding amino acid, 
usually alanine, confer to the asparagine residue the proper orientation. 
* As wi l l be discussed in Chapter 4, the high specificity of peanut agglutinin for Gal/5(l-^3)GalNAc 
appears to be generated by the formation of two water bridges (the involved water molecules are 
labelled as W3 and W4 in Figure 2) absent in the binding of other ligands. 
Despite the conservation o f key amino acids involved in the binding of the 
carbohydrate, different legume lectins c an s how d ifferent specificity. For instance, 
while Con A binds mannose and glucose, PNA, ECorL and SBA bind galactose. As 
reported in Figures 2 and 3 and better visualised in Figure 4, the aspartic acid and the 
asparagine residues form hydrogen bonds with different hydroxyl groups of mannose 
and galactose, due to the different orientation of the monosaccharides in the binding 
sites of the respective specific lectins'^^l 
C a 2 + ^ 0 = C 
Asn 
Figure 4 Hydrogen b onds b etween t he s ide chains of conserved amino acids that bind mannose 
(lighter lines) to concanavalin A or Lathyrus ochrus lectin I and galactose (darker lines) 
to ECorL, or PNA, or GSIV. 
Therefore, while the constellation of highly conserved amino acids provides the 
framework required for binding, specificity apparently arises from the variability of 
amino acids residues in other regions of the combining pocket. The amino acids that 
form the binding sites of legume lectins lie in four loops of the protomer polypeptide 
chain, designated A, B, C and D'^'I The invariant aspartic acid and glycine belong to 
A and B, respectively, whereas the asparagine and the hydrophobic residue are in loop 
C. Additional interactions are provided by amino acids in loop D , indicating the 
correlation between this loop and the lectin specificity. Thus, for instance, the size of 
loop D is identical in all mannose-specific lectins'^°l 
1.1.1.3 FUNCTIONS 
Although known longer than lectins of different origin, the physiological role 
of legume lectins is still not well understood. Many theories have been proposed in 
the course of the years, among which only two have received serious attention. 
According to the first one, they are involved in the establishment of symbioses 
between nitrogen-fixing bacteria and plants'^^'^'l Legumes are able to associate 
specifically and form symbioses with soil bacteria of the rhizobia family, a 
phenomenon that makes them independent from soil nifrogen supplies. The idea that 
lectins are responsible for this association was advanced over 20 years ago. 
Nonetheless, the mechanism of the process is still obscure. The finding that a legume 
binds to a specific rhizobial species and not to bacteria that are symbionts for- other 
legumes suggests that the interaction occurs between lectins in the roots of the plant 
and carbohydrates on the bacteria surface. Despite the fact that molecular genetics 
experiments support this hypothesis, several inconsistencies can be pointed out. First 
of all, for most host-symbiont systems there is no proof of the presence of lectins and 
of the respective ligands on the two interacting species. Secondly, the correlation 
between the sugar specificity of legume lectins and their ability to recognise bacteria 
appears not to be particularly strong. Furthermore, mutants o f soybean lacking the 
lectin are still nodulated by the rhizobial symbiont'^l 
The second theory is more general, embracing all plant lectins. In this 
assumption, lectins are considered as defence agents against predators '^'^ '^ '^. An 
essential feature of any active defence agent is the ability to specifically recognise the 
pathogen. Early investigators noted the similarities of lectins to antibodies and 
hypothesised that lectins might function as plant antibodies'^'^l The toxicity of several 
plant lectins for animals and their inhibition of fungi growth are well known 
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phenomena. Nevertheless, unlike antibodies, lectins are not produced in response to 
the exposure to an antigen. Moreover, information about the toxic effect is scarce and 
mainly the result of feeding experiments using Phaseolus vulgaris (PHA) and of. 
accidental poisoning of humans. Feeding experiments carried out with some animals 
showed their preference for lectin-free plants and their reluctance in consuming food 
containing PHA. 
1.2 CARBOHYDRATES 
Carbohydrates are widely distributed in animal tissues, where they have been 
traditionally considered as structural components and reservoirs of nutrients. 
However, research in the last 15-20 years has also shown their involvement in diverse 
physiological processes'^ ^ '^l A new discipline, glycobiology, has been established and 
devoted to the study of the role of carbohydrates in biological events. The rapid 
progress made underlines the importance of sugars in living systems, pushing them to 
the forefront o f biological sciences, a position equal to proteins and nucleic acids. 
Nowadays, the general opinion is that there is no single function of oligosaccharides 
and indicative is the title of a review published by Varki in 1993: Biological roles of 
oligosaccharides: all of the theories are correct^^^^. 
Unlike proteins and nucleic acids, polysaccharides can be highly branched and 
their monomeric units can be connected to one another by many different types of 
linkage. Each monosaccharide can be differently substituted and covalently bound to 
another one at different positions in the molecule. Furthermore, two monosaccharides 
can be linked together in two anomeric forms, the a- and y9-linkage. Laine '^'^ ^ reported 
that while the number of different hexapeptides that can be obtained connecting six 
different amino acids is 4.66x10'*, up to 1.95xl0'^different hexasaccharides can be 
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formed binding six different monosaccharides. Therefore, theoretically, carbohydrates 
can carry per unit of weight much more information than nucleic acids and proteins. 
Moreover, the size of a sugar residue is larger than that of an amino acid. Thus, for 
instance, a relatively small oligosaccharide can shield large surface areas of the 
glycoprotein o f which it is part. This does not only mean that the sugar moiety can 
strongly influence the protein properties but it also implies that cell surface 
oligosaccharides are among the first to be encountered by nearby molecules'^^'^'l It is 
in these structural features that the enormous potential o f carbohydrates to encode 
biological information, and therefore to act efficiently as recognition markers, 
residues^'*''''"I When considering that glycoproteins are major components of the outer 
surface of mammalian cells and that they are essential for many biological processes, 
such as fertilisation, immune defence, viral replication and infection, cell growth and 
cell-cell adhesion '^*^^ this hypothesis becomes even more plausible. Notable 
experimental evidence of the activity of sugars as recognition determinants has been 
collected throughout the years. Classical examples are the origin of the anticoagulant 
activity of heparin by the binding of a unique pentasaccharide to antithrombin 
or the results of the early studies of the Australian school^''''^ which showed that the 
presence of sialic acid residues on the surface of erythrocytes is an absolute 
requirement fo r the attachment o f influenza virus; prior treatment of the red blood 
cells with neuraminidase abolishes the binding. It is noteworthy that the type of cell 
has a major role in determining the extent and type of protein glycosylation, which is 
both species and tissue specific''''l Many enzymatic reactions are involved in the 
glycan-processing pathways'^ '^ ^l This explains why the glycosylation pattern is 
influenced by cellular physiological changes due, for instance, to the occurrence of a 
disease (which may affect one or more enzjones in the cell). Thus, the altered 
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glycoform population of a given glycoprotein may be diagnostic of the disease 
responsible for the alteration itself Abnormal glycosylation has been detected in cases 
of rheumatoid arthritis and cancer'"*^ .^ 
In principle, the same oligosaccharide can be attached to quite different 
proteins. However, the orientation of the oligosaccharide can significantly influence 
the properties of the glycoprotein. Therefore, the binding of the same oligosaccharide 
structure to different proteins can give rise to glycoproteins with markedly different 
characteristics, which again underlines that there is no single unifying function for 
carbohydrates'-'*^^ 
1.3 L E C T I N - C A R B O H Y D R A T E INTERACTIONS 
The idea that lectins and carbohydrates are excellent as cell recognition 
markers originates from the findings that both classes of compounds are commonly 
present on the cell surface and that sugars possess tremendous coding capacity. The 
ability of lectins to distinguish between subtle variations of oligosaccharide structure 
makes them perfectly suitable as decoders for the carbohydrate-encoded information. 
In other words, whilst sugars are able to carry the biological information, lectins are 
capable of deciphering the code. In this sense, the concept of lectin-ligand interaction 
can be seen as an extension of the lock-and-key hypothesis introduced by Fischer at 
the end of the nineteenth century to explain the specificity of the association of 
enzymes with their substrates. 
Considerable experimental evidence is n owadays supporting the assumption 
that protein-carbohydrate interactions constitute the first step of a myriad of 
physiological events. So, for instance, old erythrocytes are cleared f rom the blood 
through the recognition of the galactosyl residues on their surface by the hepatoc3^es' 
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receptors (asialoglycoprotein receptors)^ "*^^ . With age the red blood cells become 
progressively desialylated. When the density of galactose moieties on the surface is 
high enough, the cell is removed from the circulation and destroyed (Figure 5). 
Galactose was first established to be the recognition marker for the mammalian 
hepatic carbohydrate receptor in 1976^'^^\ 
8A 
new (young) erythrocyte 
5A 
il 
old erythrocyte with SA 
exposed Gal 
destruction ^ s S T ^ r - r r r S l T ^ receptor 
of old 
erythrocyte 
hepatic cell (liver) ] 
Figure 5 Clearance of non-sialylated erythrocytes from the blood by the liver. 
The mammalian asialoglycoprotein receptor of hepatocytes is the prototype for 
the C-lectins, a large family of multidomain Ca^" -^dependent animal proteins. 
Members of this group are important components of the innate immune system, 
including the mannose-binding proteins, MBPs. The role of MBPs in host defence 
against viral pathogens has been demonstrated by several studies^^°'^'l Like all other 
collectins - a group of soluble C-type lectins - , MBPs have a N-terminal collagenous 
domain and a globular C-terminal portion, containing the carbohydrate-recognition 
domain (CRD)^^^l Thus, while the C-terminal domain mediates the binding to various 
microorganisms, the N-terminal one interacts with the cell, triggering the 
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carbohydrate-dependent complement activation, which then results either in the 
killing of the pathogen^^ '^^ '*' or in the deposition of complement components on the 
surface of the microorganism (opsonisation) which is then cleared by phagocj^ic cells 
like macrophages and neutrophils. MBPs have been shown to prevent human 
immunodeficiency virus (HIV) infection of H9 cells, probably by binding to 
oligomannose units of the envelope gpl20 of the virus'^^l Unlike antibodies, whose 
reaction takes at least one to three days, these collectins react to infections or injuries 
immediately. A deficiency in MBPs has been claimed to account for a significant 
number of immunodeficiency cases in children, where the immune system is still not 
fully capable of mounting an efficient response^^^l 
Macrophages also express cell-surface galactose/A^-acetylgalactosamine-
specific C-type lectins (MMGL, mouse macrophage Gal/GalNAc-specific C-type 
lectins). These proteins have been shown to be involved in the recognition of 
cancerous cells by macrophages. Expression of MMGL, therefore, allows 
macrophages to be tumouricidal'^^^. 
Selectins, another group of C-type lectins so called because they mediate 
selective contacts between cells, play a key role in the recruitment of leukocytes to 
inflammatory sites. During the inflammatory response, damage in tissues surrounding 
a blood vessel causes the influx of signalling molecules. Selectins are thus rapidly 
expressed on the inner surface of blood vessels (E-selectins) and on platelets (P-
selectins). High specific binding of these proteins to sugars on white blood cell 
surfaces causes the leukocytes to adhere to the vessel walls, which, at this stage, 
express L-selectins. By interaction with L-selectins, leukocytes can now roll toward 
the site of damage, where they pass through to the surrounding tissue'^^l Whilst this is 
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a well-controlled process in healthy individuals, in excess it is a cause of arthritis, 
asthma and myocardial infarction. 
Many microorganisms produce lectins, also referred to as adhesins, that are 
directly involved in the initiation of infections by mediating the adhesion to host cells 
through protein-carbohydrate interactions'^ ^^ .^ Intestinal epithelial cells of young 
piglets, which are susceptible to infection by E. coli K99, contain the glycolipid 
NeuGc-GMs. Adult pigs, which are resistant to E. coli K99, lack this glycolipid'^^l 
1.3.1 M U L T I V A L E N C Y 
The most striking features of lectin-monosaccharide interactions are that they 
are relatively weak, with association constants usually in the millimolar range for 
monosaccharides'^'', and that they may show relaxed specificity, when compared to 
the strict nature of enzyme-substrate associations. The reason for this weakness lies in 
the solvent-exposed nature of the lectin binding-sites, which are shallow pockets 
making few direct contacts with the ligands'^^l There is, in fact, a significant 
difference in affinity between these shallow sites and deep sites, as is well illustrated 
by the influenza hamagglutinin lectin, which binds sialic acids with an approximately 
1000-fold lower affinity than a neuraminidase found in the same virus'^'''. 
Nevertheless, lectins exhibit both high affinity and exquisite specificity for 
oligosaccharide structures of glycoproteins and glycolipids on the cell surface. I f this 
was not the case, lectins could not act as recognition molecules in biological 
processes. It has therefore been suggested that multiple protein-carbohydrate 
interactions are involved in the recognition event, giving the required high affinity and 
specificity'^'^. Thus polyvalent associations occur throughout biology, showing a 
number of characteristics that monovalent interactions do not exhibit. 
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A well-studied polyvalent interaction involved in cell migration that may be 
important in metastasis is that between the galactosyl-transferase (GalTase) protein on 
one cell and the GlcNAc-terminated glycoproteins and glycolipids on another cell. 
Cells express different densities of both GlcNAc and GalTase, also depending on the 
time and the environment. The strength of cell-cell adhesion is related to the levels of 
GlcNAc and GalTase. It has been shown that a malignant cell expressing GalTase on 
its surface migrates along a concentration gradient of immobilised GlcNAc, whereas 
the same cell not expressing GalTase does not^ '^*^  (Figure 6). 
GlcNAc 
metastatic ce 
NHAc 
V 
Figure 6 Adhesion of a metastatic cell to laminin. GalTAse is expressed on the edges of 
migrating cells and mediates cell migration by binding to oligosaccharides terminated 
with A'-acetylglucosamine (GlcNAc). 
In most cases, biological systems seem to use polyvalent interactions rather 
than a very strong single one. Therefore, multivalency is employed in Nature not only 
to achieve the necessary high affinity, but also to ensure the correct functioning of the 
cells. 
It has been previously mentioned that old erythrocytes are removed from the 
blood through the association of the exposed galactose residues to the 
asialoglycoprotein receptors on hepatocytes. It is worth noting that only when the 
density of galactose moieties reaches a certain level the interaction is strong enough to 
lead to the erythrocyte clearance. Thus, in this case, polyvalency is used as part of a 
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timer that enables the body to judge the age of erythrocytes and select those that are 
old enough to be removed and destroyed. 
A l l classes of antibodies have multiple equivalent receptor sites. Muitivalency 
leads to high affinity binding to surfaces that show repeated epitopes, such as almost 
all invading pathogens. Mannose residues on the tail (the Fc portion) of the antibody 
interact with mannose receptors (the Fc receptors) on the surface of a macrophage 
(Figure 7a). 
antigen 
antibody 
bacteria 
Fr receptor 
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nucleus 
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^ u c l e u s ^ 
IgG-antlbody-coated 
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Fc domain oflgG 
Fc receptor 
macrophage 
g mannose 
residue 
(a) 
Figure 7 a), Polyvalent binding of a macrophage to a bacterium (or other pathogens) through 
antibodies, leading to a three-layered structure stabilised at both interfaces by polyvalent 
interactions; b), clearance of pathogens by antibody-mediated attachment to 
macrophages. The multivalent binding of the antibody-coated bacterium (or virus) to 
multiple Fc receptors of a macrophage activates the phagocytic process, leading to the 
degradation of the microorganism. 
The interaction of a single Fc portion with its receptor seems to be too weak to induce 
a response by the macrophage, whereas multiple antibodies bound to the surface of 
the bacterium can cross-link the Fc receptors, triggering an internal signal in the 
macrophage to ingest the infective agent'^ ^^ (Figure 7b). 
In the receptor-mediated endocytosis of low-density lipoproteins (LDL), the 
ligand binds to a LDL receptor on the membrane of the cells. The resulting complex 
can then bind to an adaptor molecule in the cytoplasm, which can induce the 
formation of the clathrin-coated pit by multivalent association of clathrin and other 
coat-associated proteins. In this case polyvalency leads to the required clustering of 
receptors in the clathrin-coated pit'**^ (Figure 8). 
Ilpand 
receptor extracellular 
M l i M i 
adaptor 
clathrin 
coated pit 
Figures Induction of a specific geometric shape and molecular distribution: clustering of 
receptors in a clathrin-coated pit. 
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In some polyvalent systems, the interaction induces significant conformational 
changes that can represent biological signals. IgM is a class of antibodies with five 
bivalent structures extending randomly from a central ring. On binding decavalently 
to the bacterial surface, portions of the ring become more exposed to binding and 
differently organised. These portions initiate the chain of reactions that constitute the 
complement cascade by interaction with the pentavalent protein CI in the blood. This 
cascade results in the death of the microorganism. Binding of IgM to monovalent 
ligands does not lead to any conformational change and, therefore, does not induce the 
complement cascade. In this process, polyvalency is required not for tight binding, but 
for signalling and activation through a conformational change'^ '^ (Figure 9). 
— planar form of IglVI 
antigen 
bacterial 
surface ^ ^ 
staple form of IgM 
/ 
Figure 9 Conformational change of a pentameric immunoglobulin IgM upon multivalent binding 
to antigens on the surface of the bacterium. The change activates the complement 
cascade. 
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The interaction between an allergen and a mast cell proceeds through cross-
linking of the receptors. The mast cells present multiple copies of bivalent IgE and 
can degranulate, i.e. release histamine that promotes local inflammation, in response 
to a wide range of allergens. Monovalent ligands for IgE do not trigger degranulation, 
whereas cross-linked suface-bound IgE bind to an intracellular protein, initiating a 
signal cascade that ends in degranulation^^^^ (Figure 10). 
pollen antigen pollen-specific IgE 
Fc receptor 
V 
!3 
mast cell 
O 
o 
Figure 10 Degranulation of mast cells after binding of a polyvalent allergen. 
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1.3.2 E N E R G E T I C S 
A ful l understanding of the mechanism of protein-carbohydrate association at 
a molecular level requires the elucidation of both structural and energetic aspects of 
the process. As briefly discussed in the previous sections, a large amount of structural 
data is now available. However, the link between structure and energetic properties 
remains too obscure to allow a description of the energetics of the interaction from 
structural information'^^^l Historically, the sfrength of protein-ligand complexation has 
been determined by hemagglutination and precipitation inhibition assays, although 
several specfroscopic techniques, affinity chromatography and equilibrium dialysis 
have been also utilised. The so obtained values of the binding constant, K, and of the 
free energy of binding, AG, give little information about the forces involved in the 
complex f ormation. M oreover, the e nthalpy a nd e ntropy o f a ssociation are d erived 
only indirectiy from van't Hoff analyses of the temperature dependence of the free 
energy: 
d\nK _ AH . 
dT ~ RT^ 
The employment of this equation requires the assumption that the enthalpy of binding. 
Mi, is not a fimction of the temperature, i.e. AC/. = 0, being = A C p . However, 
the heat-capacity change, AC?, for ligand binding in aqueous media is non-zero, 
making doubtful the accuracy of the calculated values. 
The accessibility of commercial high-resolution microcalorimeters has 
provided a direct method of evaluation of accurate thermodynamic data that can 
complement the stinctural information. Isothermal titration microcalorimetry, ITM, is 
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the only technique that allows direct determination of K and A/ / in a single 
experiment. Values of ACp are also obtained performing titrations at different 
temperatures. AC/, is a powerful indicator of solvent behaviour during binding^^^^ and 
provides invaluable information about the driving forces for association. Accurate 
values of AC^ are available only by microcalorimetry. 
1.3.2.1 M O N O V A L E N T LiGANDS 
Calorimetrically determined thermodynamic constants for lectin- carbohydrate 
interactions are listed in Table 1. In almost all cases the enthalpy of binding is more 
negative than the free energy. It is noteworthy that this pattern is generally found for 
association in aqueous solution and it is not a special feature of lectin-ligand 
complexation'^^''°l It has already been pointed out that water molecules are strongly 
involved in protein-sugar interactions, giving rise to bridges between the saccharide 
hydroxyl groups and the protein amino acid residues. Watson et alP^^ have reported 
that in the case of complexation of glucose with glycogen phosporylase water-
mediated hydrogen bonds are as strong as the direct ones, reinforcing the concept of 
structural water as an extension of the protein surface. However, the displacement of a 
large number of water molecules during binding can also be observed. The effect of 
this release of water has been long debated. Numerous models have been formulated 
in order to explain the thermodynamic properties of apolar organic molecules in 
water, particularly for the surprising cases where the most significant term opposing 
dissolution is enthalpic rather than entropic^^^l It has been proposed that although the 
strength of hydrogen bonds in the hydration shell of the protein is higher than in bulk 
solvent, the fraction of broken bonds is also higher, due to geometric constraints 
imposed on water by the solute. Thus, the return of water of solvation to bulk water 
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Table 1 Calorimetrically derived thermodynamic parameters of lectin-carbohydrate interaction 
Lectin Carbohydrate A C AH AS ACp Ref 
M"' kJ mol"' kJ mol"' J mol"' K"' J mor' K ' 
Gal 1.2 -17.5 -24.3 -23 
W B A l " 
GalNAc 
IVIeoGal 
7.2 
6.6 
-22.0 
-21.8 
-28.0 
-23.5 
-20 
-6 
[72] 
MeySGal 1.0 -17.1 -19.7 -9 
MeaMan -22.2 -27.6 -18.3 -251 
[69] Con A M a n « l , 6 ( M a n a l , 3 ) 
Man*. 
-30.1 -41.0 -36.5 -460 
Con A MeorMan 11.9 -22.9 -29.2 -22 
Man 2.1 -18.6 -23.9 -18 
MeoGlc 
Glc 
2.7 
0.6 
-19.2 
-15.4 
-18.1 
-17.1 
+4 
-6 [73] 
pea MearMan 
Man 
1.9 
0.9 
-18.3 
-16.5 
-27.3 
-24.8 
-31 
-29 
MeoGlc 0.6 -15.5 -13.1 -1-8 
MeaMan 8.2 -34.3 -40.7 
[74] Con A Manal,6(Manarl,3) 
Man 
49.0 -60.3 -92.7 
D G L ' MeaMan -20.5 -32.6 -40.7 -234 
ManQrl,3Man -26.4 -47.7 -71.6 -167 
ManGrl,6Man -21.0 -36.0 -50.5 -92 
Manal,6(Manal,3) -34.3 -54.4 -67.4 -402 
Con A 
Man 
MeaMan -22.2 -28.5 -21.0 -209 
[75] 
Manal,3Man -25.2 -31.0 -19.6 -460 
Manci'l,6Man -22.2 -28.9 -22.5 -184 
Manal,6(Manal,3) -31.0 -42.7 -39.3 -389 
Man 
SBA" Mey^Gal 
GalNAc 
0.5 
9 
-44.4 
-39.7 
-96.2 
-57.2 
-393 
MeyflGalNAc 
LacNAc 
22 
0.7 
-58.1 
-34.3 
-111.6 
-60.0 
-418 
ECorL " Mey3Gal 
GalNAc 
0.4 
1.2 
-18.4 
-29.7 
-11.2 
-40.4 [76] 
Me/?GalNAc 
LacNAc 
1.3 
4.2 
-28.5 
-45.6 
-34.9 
-82.3 +393 
Gal-l-^ LacNAc 6.2 -27.6 -19.5 -377 
C2S-Gal-l LacNAc 2.9 -11.7 -1-27.1 
Af-Gal-1 LacNAc 8.7 -2.5 +66.5 
Gal 1.6 -18.2 -13.7 +15.3 
MeoGal 1.4 -18.1 • -21.6 -12.0 
ECorL 
Mc/ffGal 
GalNAc 
Lactose 
0.7 
1.3 
1.9 
-16.3 
-17.9 
-18.8 
-18.2 
-23.0 
-41.2 
-6.6 
-17.1 
-75.4 [77] 
LacNAc 9.7 -22.7 -47.1 -83.2 
2'-FL « 3.7 -20.3 -18.0 +7.7 
MeaDNSGalN * 
Fucose 
351.5 
0.5 
-31.7 
-15.2 
-23.1 
-4.7 
+30.0 
+35.2 < 
Gal/?l,4Glc 6.4 -21.7 -20.9 0 
Gal;51,4Fruc 8.2 -22.4 -34.4 -40 
Gal-1 '• 
Gal;5l,4Man 
Galy91,4Ara 
Galy51,4GlcNAc 
Gal/?lSly5Gal 
11.3 
5.4 
22.2 
11.6 
-23.0 
-21.3 
-24.7 
-23.1 
-35.2 
-36.8 
-35.9 
-46.4 
-45 
-52 
-38 
-78 
[78] 
PNA -' Galy01,3GalNAc 20.6 -24.7 -59.0 -115.5 [79] 
" Basic lectin from winged bean. * 3,6-di-C»-(a-D-mannopyranosyl)-cir-D-mannopyranoside. " Lectin from 
Dioclea grandiflora. '' Soybean agglutinin. ^ Lectin from Erythrina corallodendron. ^ From Chinese hamster 
ovary cells. ^ 2'-Fucosyllactose.Methyl-g-A^-dansylgalactosaminide.'' From bovine spleen.-' Peanut agglutinin. 
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might be enthalpically driven, providing a favourable contribution to the enthalpy of 
compIexation^^°l Monte Carlo simulations, carried out to investigate the structure of 
water near the surface of the lectin binding site, have shown highly disordered water 
in the proximity o f the protein surface. The phenomenon has been explained assuming 
that the protein surface could not be complementary to any low-energy structure that 
the water could adopt'^'l Chervenak and co-workers'^ ^^ have reported a calorimetric 
evaluation of the thermodynamic binding parameters for several systems in light and 
heavy water. In all cases desolvation was found to contribute to a significant fraction 
of the binding enthalpy: ca. 25% for lectin-sugar association. To date, the role of 
protein-ligand hydrogen bonding versus solvent reorganisation as contributors to the 
enthalpy of binding remains the most polemic area of discussion. 
Another common feature of lectin-carbohydrate interactions is the strong 
linear enthalpy-entropy compensatory behaviour (Figure 11). 
•25 -20 -15 -10 
T A S (kcal/mol) 
Figure 11 Enthalpy-entropy compensation behaviour for the interaction of WBAII with 
Fuca(l,3)Galy3(l,4)GlcNAc-OMe and a series of deoxy and -OMe derivatives. The 
slope of the plot is 0.90 and the correlation coefficient 0.98'^^'. A slope value smaller 
than unity indicates that the binding is dominated by entropy. 
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This offset has been interpretated both in terms of changes in the degrees of freedom 
of the ligand upon binding'^^'^^' and in terms of solvent reorganisation'^'^'^^l 
Chervenak et alP^^ have determined the configurational and solvation entropies for 
the formation of a series of complexes with Con A and DGL (Table 2). 
Table 2 Entropic contributions to the binding of mannose oligosaccharides to Con A and DGL. 
System A O 
J mol ' K"' 
A5 
J mol ' K"' 3 mol' K ' J mol"' K"' 
Con A 
MeaMan -209 -20.5 +53.6 -40.6 
Manal,6Man-0Me -184 -3.8 +47.3 -17.6 
Manal,3Man -460 -20.1 +118.0 -104.6 
Manal ,6(ManQ;l ,3)Man -389 -51.9 +118.0 -136.4 
D G L 
MeaMan -234 -41.1 +60.2 -67.8 
Manal,6Man -92 -50.3 +23.4 -40.2 
Manal,3Man -167 -72.0 +42.7 -81.2 
Manal ,6(ManaI ,3)Man -402 -110.5 +102.9 -179.9 
The total entropy of the process can be separated into terms for changes in solvation 
and losses of configurational, rotational and translational degrees of freedom. 
^S = A5,„,, + A5,„„^^ + A5„, + A 5 , _ (2) 
The sum of the first two terms has been referred to as the unitary contribution, while 
the sum of rotational and translational entropies has been defined as the cratic 
contribution'^^l Knowing that: 
dT 
AC, (3) 
ASsoiv can be expressed as follows: 
A^ .™;v = A 5 , l + A C , l n (4) 
J 
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where T* is the temperature at which there is no solvent contribution and it is equal to 
385.15 K. AS'^ ,^  contains protonation and electrostatic contributions and for lectin-
ligand interaction can be considered equal to zero. Murphy et alP'^^ have proposed 
that for the formation of a 1:1 complex with 1 M as the standard state, the entropic 
cratic contribution, AS^ ,^ + zi5,^ „„ ,^ is equal to -33.5 J mof ' K"'. Thus, accurate 
measurements of AC? provide ASsoh and, consequently, ASconfig- For the systems 
reported in Table 2, both solvation and configurational entropies roughly scale with 
the size of the ligand, as a result of both the number of water molecules released and 
the number of degrees of fireedom restricted during binding. Moreover, unfavourable 
configurational entropies are responsible for the observed enthalpy-entropy 
compensation (shown in Table 1). The more favourable entropy of association of the 
l->3 dimannoside to Con A than to DGL has been attributed to a greatly reduced 
solvation contribution in the latter case. 
It is now clear that the heat-capacity change contains important information 
about the mechanism of protein-carbohydrate complexation. The factors affecting ACp 
have been discussed extensively and, at present, the term is usually thought to reflect 
solvent reorganisation effects and, to a lesser extent, changes in the protein vibrational 
modes'^ ^ l^ For lectin-sugar interactions, ACP values are usually small (< 400 J mof ' K" 
') and negative. The significantly larger heat-capacity changes accompanying 
antibody-saccharide associations compared to lectin-sugar complexations can be 
interpreted in terms of structural differences between the binding sites of the two 
classes of biological polymers'^^l The antibody combining site contains several 
aromatic amino acids and the burial of these hydrophobic residues represents the 
driving force for protein-antigen binding'^'l However, the entropy of binding is still 
negative, offsetting the enthalpic gain. Mutagenesis studies have revealed that part of 
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the entropic loss may be associated with the reduced mobility of amino acid side 
chains in the antibody combining site'^ ''^ . In this case, therefore, the enthalpy-entropy 
compensation is also a function of protein structure. Considering again the data 
reported in Tables 1 and 2^'^^\ considerably different mechanisms of association can 
be observed for the binding of the same ohgosaccharide to the two lectins. Small but 
significant differences in the primary sequences of the two proteins may affect the 
flexibility of the loops forming the two binding sites. Although the lectin binding sites 
are greatly preorganised, several amino acid side chains move considerably to achieve 
the optimal hydrogen b onds and Van der Waals contacts with the ligand. Thus, an 
enhanced flexibility would favour hydrogen bonding, but, at the same time, a more 
severe entropic loss would be observed. However, since the values of ACP are small, 
little changes in protein conformation are usually involved, as confirmed by X-ray 
crystallographic determinations. 
The larger -AH values obtained for the binding of 3,6-di-(9-(a-D-
mannopyranosyl)-<2r-D-mannopyranoside to Con A and DGL compared to methyl-a-
D-mannopyranoside indicate the presence of extended binding sites. The trimannoside 
is, in fact, the minimum carbohydrate epitope that completely fills the combining 
pocket, giving rise to the maximum number of hydrogen bonds and van der Waals 
interactions'^'I This oligosaccharide represents the core structure of all //-linked 
glycoproteins'^^l 
Despite the general feature of being enthalpically driven with an unfavourable 
entropic contribution, few lectin-carbohydrate systems show positive entropy 
changes. As reported in Table 1, most of the carbohydrates that bind to ECorL show 
negative AS, but positive entropic changes are observed for galactose, fucose, methyl-
-A^-dansylgalactosaminide and 2'-fucosyllactosef"l Favourable entropies are a-
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associated with non-polar contacts, for example between the aromatic dansyl moiety 
at C-2 of MeaDNSGaIN and Trp 135 in the binding site of the lectin. From X-ray 
crystal I ographic studies'^^\ the increase of entropy associated with the binding of 
galactose is explained by the release of tightly bound water molecules, not still fully 
compensated by opposing entropically disadvantaged factors. 
Differences in the thermodynamics of binding for homologous lectins, for 
which most of the amino acid residues in the binding sites are conserved, might 
indicate the indirect but critical role of non-conserved residues away from the 
combining pocket^^^l Effects of single-site mutations on the conformation of lectins 
have been investigated by Siebert and co-workers^^'*l The mutation of sites far 
removed from the carbohydrate binding site in Galectin-1 from CHO cells strongly 
affects its thermodynamics of complexation with LacNAc^^^l As shown in Table 1, 
the two mutants C2S-Gal-l and A'^-Gal-I, exhibit significantly lower -AH values than 
Gal-1, whereas the entropic contributions become favourable. 
Importantly, studies carried out with monodeoxy analogues of 3,6-di-0-(Q;-D-
mannopyranosyl)-a-D-mannopyranoside have shown that K and -AH for the 
analogues are lower than for ManQ;l,6(Manarl,3)Man'^'l The sum of the AAH and 
AAG values for the hydroxyl groups of the trimannoside, obtained from the 
monodeoxy analogues, do not correspond to the measured AH and AG for this ligand. 
This means that the magnitude of AAH and AAG represents not only the loss of the 
hydrogen bond involved, but also differences in the solvent and protein contributions 
to the binding of Manal,6(ManQ:l,3)Man and of the deoxy analogues. 
No correlation was found between the calorimetrically derived thermodynamic 
parameters of a series of ligands for the bovine spleen Galectin-1 and the number of 
protein-sugar close contacts'^^l Interestingly, binding enthalpies calculated from 
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changes in the solvent-accessible areas of the Galectin-1 binding site upon 
complexation showed poor agreement with the calorimetric values, again reflecting 
the importance o f factors other than the burial of hydrophobic surface area. 
Everything mentioned above shows the complex balance of forces before and 
after the binding event. It is therefore clear why both detailed structural and energetic 
information is essential in order to design ligand mimics. Attempts to overcome 
certain thermodynamic barriers through the planning of the glycoconjugate structure 
may not always result in the expected high-affinity association, due to the offset of 
different contributions^'^l 
1.3.2.2 M U L T I V A L E N T LIGANDS 
The "cluster glycoside effect", defined as "the enhancement in the activity of a 
multivalent ligand beyond what would be expected due to the increase in sugar local 
concentration (statistical effect) alone"''^^ is nowadays generally accepted. Despite the 
numerous observations of the phenomenon, a molecular interpretation of the effect is 
difficult and, at present, its physical origin is still not well understood. Efforts to 
provide a molecular basis for the cluster glycoside effect have been complicated by 
two issues: 1) polyvalent ligands are often polydisperse and structurally ill-defined 
and 2) methodologies used to evaluate protein-carbohydrate binding measure several 
phenomena, including protein-carbohydrate association. Moreover, there may exist a 
relationship between the measured magnitude of the cluster glycoside effect and the 
assay utilised for the determination'^^l In a first approximation, a trend of increased 
enhancement with increasing valency can be drawn. 
In principle, at least two models of association can be described: an 
intramolecular, or chelate, binding and an intermolecular aggregative process. In the 
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former a multivalent ligand spans a number of binding sites on a single protein, while 
in the latter the spanned binding sites belong to different receptor molecules, resulting 
in aggregates that may or may not precipitate. 
Considering, for simplicity, a bivalent ligand, the thermodynamic parameters 
describing a chelate complexation can be expressed as follows^''^: 
/ ^ . , = 2 A y _ + A / , . (5) 
where: AJbi = any thermodynamic parameter for bivalent complexation 
AJmono = corresponding term for monovalent association 
AJi = interaction term 
Interaction energies have been traditionally considered in enfropic terms, where 
translational and rotational savings and conformational penalties have to be taken into 
account. As the franslational and rotational entropies of a molecule are, respectively 
directly and indirectly, proportional to the logarithm of the molecular weight, the 
binding of two (or more) ligands produces a multivalent ligand with translational and 
rotational entropy roughly equivalent to that of the monovalent ligand. Therefore, the 
binding of a bivalent ligand is characterised by a favourable contribution to the 
entropic term equal to the translational and rotational entropy of the corresponding 
monovalent ligand. This term presumably accounts for a large part of the interaction 
free energy. On the contrary, the loss of conformational degrees of freedom of the 
ligand upon b inding results in an unfavourable contribution to the o verall entropy. 
Enthalpy also plays an important role in determining the overall affinity of a 
multivalent ligand. Alteration of the ligand position within the binding site would 
result i n an unfavourable contribution, while the contribution o f the linker may be 
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favourable due to its favourable interactions with the protein surface (at the periphery 
of the binding site or over the space separating the spanned binding sites) or 
unfavourable as a result of disadvantaged steric interaction. This latter aspect can 
result in a significant unfavourable contribution, due to the lock of linker dihedrals 
into gauche or eclipsed orientations, which can, in turn, preclude the complexation by 
an intramolecular mode. Considering what has just been said and combining it with 
the fact that distances between binding sites on the receptor molecule are generally of 
the order of tens of Angstroms (65 A in the canonical dimer of Concanavalin A), it 
appears clear that the achievement of chelate complexation is challenging. 
Most of the multivalent ligands reported so far reach the observed affinity 
enhancement by means of an aggregative process, where the formed cross-linked 
complexes may be stabilised by a range of forces, including protein-protein 
interactions. Alternatively, a diminished solubility of the aggregate and its 
precipitation would lead to an apparently enhanced affinity through a coupled 
equilibrium'""'I 
Few calorimetric studies of multivalent carbohydrate-protein interactions 
(indeed few for any multivalent ligand) have been reported so farf"'°""'^l Moreover, 
I T M has been limited to small or dendritic glycoconjugates possessing a maximum 
number of carbohydrate residues equal to six. Brewer et al^^^^ have recently reported 
the determination of the thermodynamics of binding of small multivalent ligands 
(with structural valency up to 4) to Con A and DGL. The structures o f those that 
showed an affinity enhancement relative to the corresponding monovalent ligands are 
reported in Figure 12. The thermodynamic parameters determined using Con A as 
receptor protein are reported in Table 3 (blue), together with those reported by Toone 
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et aiy^^^ (red) for the interaction o f the two series o f ligands (dendritic compounds 
containing up to six binding epitopes) shown in Figure 13 with the same lectin. 
Table 3 Thermodynamic binding parameters of Con A with multivalent iigands. 
Compound 10' x /T A G A / / T^s n 
M ' k J mol ' k J mol k J mol" 
Mai ia l , 6 (Mai ia l , 3 )Man y> -3 I S -61.5 -29.7 1,11 
1 2X(> -^6.8 -96.6 -59.8 0.53 
2 250 -36,4 -109.6 - -3 ,2 0.5> 
i 420 -37.6 -121.3 -83.7 0,51 
4 1:^ 50 -40.6 -221 8 -181.2 0,26 
M e « M a i i 0.76 ."••)•> -27.6 -.\4 ' 
5 0.')2 -22.6 -310 -84 1 
f) 0.80 -22 2 -31.4 -'),2 i 
7 0.79 -22.1 -32,6 -10,5 1 
8 0.75 .">'' •> - n 6 +4.6 
9 ND 
Id O.SO .11 1 -26,8 -4 
1 1 0.86 -22.(> -32,2 -9 6 
12 0.47 -20.') -29,- -8,8 
13 6.2 -27.6 -9.6 + 18,0 
14 
Blue: [Ligand] = molar concentration of the overall ligand molecule; Red; [Ligand] = valency-
corrected concentration. 
As previously discussed, the interaction o f Con A with monovalent carbohydrates was 
found to be enthalpically driven, with an unfavourable entropic contribution'^^'. 
Despite the different behaviour o f the thermodynamic parameters going from the 
mono- to the multivalent ligands in each series, the affinity enhancement observed for 
ligands 1-4 and 13-14 was in both cases explained by means o f an intermolecular 
aggregative mechanism. Assuming non-cooperativity o f the different epitopes in the 
multivalent carbohydrates, Toone et al. explained the thermodynamics o f lectin-ligand 
association (ligands 13-14) hypothesising an initial exothermic protein-carbohydrate 
interaction, which proceeds with thermodynamic parameters equivalent to those o f the 
corresponding monovalent saccharide, coupled with or followed by an endothermic, 
entropically driven, aggregation process. The diminution o f -AH was therefore 
considered the thermodynamic signature for the intermolecular aggregation 
process'^«-'°^J 
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Figure 12 Multivalent ligands used by Brewer et a/.''°^'. The corresponding thermodynamic binding 
parameters are reported in blue in Table 3. 
5, 10 
6,11 
7,12 
0-^ R 
glycylglyclne s p a c e r (5-9) 
t^- HO o 
H 
8,13 
9,14 
O ' R 
tetraethylene glycol s p a c e r (10-14) 
- O H 
R= "° 
> \ / - I . ^ N H 
0 
Figure 13 Dendritic ligands used by Toone et a/.'"* '^. The corresponding thermodynamic binding 
parameters are reported in red in Table 3. 
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Studies previously carried out by the Toone and co-workers employing another series 
of dendritic multivalent ligands'""\ where crystals of both bi- and trivalent ligands 
were grown in the presence of succinylated Con A, showed that the carbohydrate 
orientation within the binding site was identical to that of the corresponding 
monovalent ligand. Interestingly, ligands with valencies greater than three showed 
affinity enhancements in agglutination assay but not by ITM. On the other hand, tetra-
and hexavalent carbohydrates showed substantially diminished enthalpy (in absolute 
value) and visible cloudiness. Therefore, the IC50 values were found to correlate with 
the calorimetrically derived entropies, but not with the free energies of ligand binding. 
The authors deduced that the agglutination assay did not evaluate the strength of 
protein-carbohydrate interaction, but rather the ability of multivalent ligands to drive 
aggregation processes. Based on these results, the overall thermodynamic parameters 
could be expressed as the sum of two contributions, the actual protein-sugar 
interaction - characterised by thermodjTiamic values equal to those determined for the 
corresponding monovalent ligand - and the aggregation process. Enthalpies of 
aggregation were thus determined. 
Despite the common explanation for the observed enhancement of the binding 
affinity through an intermolecular aggregative mechanism, the results reported by 
Brewer et al. are rather different from those of Toone and co-workers. In the former 
case, an increase of -AH was observed going from the monovalent to the multivalent 
ligand (1-4). With the exception o f c ompound 3 (which was found to behave as a 
divalent ligand despite its structural valency being equal to three'"'^'"'^'), AH scaled 
proportionally to the number of epitopes in the multivalent ligand, whereas AS did 
not. The entropy variation was instead more negative than the sum of AS of individual 
epitopes. According to the authors, this behaviour of AS indicated the binding of the 
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multivalent ligands to separate receptor molecules (aggregation). Moreover, the non 
linearity of Scatchard and Hi l l plots was explained by a negative cooperativity for the 
binding of multivalent ligands''"'*^, which was experimentally demonstrated by 
measuring the microscopic thermodynamic parameters of each carbohydrate residue 
in the ligand by means of reverse isothermal titration microcalorimetry'"'^'^ In this 
case solutions of the mono-, bi- and trivalent ligands were placed into the cell and 
Con A used as the titrant. For instance, the binding constant, A^i, of the first epitope of 
the bivalent ligand was found to be one order of magnitude greater than those of the 
second epitope and of the corresponding monovalent carbohydrate. The average of the 
two microscopic binding constants determined agreed with the macroscopic binding 
constant determined using the sugars as injectants. The enthalpic contribution of the 
two epitopes was essentially the same and very close to that for the monovalent 
ligand. Therefore, the enhancement in. affinity observed was associated with a 
favourable entropy of binding of the first epitope relatively to the second one. 
However, while the sum of the two enthalpic contribution was very close to the 
enthalpy determined by "normal" microcalorimetry, the sum of the two microscopic 
entropies was much lower, in absolute value, than the one reported when the ligand 
was injected into the lectin solution. Hemagglutination inhibition measurements 
perfectly correlated with the results obtained by ITM. The authors provided some 
hypotheses of explanation for the differences between their results and those reported 
by Toone and co-workers. For instance, they underlined the difference in the way 
adopted to express the concentration of the ligands. While Toone et al. considered the 
epitope equivalents. Brewer et al. referred to the molar concentration of the ligand 
molecule. Their arguments against the use of valency-corrected concentrations were 
^ For general aspects of isothermal titration microcalorimetry, see Chapter 4, Section 4.1.1. 
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the observed negative cooperativity of binding and the determined difference between 
the structural and functional valency'"''*^ 
Most examples of intramolecular/chelate binding involve either bacterial 
toxins or poljTneric ligands. Studies have shown that the enhancement in binding 
affinity is much higher when different carbohydrate residues of the ligand bind to sites 
on the same receptor molecule. 
In 1983, Lee et a/.'"'^ ^ reported that a synthetic tetraantennary 
undecasaccharide showed an inhibition constant for the hepatic Gal/GalNAc receptor 
10^ times greater than an equivalent monoantennary trisaccharide, despite the only 4-
fold statistical increase in absolute galactose concentration. It was therefore pointed 
out that the number of Gal residues per cluster and their branching mode were major 
determinants of the binding affinity of a ligand to the mammalian hepatic lectin. 
An extraordinary affinity enhancement achieved through multivalency was 
reported by Rao et a/.''^ ^^ in 1998. The binding constant of a trivalent derivative of 
vancomycin, RtVs, to a trivalent derivative of D-Ala-D-Ala ( D A D A ) , R'tL'3, was ca. 
1 0 ' ^ M"' compared to the value of ca. 10^ M"' of the corresponding monovalent 
analogues (Figure 14a). Calorimetric studies showed that both enthalpic and entropic 
terms were approximately three times those determined for the interaction of RtV3 and 
the monovalent ligand R' tL' (Table 4). In a subsequent study'""', the same authors 
reported that the efficiency of a dimeric analogue of vancomycin, V-R<i-V, in 
inhibiting the growth of vancomycin resistant enterococci was 100 times greater than 
that of monomeric vancomycin, V. Moreover, the binding constant of V-Rd-V to Lac-
R'd-Lac, whose structures are reported i n Figure 1 4b, was approximately 40 times 
tighter than that of V to Ac2KDADLac (analogous monovalent system). The 
corresponding thermodynamic binding parameters are reported in Table 4. 
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(a) (b) 
Figure 14 a), Structures of the trivalent derivatives of vancomycin, R.Vj and R'tL'3; b), structures 
of the dimeric vancomycin, V-Rd-V and dimeric lactate ligand, Lac-R'a-Lac. 
Table 4 Thermodynamic parameters of binding of vancomycin derivatives to mono- and 
multivalent ligands. 
Receptor 'Ligand W^xK AC AH TAS 
M' kJ mol"' kJ mol ' kJ mol ' 
R.V3 R ' . L ' 3 2.5 X 10'° -94.1 -166.9 -72.8 
RtVj R ' ,L' 9.1 X 10"' -33.9 -51.9 -18.0 
RV3 L 3.7 X 10-' -31.8 -50.2 -18.4 
Vancomycin R \ L ' 3 - 2.9 -36.8 -73.2 -36.4 
Vancomycin L 6.3 X 10 ' -33.0 -50.1 -17.1 
V-Rd-V Lac-R'd-Lac 2.3 X IQ-^ -25.1 -27.2 -2.1 
Vancomycin A c 2 K D A D L a c 5.9 X 10 " -15.9 -15.5 +0.4 
Most of the currently synthesised polymeric and dendritic multivalent ligands 
show a "random" multivalency, which rarely allows an affinity enhancement higher 
than 1,000-fold. Moreover, as already pointed out, the reasons underlying this activity 
gain are poorly understood^^^l In a different approach, structural information about 
the spatial arrangement of the target binding sites are taken into account for the design 
of ligands ideal for maximising the interaction with the receptor. 
The modular synthesis of multivalent ligands of the heat-labile enterotoxin 
(LT) from E. coli was recently reported by Fan and co-workers'""l The five B 
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subunits of the toxin present a 5-fold symmetric configuration. In this study, 
pentavalent hgands constituted by a semirigid "core" which can adopt a conformation 
close to 5-fold symmetry, flexible "linkers" that project toward the receptor binding 
sites and "fingers" represented by 1-^^-amidated D-galactose, were synthesised. 
Different lengths of the linker were tested and the receptor-ligand interaction analysed 
by an enzyme-linked immunosorbent assay, ELISA. A l l pentavalent ligands led to 
significant affinity gains compared to the corresponding monovalent ones. The best 
one showed an IC50 10^-fold higher than galactose, approaching the affinity of the 
oligosaccharide portion of the natural ganglioside G M l . The pentavalent ligand also 
showed a lO'^-fold gain compared to the corresponding monovalent ligand, or 2,000-
fold on a valency-corrected basis. Dynamic Hght scattering ruled out the possibility of 
an aggregative process, supporting the expected formation of a 1:1 toxin-ligand 
complex. The analysis of the effect of linker-length on the affinity showed that the 
greatest enhancement was detected for the ligand whose linker effective length'"'^ 
best matched the distance between nonadjacent binding sites. 
One of the most striking examples of affinity enhancement was recently 
reported by Kitov et a/. '"^l Shiga-Hke toxins SLT-I and SLT-II were inhibited by a 
decavalent ligand, designated STARFISH, whose structure was complementary to 
that of the receptor. The SLTs are AB toxins constituted by an enzymatic (A) 
component and a cell-binding (B) part. The A-subunit is situated on one face of the B-
component, which is a pentamer of identical subunits. In the absence of the A-
subunits, the B-subunits still form pentamers that are functionally equivalent to the 
overall toxin in their attachment to host cell. The in vivo cytotoxicity of SLTs has 
been correlated with their binding affinity toward the glycolipid 
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globotriaosylceramide (Gbs). The crystal structure of SLT-I B-pentamer complexed 
with a Gbs analogue revealed three Gba-binding sites per B-subunit'"''^ (Figure 15). 
Site1 
Figure 15 View along the 5-fold axis of the SLT-I B-pentamer bound to the Pk-MCO 
trisaccharides. The surface toward the viewer is the sugar binding surface. 
As determined by means of an ELISA protocol, STARFISH exhibited more than 10 -
fold increase in inhibition over the Pk trisaccharide. STARFISH was designed to 
achieve high affinity through the simultaneous binding of all five peripheral bridged 
Pk dimers to the ten sites 1 and 2 of the B-pentamer (with each trisaccharide dimer 
bridging sites 1 and 2 of the monomer). Crystallographic studies of the formed 
complex revealed a different mode of binding (Figure 16). One STARFISH molecule, 
in fact, bound two B-subunit monomers from separate toxin molecules, with the 
saccharide residues occupying only the ten sites 2. Each trisaccharide interaction was 
identical to that seen for the corresponding univalent ligand. A higher affinity of 
binding of site 2 compared to 1 had been already highlighted by previous studies 
carried out on toxin mutants. Therefore, the observed mixture of aggregative and 
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chelate mechanisms through which STARFISH exerted its activity could be explained 
by the stronger interactions o f the carbohydrate within site 2, possibly coupled with 
unfavourable entropic and enthalpic contributions o f the bridging. 
Figure 16 Diagrams of STARFISH ligand bound to the SLT. 
A calorimetric study o f the interaction o f bivalent glycopeptides with SLT-I 
was carried out by Toone and co-workers''''^^ The two ligands used diflFered in the 
nature o f the peptidic linker. Both ligands showed affinity gain, but the mechanism 
through which this was achieved depended on the nature o f the linker domain: while 
the compound characterised by a hydrophobic Unker seemed to work through a 
chelate mechanism, the hydrophilic one bound by means o f an intermolecular 
aggregative process. Again the binding enthalpy o f the latter appeared to be 
significantly lower (in absolute value) than that o f the monovalent compound, a trend 
that this group akeady recognised as the signature for an intermolecular binding. The 
affinity enhancement reached through the intramolecular mechanism was slightly 
higher than that o f the hydrophilic compound. Peptidic spacers were chosen in the 
search for possible favourable additional interactions o f the ligand with the protein 
surface. These interactions were given as an explanation for the higher affinity o f the 
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ligand with the hydrophobic linker and for its intramolecular mechanism. For the 
hydrophilic linker, either there were no favourable contacts or there were in fact 
repulsive interactions of the linker with hydrophobic regions on the protein surface. 
Therefore, the affinity was lower and t he binding proceeded via a n i ntermolecular 
mechanism. 
The greatest increases in activity on a valency-corrected basis are reported 
with polymeric ligands^^^l Nevertheless, the only polymeric ligands synthesised so far 
which seem to bind through an intramolecular mechanism are those prepared by 
Kanai et a/.'^ "'*^  (Figure 17); Several ligands with different backbone lengths were 
synthesised and tested as inhibitors for Con A-carbohydrate interaction. The 
maximum inhibitory activity seemed to coincide with an average length sufficient to 
span two lectin binding sites belonging to the same protein molecule, supporting the 
hypothesis of a chelate mechanism of binding. 
a orb 
OH 
OH 
1 2 3 
Figure 17 Scheme for the synthesis of neoglyopolymers by ROMP: (a), MeOH/HaO/DCM (6:1:5) 
then add H2O, room temperature; (b), H2O/DCM (2:1), DTAB, room temperature; (c), 
TSNHNH2, H2O, 100 °C, 56% {n = 10), 91% (« = 25), 58% (« = 52), 100% {n = 143). 
The enhancement in affinity determined for polymers too short to bridge two binding 
sites was attributed to a high local concentration of sugar moieties (statistical effect), 
which would perturb the rate of dissociation of the formed complex. The authors 
concluded that the observed dependence of the inhibition activity on the polymer 
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length was largely due to a combination of statistical and chelation effects. Moreover, 
despite the differences in backbone flexibility, the most potent ligands of each series, 
2 and 3, had approximately the same efficacy. This latter observation points out an 
interesting aspect of multivalent ligand-protein binding. It is believed that rigid linkers 
would favour the interaction, due to a reduction of the entropic penalties 
accompanying the b i n d i n g ^ H o w e v e r , the great enhancements achieved with 
flexible linkers and the negligible gain in activity observed with dendritic ligands 
characterised by rigid arms, have recenfly led Toone and co-workers to suggest that 
entropic concerns might be less severe than was previously thought and probably less 
severe than those related to unfavourable enthalpic contributions^'^l 
1.4 C A R B O H Y D R A T E - B A S E D T H E R A P E U T I C S 
A myriad of physiological processes depend on the formation of receptor-
ligand complexes at the cell surface. As already underlined, multivalent interactions 
are usually required. The ability to inhibit and/or activate, or exploit such interactions 
can bring enormous developments in medicinal chemistry. Consequently, 
extraordinary efforts are made in order to discover natural and non-natural products 
able to interfere with the cell surface binding events. In this respect, synthetic 
polyvalent ligands seem to represent the best option. Natural compounds are, in fact, 
often too scarce, too complex to identify the relevant molecular mechanisms of 
interaction and structurally heterogeneous^'^'l When considering glycoconjugates, for 
example, unlike natural substances, synthetic materials, called 
neoglycoconjugates'^"^\ possess the advantage of containing carbohydrate residues of 
known structure and assured purity. Between neoglycoconjugates, several 
glycopolymers represent p robably the most promising materials, due to their lower 
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immunogenic and toxic effects compared, for example, to glycoproteins and to the 
possibility of bearing more sugar moieties and drug molecules than a protein of 
identical molecular mass^"^ .^ In general, many features of multivalent synthetic 
ligands, such as the number and the orientation of the binding epitopes, the flexibility, 
size and shape of the scaffold from which the binding sites protrude, can be varied 
systematically, providing a powerful tool for the investigation of the single aspects of 
receptor-ligand complexation^"^'"^^ and for the design of very effective compounds. 
Moreover, synthetic materials can either mimic natural products or alter the cellular 
function by mechanisms inaccessible to natural substances. Synthetic polyvalent 
ligands can be used to investigate the binding events, as diagnostic tools, to inhibit or 
activate receptor-ligand interactions and as drug carriers to deliver the pharmaceutical 
to a selected organ/tissue. Numerous kinds of specific receptor-ligand interactions are 
involved in the complex functioning of the mammalian body. Therefore, ligands 
containing different recognition moieties can be prepared. 
The recognition of the vital role of lectin-carbohydrate interactions has 
provided the basis for the development of lectin- and carbohydrate-based 
therapeutics^'^^l Lectins are nowadays employed as recognition determinants for the 
preparation of colloidal vehicles for, for example, the mucosal delivery of drugs and 
vaccines^'^'l A l l the mucosal surfaces have the disadvantage that fluid secretion 
dilutes and may flush away applied delivery vectors. The presence of lectins improves 
the absorption of the delivery system: the lectin acts as a bioadhesive, interacting with 
specific carbohydrates expressed on the cell surface. The residence time of drugs and 
vaccines is so prolonged, reducing the dosage and the frequency of administration. 
Moreover, cell surface carbohydrate expression is cell type specific, allowing the 
targeting of the active agent to selected areas of the mucosal tract. One of the major 
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drawbacks for lectin-mediated mucosal delivery is represented by the possible cross-
reactivity, where different areas presenting the same carbohydrate structure may 
compete with the selected cells for the lectin-binding. Furthermore, many lectins are 
toxic and/or immunogenic and the effects of repeated dosage are largely unknown. 
However, these latter problems could be overcome by using tmncated forms of the 
proteins. 
Carbohydrates are particularly suitable as recognition moieties. As already 
said, the combination of different monosaccharides can give potentially limitless 
oligosaccharide structures. This aspect, combined with their small size (i.e. a lower 
risk of immunogenity compared to large molecules) and their usually easy 
accessibility, makes them perfect candidates as targeting determinants. 
Neoglycoproteins have been shown to be potent drug carriers: muramyl dipeptide 
(MDP), an immunoactivator, bound to Man-BSA is able to activate macrophages to a 
tumoricidal state, reversing the development of lung metastases in mice^'^^l However, 
concerns regarding immunogenicity and pl shifts of the carrier protein have moved 
the attention toward aglycons mainly derived by polymerisation procedures''^^l The 
possibility o f obtaining biodegradable, non-toxic and non-immunogenic materials of 
known composition and with the required stmctural characteristics reproducibly and 
in high yields sets glycopolymers at the centre of the research for carbohydrate-based 
therapeutics. 
Importantly, carbohydrates can be used not only as targeting moieties of drug 
delivery systems or inhibitors/activators, but also as scaffolds and dmgs themselves. 
Sialic acid amino-acid (SAAs) oligomers have been synthesised to mimic natural 
polysaccharides, such as dextran sulphate and heparin, and tested as inhibitors of HIV 
replication. In this case, the use of synthetic ligands allows the overcoming of 
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problems of poor absorption, instability and anticoagulant activity associated with the 
natural products''^"^l A macromolecular prodrug of cisplatin (CDDP, one of the most 
potent antitumour platinum complexes), has been recently synthesised by 
immobilising CDDP onto dextran (Dex) through a six-membered chelate-type 
coordination bond. The targetability of the product to hepatocytes was provided by 
introducing tetraantennary galactose units (Figure 18). 
GaMA 
DCM-Dex/Gal4A/CDDP conjugate 
H 3 N ' ^ N H , 
OH 
Gal4A 
OH C " ^ ' ^ C H i 
OH 
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OH OH 
O (OH 
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Figure 18 Structure of DCM-Dex/Gal4A/CDDP conjugate. 
The binding constant of this conjugate, DCM-Dex/Gal4A/CDDP, to Ricinus 
communis agglutinin (RCA) was higher than that of dextran carrying monomeric 
galactose residues. Moreover, DCM-Dex/Gal4A/CDDP showed cell-specific 
cytotoxic activity against HepG2/iuman hepatoma ceWs in vitro. This activity was 
inhibited by the addition of galactose and GaWA '^^ ^ .^ 
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As for lectins'^'*'''^"', sugars can also be considered pharamaceutical agents in 
their own right. The rigidity, of the pyranose ring allows the attachment of 
pharmacophoric groups with well-defined spatial o r i e n t a t i o n ' T h e same structural 
features can be exploited to introduce conformational constraints in pre-existing 
molecules^'^^l Recent studies have shown that introduction of SAA in somatostatin (a 
14-residue cyclic peptide hormone formed in the hypothalamus) leads to a 
pharmaceutical with strong antiproliferative activity against multi-drug resistant 
hepatoma carcinoma''^^l This is of special interest, since resistance to chemotherapy 
has become a serious problem in cancer therapy. 
1.4.1 S Y N T H E T I C M U L T I V A L E N T LIGANDS AS INHIBITORS 
AND E F F E C T O R S 
Synthetic multivalent ligands can be used to explore/interfere with either 
cellular interactions in which the ligand prevents the binding (inhibitor) or in which it 
induces a response (effector). 
Inhibitors can be employed to block viral and bacterial binding to the host cell 
and to inhibit the binding of leukocytes to endothelial cells. Some of the first 
applications of polyvalent inhibitors were focused on preventing the binding of 
influenza virus hemagglutinin to host cells''^^^ and this area of research is still 
a c t i v e ' T h e virus binds the host cell through the interaction of its trimeric 
hemagglutinin with sialic acid residues on the cell surface (Figure 19a). 
47 
v i r u s 
(a) 
S A HA3 
pA(SA) 
^ ^ ^ # ^ + 1 ^ : : virus 
2 H.-l Ka = 4x10" M 
Ka<4x10^ M '' 
(per SA group) 
virus 
Figure 19 
(b) 
a), The attachment of the influenza virus to a target cell occurs through multiple 
simultaneous interactions between hemagglutin (HA) and sialic acid (SA). The 
attachment can be' blocked by a polyvalent inhibitor; b), association constants of 
monomeric SA and HA, SA from polyvalent polyacrylamide and HA, and SA from 
polyvalent polyacrylamide and HA on the surface of the virus. 
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High concentrations of monovalent sialic acid derivatives are required in order to 
inhibit the binding {ca. 10"^  M)''^'l A variety of ligands bearing multiple residues of 
sialic acid has been synthesised, ranging from liposomes to glycopolymers. One of the 
most effective inhibitors, consisting of a linear polyacrylamide bearing sialic acid 
residues on the side chains, shows an association constant 10^-10^ times higher than 
the corresponding monomer''^^^ (Figure 19b). However, the concentration of polymer 
required to inhibit the cell-vims interaction is approximately 10''-10^ times lower than 
that of the monovalent ligand. The authors have suggested that approximately 10^  of 
the total enhancement is due to an increased affinity of the poljmier for the surface of 
the virus, whereas ca. 10^ is due to steric stabilisation. The multivalent ligand forms a 
loose, water-swollen, gellike layer surrounding the viral surface, which sterically 
prevents the close approach of the interacting species''"I 
Helicobacter pylori are the bacteria that cause gastric ulcers. They attach to 
gut cells by binding to extracellular sialylated glycoproteins. This adhesion has been 
effectively inhibited by albumin glycosylated with 3'-sialyllactosyl residues''^'*'. 
Again, studies have shown the critical importance of the ligand stmcture. Two 
examples of modular synthesis have been already described in Section 1.3.2.2'"'''"^l 
The stmctures of the ligands are reported in Figure 20. In both cases, the extremely 
high inhibitory activity determined is due to the matching of the 3D-structure of the 
ligand with the respective toxin. 
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Figure 20 a), Structure of a decavalent ligand (STARFISH) that acts as a potent inhibitor of SLT-
l ' " ^ ' ; b), structure of a pentavalent ligand that is an extremely effective inhibitor of LT-
Polyvalent ligands can also be used to manipulate signal transduction 
pathways. For instance, dimerisation of cell surface receptors induced by ligand 
binding can initiate a particular cellular response'''^^l Divalent ligands have been used 
to investigate the role of receptor clustering in signal t ransduc t ion ' 'The most 
common partially or fully synthetic multivalent activators are those that can cause an 
immune response. Examples are vaccines, which display multiple copies of an antigen 
bound to a synthetic scaffold or to a protein carrier. Great research is at present 
devoted to the formulation of carbohydrate-based anticancer vaccines''^^''^^^. In recent 
years, many tumour-associated carbohydrate antigens have been identified and some 
of them, including the Tn [GalNAca(l->0)Ser/Thr] and T 
[Gaip(l-»3)GalNAcc!!(l->(9)Ser/Thr] antigens, are highly expressed on carcinoma-
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associated mucins, resulting from truncation of carbohydrate chains during malignant 
transformation''^^l St Hilaire and co-workers'*''*'^  have recently reported the synthesis 
of several glycopeptides containing the T-antigen potentially suitable as cancer 
vaccines. Glycopeptides with variations in both peptide amino acid sequence and 
distance b etween the T-antigen and t he peptide s caffold w ere p repared in order to 
investigate the in vivo effects of these parameters. Glunz et a/.'''*'^  have recently 
reported the preparation of a hexasaccharide-keyhole limpet haemocyanin (KLH) 
protein conjugate. The hexasaccharide moiety, termed globo H, was originally 
isolated fi^om a glycoceramide associated with breast cancer. The synthetic globo H-
K L H conjugate was successfully used to induce high amounts of anti-globo H 
antibodies and caused cell lysis at levels approaching those of monoclonal antibodies 
raised against cancerous cells. 
A polyvalent ligand may present simultaneously effectory and inhibitory 
properties. I f the effector promotes receptor down-regulation, the same product may 
inhibit the receptor activity by means of the same mechanism''''^l Labeled 
glycopolymers have been recently synthesised by ring-opening metathesis 
polymerisation (ROMP) by Gordon and co-workers''''^l The materials were found to 
bind specifically L-selectin, a surface protein that mediates lymphocytes homing and 
leukocytes recmitment to inflammatory sites. The ligands act to down-regulate the 
amount of L-selectin at the cell surface'''''*^ and at the same time to block L-selectin-
mediated leukocyte rolling'''*^'. 
1.4.2 T A R G E T E D D R U G D E L I V E R Y 
.Targeted dmg delivery arises from the field of cancer therapy, where 
chemotherapy involves the utilisation of cytotoxic drugs to k i l l cells. The majority of 
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pharmaceuticals currently in use have not been designed to exert their activity only at 
a certain disease site, resulting in an even distribution of the therapeutic agent 
throughout the body. The problem is that the activity of anticancer drugs against 
tumour and non-tumour cells is roughly the same, leading to serious damage of 
healthy tissues and, in some cases, to the death of the patient. The drug has, in fact, to 
cross many biological barriers before reaching the desired site of action, so affecting 
other organs. At the same time its concentration at the pathological area is 
significantly diminished. As a result, the dosage and the frequency of administration 
are largely augmented, increasing not only the life-threatening side effects, but also 
the complexity of the administration protocol and the expenses of the treatment. Drug 
targeting, that is the capability of delivering the therapeutic agent selectively and 
quantitatively to the organ affected by the pathology, represents a solution to all these 
problems. Ideally, targeted drug delivery should ensure a high drug concentration at 
the disease site, keeping that at non-target organs and tissues below acceptable 
minimal levels. 
The concept of drug targeting was firstly suggested by Ehrlich roughly a 
century ago'"^l In this approach, drug targeting is achieved by means of a 
hypothetical "magic bullet" consisting of two components: one able to recognise and 
bind the target, the other providing the therapeutic action. Since the expression o f 
some plasma membrane receptors and antigens is, to a first approximation, 
characteristic o f certain cells or related to certain diseases, cell-specific targeting can 
be achieved using antibodies or receptor-specific ligands'''*^^ The first real attempt to 
target leukaemic cells via an antibody-linked methotrexate (MTX, one of the currently 
used anticancer drugs) dates back to 1958'''*''l Since then enourmous progress has 
been made. The concept of drug targeting has been extended and, nowadays, the 
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"magic bullet" is generally thought as the combination of three elements: the drug, the 
targeting moiety and a macromolecular carrier used to increase the residence time of 
the therapeutic agent in the body and to multiply the number of drug molecules per 
targeting unit'''*^l 
1.4.2.1 T Y P E S O F D R U G T A R G E T I N G 
Most o f the drug delivery systems prepared so far lack the targeting moiety. In 
these cases the actual targeting is achieved by the exploitation of differences between 
healthy and tumour tissues'''*^l Thus, especially for the treatment of solid tumours, a 
certain distribution control can be attained by taking advantage of the enhanced 
vascular permeability of tumour tissues'""'. The leaky vasculature of neoplastic 
regions can, i n fact, allow the extravasation of even relatively large particles, with 
diameters ranging from 10 to 500 nm. As a result, high molecular weight substances 
carrying the therapeutic agent preferentially accumulate at these sites. This is a type of 
passive targeting, known as "Enhanced Permeability and Retention Effect, EPR"''^'" 
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It is also known that inflamed and neoplastic areas usually show some acidosis 
and hyperthermia. This makes possible the use of stimuli-responsive drug carriers that 
can disintegrate at lower pH values or at higher temperatures, releasing the drug only 
at the affected sites''"''^^l pH-sensitive liposomes, such as 3yS-(A -^(A ,^A -^
dimethylaminoethane)carbamoyl)cholesterol:dioleoylphosphatidylethanolamine (DC-
Chol:DOPE), have been shown to give good transgene expression in both epithelial 
cells in v/^ra''"' and directly injected human tumours in mice''^^l Several 
temperature-responsive block copolymer micelles have been prepared using poly(A''-
isopropylacrylamide), PNIPAAm. Above the lower critical solution temperature 
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(LOST), PNIPAAm becomes insoluble with subsequent destabilisation of the micelles 
and burst-like release of the entrapped dmg'"'''^"'. 
Despite the good results obtained with these drug targeting methodologies, 
often the affected area does not differ much from normal tissues in terms of vascular 
permeability, temperature and acidity and the targeting strategies described above 
may become ineffective. The most efficient way to impart specificity toward the 
target organ to a drug-macromolecule conjugate is to bind it to another molecule able 
to recognise specifically and bind the target site. A wide range of substances can be 
used as targeting moieties: antibodies and their fragments, lectins, lipoproteins, 
hormones, saccharides, peptides and folate'''*^l 
Monoclonal antibodies are the most employed targeting molecules. 
Nevertheless, besides the problems of immunogenicity associated with their use, other 
aspects are limiting their suitability as recognition determinants. First of all, problems 
of steric hindrance can complicate the attachment of the antibody to the water-
exposed termini of the hydrophilic block of block copolymer micelles used as dmg 
carriers''^'^ or the coupling of the antibody with the pharmaceutical agent can result 
in the loss of its specificity''^^l Moreover, even when these problems are not 
encountered, antibody-carrying species may still be captured by circulating antigens 
before reaching the target''^ ^^ and, most important, most of the "tumour-associated" 
antigens are only quantitatively different in tumour and normal tissues, leading to 
serious problems of cross-reactivity' 
The reasons that m ake carbohydrates good c andidates a s targeting m oieties 
have been already discussed throughout the previous sections. 
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1.4.2.2 R E C E P T O R - M E D I A T E D E N D O C Y T O S I S , R M E 
The ligands present on the surface o f the carrier molecules can mediate 
cellular uptake by interacting with specific receptors expressed on the surface o f the 
target cells. This initial interaction may induce the intemalisation o f the drug-carrier 
conjugate by a process called receptor-mediated endocytosis, RME''^'*'^^1 The 
concept o f RME was formulated in 1974 by Ashwell and Morell^'**', and Goldstein 
and Brown^'^^' to explain the hepatic uptake o f asialoglycoproteins (ASGPs) and low-
density lipoproteins (LDLs), respectively. A simplified schematisation o f RME is 
reported in Figure 21. 
Plasma 
membrane 
Receptor 
Recycling of 
receptors 
Ligand 
Early endosomes 
Dissociation 
and sorting 
Matured 
endosomes 
Lysosome 
Degradation 
Figure 21 Receptor-mediated endocytosis, RME. 
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The process is initiated by the interaction of a cell surface receptor with its specific 
ligand present, for example, on the surface of the drug carrier. The receptor (-ligand 
complex) moves to and clusters within special regions of the plasma membrane 
termed coated pits. These invaginations of the plasma membrane, approximately 100 
nm in diameter, have a cytoplasmic coat composed of clathrin (see Figure 8). Coated 
pits are then excised from the membrane to form coated vesicles. These rapidly lose 
their clathrin shells and fiise with endosomes. In turn, endosomes fiise with one 
another to form mature endosomes having diameters ranging from 200 to 600 nm. 
The slightly acidic pH of the endosomes (pH 6.3-6.8) induces dissociation of the 
receptor-ligand complex. Whilst the receptor is recycled and reinserted into the 
plasma membrane, the ligand-carrier conjugate is generally directed to the more 
acidic lysosomal compartment (pH 4.5-5.0), rich in enzymes, where the carrier is 
degraded and the drug released. Low-molecular weight pharmaceuticals can then 
cross the lysosome membrane and exert their action. 
Clathrin-mediated uptake is believed to be the principal mode of cellular 
endocytic intemalisation^'^'^l Moreover, the presence of lectins in endosomes and in 
the nucleus''^'^ suggests that lectin-carbohydrate interactions could be exploited not 
only for cellular but also for sub-cellular targeting. However, it should be noted that 
most of the receptors are not entirely specific, since they are expressed at different 
levels on different tissues. Nevertheless, receptor-mediated endocytosis of 
carbohydrate-carrying drug delivery systems in the liver r epresents one o f the few 
examples in which quite selective drug targeting has been achieved in v/vo^'^^l 
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1.4.2.3 M A C R O M O L E C U L A R C A R R I E R 
Numerous types of drug carriers have been employed, including proteins and 
glycoproteins, soluble polymers, micro- and nanoparticles made of insoluble or 
biodegradable natural and synthetic polymers, microcapsules, cells, liposomes and 
micelles''^^''^'''*'''^*"''^l Each o f these carrier tj^ Des shows its own advantages and 
disadvantages and the choice of a certain structure has to be made only after a 
thorough consideration of all the aspects of the case to which it has to be applied. 
Since 1972, when Gregoriadis proposed the use o f liposomes as carriers o f 
enzymes in the treatment of lysosomal storage disease, the application of liposomes 
has been extended to a variety of drugs''^'''^"1 Liposomes can be used to entrap 
hydrophobic drugs, such as most of the anticancer therapeutic agents currently in use, 
increasing their bioavailability, their residence time in the body and protecting them 
from blood components whose action could result in their degradation and 
inactivation^'^'l However, following infravenous administration, liposomes tend to be 
rapidly removed from the circulation by the phagocytic cells of the reticuloendothelial 
system (RES)''*^l Phagocytosis by elements of the RES in the liver is mediated by 
adsorption of opsonins on the particle surface. Hydrophilically stabilised 
nanoparticles can avoid phagocytosis and achieve prolonged circulation times' 
(Figure 22). Thus, m odification of liposome surfaces with p oly(ethylene glycol) is 
often employed''^''l Glycosylation of liposomes can be attained through coating with 
glycoproteins or by incorporation of synthetic glycolipids''^^l However, the 
introduction of glycoproteins is rather difficult and problems of reproducibility and 
immunogenicity are often encountered. On the other hand, low-molecular weight 
glycolipids can be easily removed from the liposome via interaction with lipoproteins. 
Furthermore, the relatively large size of liposomes make them unusable when certain 
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areas have to be reached: for hepatocytes the dimension o f the drug carrier should not 
exceed 150 nm in diameter' 
PEG coating 
Macrophage 
Figure 22 Modification o f the liposome surface by PEG prevents its capture by the RES (orange 
spheres represent opsonins). 
The use o f partially or fully synthetic glycoproteins and glycopolymers allows 
the overcoming o f some o f these problems, especially those related to size restrictions 
and, obviously, those concerning the targeting moiety. Glycoproteins have been 
successfiilly used as drug carriers'^^l Complexes o f albumin with oligosaccharides 
have been employed in experimental chemotherapy as vectors o f anticancer agents. 
However, their clinical use is limited by an immune response that they might 
cause"^«J. 
One class o f drug delivery vehicles that has and is receiving great attention is 
represented by micelles formed by self-assembly o f amphiphilic block 
copolymers''^^"'^''^. It has been shown that amphiphilic AB-type block copolymers 
with the length o f the hydrophilic block exceeding to some extent that o f the 
58 
hydrophobic one can form spherical micelles in aqueous media '^^ l^ The aggregates 
are composed of an inner hydrophobic core stabilised by a corona of hydrophilic 
polymer chains (Figure 23). 
Figure 23 Structure of a micellar drug carrier. The pattern of drug association with the micelle 
depends on the drug hydrophobicity (black colour of the drug molecule shows 
hydrophobic area, white shows the hydrophilic one). Completely water-soluble 
hydrophilic drug can only be adsorbed within the micelle corona (case I ) ; completely 
insoluble hydrophobic molecules can only be incorporated into the micelle core (case 5); 
drug molecules with intermediate hydrophobic/hydrophilic ratio wi l l have intermediate 
positions within the carrier particle (cases 2-4). 
This core-shell architecture is ideally suitable for targeted drug delivery. First of all, a 
significant amount o f a variety of drugs, including genes and proteins, can be loaded 
into the aggregate and delivered to the target site. For hydrophobic drugs, the 
entrapment into micelles' core increases their bioavailability, reduces their toxicity 
and other associated side effects, protects them from the surrounding biological milieu 
and may enhance their permeability across physiological barriers''^^l 
The distribution of the drug-loaded micelles in the body is mainly determined 
by their size and their surface properties. Both these parameters can be controlled, for 
instance varying the length o f the hydrophobic''^"^ and hydrophilic''^'^ blocks and 
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differently functionalising the hydrophilic segment. The hydrophobic core is generally 
constituted by biodegradable polymers, such as poly(lactic acid) (PLA)'''^^, 
poly(lactic-co-glycolic acid) (PLGA)'"^^ or poly(8-caprolactone)'"'*l The hydrophilic 
shell is usually composed of nonbiodegradable biocompatible polymers. 
Poly(ethylene glycol) (PEG) of molecular weight firom 1 to 15 kDa remains the most 
widespread choice, due to its high solubility, high hydration and efficiency to act as 
steric protector in biological media^'^'l The presence of PEG, in fact, increases the 
aggregates longevity, suppressing their non-specific uptake by the RES (see Figure 
22). 
Altematively, the starting copolymers can be prepared from two hydrophilic 
blocks, one of which is then modified by covalent attachment of or non-covalent 
interaction with a hydrophobic pharmaceutical (cisplatin, adriamycin, doxombicin, 
hydrophobic diagnostic units, charged dmgs, DNA, etc.), yielding an amphiphilic 
micelle-forming polymer'^'l Kataoka and co-workers have used this procedure to 
conjugate several anticancer dmgs (cisplatin''^'\ adriamycin''^^''^^^ and 
doxombicin''™''"^) to the poly(aspartic acid) (PAA) block of PEG-PAA micelles. The 
stmcture of doxombicin-conjugated PEG-PAA block copolymer is reported in Figure 
24. It is noteworthy that fiirther loading of the dmg can be attained by physical 
entrapment of the therapeutic agent into the inner core. The physical incorporation of 
doxombicin results in an increase of the micelles' stability and in a very high in vivo 
antitumour activity. PEG-PAA(DOX) micelles, with both chemically bound and 
physically entrapped doxombicin, were shown to achieve prolonged circulation time 
in the blood and to accumulate significantiy at the solid tumour by exploitation of the 
EPR effect. The complete tumour regression observed was attributed mainly to a 
sustained release of physically entrapped doxombicin. 
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Poly(ethylene glycol) Drug-conjugated poly(a,p-aspartic acid) 
(hydrophilic segment) (hydrophobic segment) 
, . ^ ^ W W ^ ^ 
CHa^CHaCHahr NH<COCHNHJHCOCH2CHN»%H 
CHsCOf? COfl 
Drug 
(Doxorubicin) 
[ PEG-PAA(DOX) ] 
0 OH 
R = OH or 
COCHaOH 
CHaO O OH 
Figure 24 Structure of doxorubicin-conjugated poly(ethylene glycol)-poly(a,/?-aspartic acid) block 
copolymer. 
A simpler system has been developed by the same authors, where the micelle-
forming copolymer is poly(ethylene glycol)-poly(y3-benzyl-l-aspartate) (PEG-PBLA). 
Doxorubicin was successfully incorporated within the core, due the structure 
matching of the drug and the hydrophobic core (tt-ti interactions). Micelle-entrapped 
doxorubicin was shown to have considerably higher antitumour activity than the free 
dmgf'^^l 
Al l the micelles described above lack a recognition moiety. Their targeting to 
the pathological area is achieved only through the spontaneous accumulation in 
regions presenting a leaky vasculature. 
Amphiphilic block copolymers of vinyl ethers having pendant A^-acetyl-D-
glucosamine residues were synthesised by Yamada and co-workers''^'l The 
interaction of the polymer with wheat germ agglutinin (WGA) was investigated and 
the association constants evaluated by measuring the changes in fluorescence of WGA 
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upon binding. It was demonstrated that the GlcNAc-carrying polymer shows a. 
significant increase in binding affinity toward the lectin compared to GlcNAc and its 
oligomers. 
Kataoka et alP'^'^^ have recently reported the synthesis of poly(ethylene 
glycol)-poly(d,l-lactide) block copolymers containing galactose residues at the PEG 
chain end. The copoljoners were obtained by successive anionic ring-opening 
polymerisation of ethylene oxide and d,l-lactide using a metalated protected sugar as 
initiator (Scheme 1). 
Potassium Naphthalene 
R ^ O K* H , C — C H ; 
° • 
0 
• .0 
CHsO-^CHsCHsOj-CHsCHjO- K* 
'9 CH2O—fcHsCHsOHc OH—0)—H 
(ii) 
HO CH2O—f-CH2CH20)-(C CH 0)—H 
0 CH3 
80% TFA 
0 CH3 
Scheme 1 Synthetic route of gaiactose-PEG-PLA block copolymers by anionic ring-opening 
polymerisation. 
The presence of galactose residues at the surface was confirmed by passing the 
micelles loaded with pyrene through a column packed with RCA lectin immobilised 
beads. The galactose-containing micelles were retained in the column, indicating a 
strong lectin-carbohydrate interaction. 
The possibility of physically entrapping hydrophobic drugs into the inner core 
represents a great advantage of micellar drug delivery systems. In fact, the covalent 
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binding of pharmaceuticals can result in the loss of their activity once they are 
released fi:om the carrier. Moreover, the macromolecule-dmg bond needs to be 
accessible so that it can be cleaved. Therefore, linkers are usually required. The best 
option is represented by linkers which can be cleaved only intracellulary by specific 
enzymes''^''l Spacers of this type contain a variety of amino acids. Several peptide 
linkers have been coupled to the carboxyl groups of methotrexate (MTX). The rate of 
release of the dmg has been shown to depend on the length of the spacer''^^l 
Polymeric micelles are generally more stable than surfactant ones, showing a 
significantly lower critical micelle concentration (CMC) and a slower rate of 
dissociation'^*"l Therefore, polymeric micellar aggregates may retain their stmcture 
upon dilution after injection, allowing retention of the loaded dmg and, eventually, its 
accumulation at the target site. In principle, a micellar dmg delivery system should be 
stable enough to reach the pathological area and once there allow the release of the 
active agent. The stability of micelles can be increased by cross-linking of either the 
core or the corona'^^^'^^^l Kataoka et alP'^^^ have recentiy reported the preparation of 
reversibly cross-linkable micelles constituted of poly(ethylene glycol)-poly(l-lysine) 
(PEG-PEL) by introduction of thiol groups on a small fraction of the lysine repeating 
units. The soluble copolymer is made amphiphilic by addition of DNA. Oxidation of 
the thiol groups results in the formation of disulfide bonds and cross-linking of the 
core. Disulfide bonds can be easily broken by an appropriate reducing agent. The 
most abundant reducing agent in cells is glutathione (GSH). The intracellular GSH 
concentration is 300-fold higher than that in the blood. The authors demonstrated that 
the micelles, called polyion complex micelles (PICs), are stable at low concentrations 
of GSH, whereas they dissociate increasing the concentration of the reducing agent at 
the millimolar level, as present in cells (Figure 25). These experiments clearly 
63 
demonstrated the potential of block copolymer micelles as carriers for DNA in gene 
therapy. 
PEG-PLL-thiol 
Spontaneous _ _ _ _ _ 
l^fX. association throug- ^^^£^£^9^ Oxidation of thiols to H^^HSH^^B^**^ Dissociation after the 
^ electrostatic i n t e r a c t i o n s > | ^ W M a ^ _isulfide bonds to give ^ W^f^Bfj? cleavage of disulfide 
Antisense ^gggggfr cross-linking of the core ^l^jBflJj^ bonds by glutathione 
Oligonucleotide 
Figure 25 Schematic representation of the formation of reversibly cross-linked micelles from thiol-
modified PEG-PLL block copolymers. 
Cross-linking of the corona could lead not only to highly stable micelles, but 
subsequent removal o f a degradable inner core could allow the preparation of 
nanosized hollow particles'^°'''^°^^. Such nanocontainers might be of particular interest 
for drug delivery, due to their higher loading capacity compared to the original 
micelles and due to the fact that they might provide an interior suitable for the 
transport of hydrophilic molecules. Although shell cross-linked block copolymer 
micelles and their corresponding nanocages have been developed only recently, initial 
studies have suggested that they posses great potential for the preparation of advanced 
drug delivery systems'^ '^ '^'^ " '^. 
1.5 CONCLUDING REMARKS 
Recent progress in glycobiology has revealed that cell surface 
oligosaccharides play an essential role in recognition events. The ubiquity of lectin-
carbohydrate interactions throughout biological processes opens enormous potential 
for their exploitation in medicine. Lectin-carbohydrate associations are usually weak 
{K of the order of mM for monosaccharides) when compared to others in Nature. 
However, when more saccharides of the right type are clustered together with the 
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right geometry, the interaction becomes strong and highly specific. This increase is 
more than what would be expected on the basis of the increased sugar local 
concentration. The reasons of this phenomenon, termed "cluster glycoside effecf, 
have not been rigorously determined yet, but its implications are extraordinary. 
Lectins are good candidates as model systems for elucidating protein-
carbohydrate interactions. On the other hand, neoglycoconjugates seem to represent 
the most suitable counterpart. Unlike natural products, they contain sugar residues of 
known stmcture, they are homogeneous and they can be prepared reproducibly and in 
large quantities. 
It has been repeatedly pointed out that a thorough understanding of the lectin-
carbohydrate interaction is absolutely required i f this is wanted to be exploited for 
biomedical applications'^^'^^''*^l A deep knowledge of both stmctural and energetic 
aspects of the process is thus necessary. Indeed, the failure of a number of 
carbohydrate-based dmgs may be attributed to a poor understanding of their supposed 
mechanism of action rather than to any inherent deficiency of carbohydrate 
therapeutics'^^l It has, in fact, been shown that when good understanding was 
achieved, the results have been impressive'"°'"^l 
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G L Y C O S Y L A T E D POLYMETHACRYLATES: 
SYNTHESIS AND CHARACTERISATION 
2 . 1 INTRODUCTION 
Polymers consisting of a chemically and biologically stable C-C backbone and 
a hydrophilic saccharide moiety in the side chain are called "glycopolymers"''l Due 
to their application in basic biochemical and biomedical research, glycopolymers have 
attracted increasing attention since they were first developed by Horejsi et al. in 
1978^ 1^ 
The sjmthesis of carbohydrate-based polymers usually requires the preparation 
of polymerisable sugar derivatives^^"'^ \ although the less frequently employed 
glycosylation of polymers is also possible^'^''^l Given that the synthesis of 
glycosylated monomers often requires multi-step reactions, it is somewhat surprising 
that post-polymerisation glycosylation of already defined polymers has not been more 
widely applied. Whitesides and co-workers^ '^ -' have compared pre- and post-
polymerisation glycosylation techniques in the preparation of polyacrylamides 
carrying sialic acid residues (Scheme 1). They demonstrated that post-polymerisation 
glycosylation resulted in glycopolymers that were more effective inhibitors (ca. 100-
fold) of the hemagglutination of erythrocytes by influenza virus. The authors 
hypothesised that the observed differences in inhibitory activity might be related to 
differences in the distribution of sialic acid groups along the polymer backbone. They 
suggested that polymers obtained by copolymerisation of acrylamide and the 
acrylamide derivative bearing the carbohydrate moiety might not have a random 
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distribution of the glycosyl residues, due to differences in the polymerisation rates of 
the two monomers. The uneven distribution of sialic acid groups limits the surface of 
the virus that can interact with the polymer, decreasing the binding constant. In 
contrast, post-poljonerisation glycosylation is more likely to give a random 
distribution of sugar moieties, since the latter parameter is in this case controlled by 
differences in the reactivity of the side chains of poly(A'-acryloyloxysuccinimide). 
These differences are probably small because neutral polyacrylates in good solvents 
tend to behave as random coils. The introduction of biotin into the polymers allowed 
ELISA assays, which demonstrated that the inhibition of agglutination correlated well 
with the affinity of the poljoners for the lectin. 
OH COOH O 
I OH II 
•^^l^-^ HO- JL _ J II , polymerise 
A c H N - _ 7 ^ . 7 ^ 2 y ^ O ( C H 2 ) 4 0 ( C H 2 ) 3 N H ^ \ ^ *' (j-T ° 
OH 
HO. 
OH _ C O O H 
0 
AcHN~-_7i!-r-2r7^(CH2)3S(CHj)2NH2 
polymerise 
^ ol3 
(iii) NH40H 
HN' "NH 
O NH, 
OHNvN^. ^ S A 
Blotin 
\^^(CH2h^ /NH(CH2)20(CH2)20(CH2)2NH2 
s 
c 
Scheme 1 Pre- (top) and post-polymerisation (bottom) glycosylation techniques. 
Perhaps the reason why post-poljonerisation glycosylation procedures have 
not been more widely employed has to be sought for in the lack of methods for high 
yielding well-defined glycosylation of macromolecules '^^ l Glycosylation of 
preformed polymers is usually incomplete, due to steric hindrance. Thus, the 
glycopolymers obtained present an ill-defined structure, with some functional groups 
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still unreacted. To carry out reactions as completely as possible, less reactive pendant 
functional groups have to be appropriately activated before the glycosylation step'^°l 
In general, glycopoljmiers synthesised by glycosylation of preformed polymers are 
more suitable for practical purposes where a strictly well-defined structure is not 
required. 
Different types of glycopolymers have been synthesised, mainly 
polyacrylamides, polystyrenes, polyacrylates and polymethacrylates. N-{2-
hydroxypropyl)methacrylamide, HMPA, copolymers containing fiicosylamine and 5-
aminosalicylic acid (5-ASA, a drug for the treatment of ulcerative colitis) have been 
prepared by Kopecek and co-workers^ '^'^ ^l The materials have been shown to be 
suitable as colon-specific drug delivery systems. Whilst the fucosylamine allows the 
targeting by interaction with specific colonic mucosal lectins, the drug, bound through 
aromatic azo bonds, can be released by the degradative action of microbial 
azoreductases present only in the colon. Kobayashi et alP'^^ have synthesised a variety 
of carbohydrate-containing polystyrene derivatives, which have been used as cell-
specific biomedical materials. In particular, lactose-carrying polystyrene (PVLA) has 
been shown to be a useful substratum for the culture of hepatocytes. The adhesion of 
hepatocytes is attained by the specific inolecular recognition between the hepatic 
asialoglycoprotein receptors and the highly concentrated galactose residues on the 
polymer chains. Polystyrene derivatives bearing sialyllactose moieties have been 
prepared by Kobayashi and co-workers'^ '^'^  from a mixture of («-2,3) and (a-2,6) 
linked sialyllactose isomers isolated from bovine milk. The reducing ends of the 
oligosaccharides were converted to amino groups and then coupled with p-
vinylbenzoyl chloride. The obtained styrene derivatives were polymerised by free 
radical polymerisation and the interaction of the resulting glycopolymers with 
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influenza virus was investigated. The glycopolymers inhibited the hemagglutination 
of influenza A virus 1000-fold stronger than the corresponding oligosaccharides 
themselves. Moreover, various viruses could be trapped by the glycopolymers 
adsorbed on a polystyrene surface. The inhibitory and trapping affinities correlated 
with the sialyl linkage specificities of the virus strains. Ohno et alP'^^ reported the 
synthesis of PVLA obtained by means of a different route. 
H 2 C = C H 
Figure 1 
C NH CHj 
Ac-VLA (R = acetyl) 
H3C OH 
C , B H : 
H 3 C — c — o — n : 
fBu 
(Bu 
C = 0 
C18H37 
DODA-PE-DBN 
H2C CH 
C NH CH, 
DODA-PAcVLA (R = acetyl); DODA-PVLA (R = H) 
Structures of Ac-VLA, DODA-PE-DBN, DODA-PAcVLA and DODA-PVLA. 
The protected glycosylated monomer was polymerised by nitroxide-mediated free 
radical polymerisation with a lipophilic alkoxyamine "initiator" (Figure 1). The 
deprotected polymer DODA-PVLA was then used to prepare sugar-carrying 
liposomes, the galactose residues of which were specifically and effectively 
recognised by the galactose-specific lectin RCA. Polyacrylamides containing glucose 
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and galactose units were synthesised from poly(acryloyl chloride) using glucosamine 
and galactosamine, respectively^^^l The attachment of different kinds of cells to tissue 
culture polystyrene plates coated with the glycopolymers was then investigated. 
Glycopolymers bearing triaantennary T^-acetyllactosamine were prepared by radical 
copolymerisation of the glycomonomer and acrylamide. Enzymatic sialylation of the 
copolymer resulted in glycopolymers bearing different sialooligosaccharides 
depending on the enzyme used'^ ^^  (Figure 2). 
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C O O H OH 
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™ O H / 
I (, NHAc 
OH ^ O H 
0 HO 
O H ^ O H 
NHAc 
Figure 2 Structures of polymers carrying sialooligosaccharides. ( i) , Q'-2,3-sialyltransferase 
porcine liver; ( i i) , Qr-2,6-sialyltransferase from rat liver. 
from 
Poly(7V^-/7-vinylbenzyl-D-glucoronamide) (PV6Gna) was synthesised by fi-ee radical 
polymerisation of the corresponding monomer^ ^ l^ Surprisingly, hepatocytes were 
shown to adhere to polystyrene dishes coated with the glycopolymer. It was 
hypothesised that the mechanism of the interaction between PV6Gna and the cells is 
different fi-om that previously mentioned for PVLA and probably mediated by a 
84 
different C-type lectin. Ring-opening metathesis polymerisation (ROMP) was used by 
Kiessling et alP'^^ for the preparation of several glycopolymers, including that 
reported in Scheme 2. The attachment of the fluorescein derivative allowed the 
visualisation of the polymer binding to cells displaying L-selectins. The results 
suggested that the polymer binds specifically to cell surface L-selectins through 
multivalent interactions. 
RuL^= 
O 
^ ^ ^ ^ j . / ^ C H 2 0 ( C H 2 ) 2 0 . ^ ^ 
0 Ph, 
0 ( C H 2 ) 2 T M S 
(ii) 
0 ( C H 2 ) 2 0 ' ^ ' 
0 ( C H 2 ) 2 T M S 
•O3SO 
O H ^ O S O j -
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N H , 
? V ° ^ ° = ' H N ' 
OH 
0 ( C H 2 ) 2 T M S 
(iv, V) 
Scheme 2 
s 
X 
' ' ' % , = = ^ ^ - - ' \ ^ ^ , J ^ / . ^ H N ( H 2 C ) 5 H N N 
OH 0 S 0 3 - H N ' ^ ° 
OaSO-^SZ^^^Sii/O^/' 
OH 
Synthesis of glycopolymers by ROMP, (i), dichloroethane, DCE, 30 min; (ii) , excess of 
end-capping agent; ( i i i ) , diisopropylcarbodiimide, DIG; (iv), 50 mM NaOH, 60 °C, 2 h; 
(v), 5-((5-aminopentyl)-thioureidyl) fluorescein, EDCl, A'-hydroxysulfosuccinimide, 
H 2 O , 24 h. 
Baek and Roy^ ^^ ^ reported the synthesis o f a series o f T-antigen c ontaining 
glycopolymers. The materials were prepared from poly[7\^-(acryloxy)succinimide] by 
amidation with an amine-ending T-antigen derivative and various amines of 
increasing alkyl chain length. The glycopolymers were used as coating antigens for 
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solid-phase ELISA. It was shown that the most lipophilic polymer exhibited the 
strongest antigen-antibody interaction. 
Tailor-made glycopolymers were prepared by Nagahori and Nishimura^^'l A 
poljTTierisable glycomonomer, containing a trimannoside residue, was incubated with 
concanavalin A (template lectin as guest molecule) in a buffer solution and 
copolymerised with acrylamide and a cross-linker. The obtained cross-linked polymer 
showed higher affinity for the lectin compared to the corresponding linear 
glycopolymer, indicating that specific cavities for the guest proteins were constructed 
in the glycoligand by the adopted template-based polymerisation strategy. 
Due to the polyfunctionality of sugars, multistep reactions including 
protecting-group chemistry are typically required for their manipulation. Indeed, 
selective reactions of non-protected sugars to form polymerisable monomers have 
usually been achieved by enzymatic catalysis^ ^^ '^ l^ The removal of protecting groups 
can be c arried 0 ut e ither before or after the polymerisation. When considering the 
point at which to deprotect, the lability of the monomer and, to a lesser extent, the 
pol3mier, together with the possibility of a non-quantitative deprotection of the 
polymer, all have to be taken in account. Usually deprotection of the polymers is not 
quantitative; therefore the removal of protecting groups is, i f possible, preferably 
carried out at the monomer stage'^ l Nevertheless, to our knowledge, only few 
examples of deprotection at the monomer stage have been reported so far''''^l Despite 
the importance of this strategy, no systematic comparison h as b een made between 
deprotection pre- or post-polymerisation. 
In this study methacrylate derivatives of glucose and galactose were 
synthesised by glycosylation of 2-hydroxyethyl methacrylate (HEMA) following the 
procedure reported in Schemes 3 and 4'''''l 
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I ^ O A c 
AcO 1 
Br 
O 
HEMA 
(i) 
r 
-OAc 
OAc 1 
1a (72%), 1b (80%) 
acyl transfer side 
products 
(ii) 
la , 1b- 3a (80%), 3b (75%) 
4a (95%) 
4b (93%) 
A: (iv) 
5a-A,B 
(82%, 63%) 
5b-A,B 
(86%, 65%) 
la , 4a R^=OAc R2 = H 
3a, 5a = OH R^  = H 
l b , 4b R^ = H R2 = 0AC 
3b, 5b R^ = H R^ = OH 
Scheme 3 Synthesis of monomers and polymers carrying glucose and galactose residues. Reagents 
and conditions: (i), HEMA (3 eq.), AgOTf (1.2 eq.), dry DCM, under N2, -40 °C, 48 h; 
(i i) , NaOCHj [cat.], dry C H 3 O H , RT, under N2; (i i i ) , AIBN, C H C I 3 , 65 °C, 48 h; (iv), 
K2S2O8, HzOiCHjOH (4:1), 65 °C, 48 h; (v), NaOCHj [cat] , CHjOHiCHClj (1:1), RT, 
under N2. 
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Synthesis of monomer and polymer carrying lactose residues. Reagents and conditions: 
(i), AcjO/NaOAc, reflux; (ii) , HBr/CHjCOOH (30%), dry DCM; (i i i ) , HEMA (3 eq ), 
AgOTf (1.2 eq.), dry DCM, under N j , -40 "C, 48 h; (iv), NaOCHj [cat.], dry CHiOH, 
RT, under N2; (v), A I B N , CHCI3 , 65 °C, 48 h; (vi), KjSjOg, HjOiCHjOH (4:1), 65 °C 
48 h; (vii) , NaOCHj [cat.], CHjOHiCHCb (1:1), RT, under N2. 
The protected monomers were first deacetylated with s odium m ethoxide i n 
methanol and then polymerised in a mixture 4:1 of water and methanol at 65 "C using 
potassium persulfate as initiator (route A).Altematively, the protected monomers 
were polymerised with 2,2'-azoisobutyronitrile (AIBN) in chloroform at 65 °C and the 
resulting polymers w ere subsequently d eprotected with s odium methoxide in a 1:1 
mixture of chloroform and methanol (route B). 
Methacrylate and acrylate derivatives containing glucose and galactose have 
been synthesised previously. Kitazawa et alP^^ reported the glycosylation of HEMA 
and HEA using several methyl glycosides as glycosyl donors, including methyl 
glucoside and methyl galactoside, in the presence of phosphomolybdic acid as catalyst 
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and 2,4-dinitrochlorobenzene as a polymerisation inhibitor. However, the 
stereoselectivity of this method is low and a ratio of a,/? anomers is obtained. Nakaya 
et alP^^ synthesised 2-(2',3',4',6'-tetra-C>-acetyl-;5-D-glucopyranosyloxy)ethyl 
methacrylate by reacting HEMA with 2,3,4,6-tetra-0-acetyl-«-D-
glucopyranosylbromide by the method of Helferich^"', in the presence of silver oxide 
or mercury(II) cyanide, with yields of 54% and 58% respectively. After free radical 
polymerisation, the polymer obtained was deacetylated with sodium methoxide and 
the title polymer identified by infrared spectroscopy data alone. 2-(2',3',4',6'-tefra-(9-
acetyl-y9-D-glucopyranosyloxy)ethyl acrylate (AcGEA) was synthesised by Liang e< 
al?'^'^^^ according to the method of Helferich'"^, by glycosylation of HEA with 
2,3,4,6-tefra-0-acetyl-Q:-D-glucop3T:anosylbromide using m ercury(II) bromide as the 
catalyst. After polymerisation by conventional free radical and atom fransfer radical 
polymerisation, the pol3Tner was deprotected with sodium methoxide. The self-
association tendency of PGEA in water was studied; a dependence of the critical 
aggregation concentration on the molecular weight of the polymer and on the 
temperature was observed. In order to understand the influence of hydrophobicity on 
the critical aggregation concentration, AcGEA was copolymerised with stearyl 
acrylate in different ratios. /?-D-galactopyranosyloxyethyl methacrylate has so far 
been synthesised in a stereo-confrolled manner exclusively by enzymatic 
catalysisf^^'^l 
In light of these disparate routes, some with low yields or stereoselectivities 
and/or involving toxic mercury salts, we derived parallel routes to protected la,b, 8 
and deprotected 3a,b, 9. Not only was /^-stereoselectivity in the glycosylation 
reactions ensured by neighbouring group participation of acetyl groups at 0-2 in the 
glycosyl donors, but also the yields of these monomer syntheses were considerably 
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improved compared to previous syntheses. It is worthwhile to note that stereoselective 
sjmthetic procedures represent an essential requirement for the preparation of 
glycoconjugates with potential applications in medicinal chemistry. Only one anomer 
is, in fact, often preferentially recognised by the specific biological receptor. Thus, for 
example, the asialoglycoprotein receptor on the surface of hepatocytes binds 
efficiently only to /^-galactosyl residues. Furthermore, also when the receptor lacks 
high anomeric selectivity, its affinity toward the two stereoisomers may still be 
different. Therefore, if, for example, the binding of a glycopoljoner to a certain 
specific protein is under investigation, different sugar units' compositions would lead 
to significantly different results (see Chapter 4). All monomeric and polymeric 
products have been characterised fully by infrared and NMR spectroscopy, optical 
activity measurements, elemental analysis and, for the monomers, mass spectrometry, 
leading to a more thorough characterisation than those reported so far^ -'^ '^ '^^ *^ "' -
critical for a proper comparison of the influence of sugar type in biological 
applications. Absolute molecular weights were obtained for all polymers by size 
exclusion chromatography (SEC) using the previously estimated refractive index 
increments, dn/dc. Good characterisation, high purity, and a fully known composition 
are important requirements for the precise use and application of glycopolymers and 
for a true understanding of any results obtained. Therefore, in this study a detailed 
characterisation of the monomers and polymers was carried out and for the first time 
we investigated how the polymer composition depends on the method of preparation 
used. 
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2 . 2 R E S U L T S A N D D I S C U S S I O N 
2.2.1 G L Y C O M O N O M E R S 
The protected monomers AcGlcEMA (la), AcGalEMA (lb) and AcLacEMA 
(8) were synthesised by coupling the glycosyl donors, 2,3,4,6-tetra-O-acetyl-a-D-
glucopyranosyl bromide, 2,3,4,6-tetra-0-acetyl-a:-D-galactopyranosyl bromide and 
2',3',4',6'-tetra-0-acetyl-/?-D-galactopyranosyl (l'^4)-2,3,6-tri-C>-acetyl-Q:-D-
glucopyranosyl bromide (7), respectively, with the glycosyl acceptor 2-hydroxyethyl 
methacrylate (HEMA), in dry dichloromethane, using silver trifluoromethanesulfonate 
as a catalyst. For the disaccharide, lactose needed to be converted to the more reactive 
peracetylated bromide, carrying a good leaving group at the anomeric centre, before 
the coupling reaction. The synthetic procedures are reported in Schemes 3 and 4, for 
la,b and 8, respectively, ^^-stereoselectivity in the glycosylation reactions was ensured 
by neighbouring group participation of acetyl groups at 0-2 in the glycosyl donors. 
Acetyl fransfer to the nucleophilic alcohol (HEMA) led to the formation of AcEMA 
(2) as the major side product. Such side reactions have been reported previously''^ "'"" 
'^ ^^  and may be attributed to rearrangements of ortho ester intermediates''*l According 
to several proposals''*'*''*^ ' in the literature, the glycosylation reaction proceeds by 
activation o f the glycosyl donor by silver triflouromethanesulfonate, leading to the 
irreversible f ormation of a g lycosyl oxocarbenium ion'''^' t hat, d ue t o neighbouring 
group participation, is in equilibrium with the corresponding carbocationic 
species''^ ''* l^ Nucleophilic attack of HEMA on the latter species can then result in the 
formation of the desired products la, lb and 8 with AcEMA and monodeacetylated 
compounds as side products. Inframolecular neighbouring group participation is 
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expected to be kinetically favoured with respect to intermolecular nucleophilic attack 
so that the oxocarbenium ion is unlikely to have a long lifetime^''^'''''. 
Products la, lb, 2 and 8 were isolated by flash column chromatography. 2-
(O-acetyl)ethyl methacrylate (AcEMA, 2) was characterised by N M R spectroscopy 
and mass spectrometry. In addition to 2, unreacted HEMA was also present in each 
crude product; this was not separable from the desired product by column 
chromatography. This problem was overcome by acetylation of HEMA at the end of 
the glycosylation reaction to give 2, which was removed easily by flash 
chromatography. In this manner, AcGlcEMA, AcGalEMA and AcLacEMA were 
obtained in yields of 72%, 80% and 37%. It is worth noting that the yields for 
products la and lb are significantly higher than those previously reported. All 
compounds were characterised by IR and N M R spectroscopy, optical activity 
measurements, mass spectrometry and elemental analysis. All glycomonomers were 
identified by ' H - N M R spectroscopy as being the y5-anomers. 
AcGlcEMA was obtained as a colourless crystalline solid' and its crystal 
structure was determined by single-crystal X-ray diffraction (Figure 3). The 
heterocycle adopts a normal chair conformation, with all the substituents in equatorial 
orientations. The olefinic C(10)=C(12) bond and the adjacent ester group are nearly 
coplanar: the O(9)C(9)C(10)C(12) torsion angle is 3.1(3)°. AcGalEMA was obtained 
as colourless oil that was stored at 4 °C after addition of a radical polymerisation 
inhibitor (hydroquinone, 10 ppm). AcLacEMA was obtained as an amorphous solid 
after freeze-drying. 
The glycomonomers are soluble in chloroform, methanol, dichloromethane, 
tetrahydrofuran, acetone, benzene and DMF. 
Crystal data are reported in Appendix I . 
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^(12) 
0(9) 
Figure 3 Crystal structure of AcGlcEMA (la) 
The monomers were deprotected using a catalytic quantity of sodium 
methoxide in methanol, as reported in Schemes 3 and 4. The reaction, monitored 
continuously by TLC (acetonitrileiwater, 9:1), was stopped when the product resulting 
from the cleavage of the ester bond of the HEMA moiety was observed (as a spot 
having Rf= 0.2 for the monosaccharide derivatives and Rf = 0.1 for the monomer 
carrying the disaccharide residue). The purification of GIcEMA (3a) and GalEMA 
(3b) by chromatography (chloroformmethanol, 8:2) afforded the products in high 
purity. GlcEMA and GalEMA were obtained as sfrongly hygroscopic amorphous 
colourless solids, with yields of S0% and 75%, respectively. LacEMA (9) was 
isolated by chromatography (dichloromethane:methanol:acetic acid:water, 70:20:1:2). 
After removal of solvent under vacuum and freeze-drying, the product was obtained 
as an amorphous solid, with yield of 41%. 
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All deprotected monomers were fully characterised for the first time by IR and 
NMR spectroscopy, optical activity measurements, mass spectrometry and elemental 
analysis (Table 1). ES-mass spectra showed only one signal each, corresponding to 
the completely deprotected products. Infrared spectra showed the complete 
disappearance of the carbonyl absorption bands at ca. 1750 cm'' corresponding to the 
(9-acetyl protecting groups. No signals due to the protecting groups could be seen in 
the ' H - and '^C-NMR spectra. 
GlcEMA, GalEMA and LacEMA are soluble in methanol, DMF and water. 
Table 1 Yields and properties of monomers. 
Monomer Yield 
(%) 
[alD^ Elemental Analysis 
AcGlcEMA 
(la) 
72 -12.8 (c 0.14, CHClj , 28 °C) C2oH280,2 (460.43) 
calc. C = 52.17%, H = 6.13% 
found C = 52.11 %, H = 6.19% 
AcGalEMA 
(lb) 
80 -5.5 (c 0.25, CHCI3, 28 °C) C20H28OU (460.43) 
calc. C = 52.17%, H = 6.13% 
found C = 51.94%, H = 6.03% 
A c L a c E M A 
(8) 
37 -16.9 (c 0.10, CHCI3, 23 °C) [C32H44O20 (748.68) + 0.25 mol H2O] 
calc. C = 51.03%, H = 5.96% 
found C = 50.82%, H = 5.96% 
G l c E M A 
(3a) 
80 -22.5 (c 0.20, CH3OH, 20 °C) C,2H2o08 (292.28) 
calc. C = 49.31%, H = 6.90% 
found C = 48.99%, H = 7.01% 
G a l E M A 
(3b) 
75 -5.5 (c 0.20, CH3OH, 20 °C) [C12H20O8 (292.28) + 0.3 mol HjO] 
calc. C = 48.42%, H = 6.97 % 
found C = 48.34%, H = 6.96% 
L a c E M A 
(9) 
41 -7.6 (c 0.10, H2O, 24 -C) Ci8H3oO,3 (454.42) 
calc. C = 47.58%, H = 6.65% 
found C = 47.31 %, H = 6.46% 
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2.2.2 G L Y C O P O L Y M E R S 
pAcGlcEMA (4a), pAcGalEMA (4b) and pAcLacEMA (10) were obtained as 
white solids by polymerising la, lb and 8, respectively, with 2,2'-azoisobutyronitrile 
(AIBN) in chloroform at 65 °C for 48 h. The IR specfra showed that the vinyl 
absorption bands (1321 and 1299 cm"', 1320 and 1295 cm"', 1321 and 1298 cm"' for 
AcGlcEMA, AcGalEMA and AcLacEMA, respectively) had disappeared. Moreover, 
no signals due to vinyl protons and carbons could be seen in the ' H - and '^C-NMR 
specfra. 
Table 2 Yields and properties of polymers. 
Polymer Yield 
{ % ) 
[alo^ Elemental Analysis 
pAcGlcEMA 
(4a) 
95 -11.7 (c 0.11, CHCI3, 22 "C) (C2OH280,2)M, (460.43)„, 
calc. C = 52.17%, H = 6.13% 
found C = 52.03%, H = 6.17% 
pAcGalEMA 
(4b) 
93 -12.2 (c 0.11,CHCl3, 22 °C) (CjoHjsOn)™, (460.43), 
calc. C = 52.17%, H = 6.13% 
found C = 51.92%, H = 6.26% 
pAcLacEMA 
(10) 
72 -31.0(c 0.12, CHCl3,23 °C) [(C32H4402„)„„ (748.68), + 0.5 mol H jO] 
calc. C = 50.73%, H = 5.99% 
found C = 50.71%, H = 5.90% 
pGIcEMA 
(5a-A) 
82 - 15.2 (c 0.12, H2O, 22 °C) [(CuHjoOs),, (292.28), + 0.1 mol HjO] 
calc. C = 49.01%, H = 6.92% 
found C = 48.82%, H = 6.92% 
pGalEMA 
(5b-A) 
86 + 8.0(c 0.10, H2O, 22 °C) [(CnHjoOs),, (292.28), + 0.1 mol HjO] 
calc. C = 49.01%, H = 6.92% 
found C = 48.84%, H = 6.91% 
p L a c E M A 
(11-A) 
59 -12.7 (c 0.11,H20, 24 °C) [(C18H30O13),, (454.42)„ + 0.3 mol HjO] 
calc. C = 47.02%, H = 6.71% 
found C = 46.79%, H = 6.82% 
pGlcEMA 
(5a-B) 
63 - 10.0 (c 0.08, H2O, 22 °C) (CnHjoOs), , (292.28), 
calc. C = 49.31%,H = 6.90% 
found C = 51.26%. H = 6.69% 
pGalEMA 
(5b-B) 
65 -1- 15.7 (c 0.09, H2O, 22 °C) (CnHjoOs), , (292.28), 
calc, C = 49.31%, H = 6.90% 
found C = 51.20%, H = 6.75% 
p L a c E M A 
(11-B) 
76 -6.5(c0.10,H2O, 24°C) (Cj8H3oOi3)„„ (454.42), 
calc. C = 47.58%, H = 6.65% 
found C = 5L31%, H = 6.38% 
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As for the corresponding monomers, pAcGlcEMA, pAcGalEMA and 
pAcLacEMA showed optical activity due to the saccharide units. The specific 
rotations [ajo^, measured in chloroform, are reported in Table 2. 
All protected glycopolymers are soluble in chloroform, THF, benzene, DMF 
and acetone. 
The number- and weight-average molecular weights were determined by size 
exclusion chromatography (Table 3). 
Table 3 Absolute molecular weight as determined by SEC and dn/dc of polymers. 
Polymer M„ M„ M„/M„ dn/dc 
g mol'' g mol"' mlg-' 
pAcGlcEMA 61,600 135,900 2.21 0.058 ±0.001 
(4a) 
pAcGalEMA 63,000 156,870 2.49 0.071 ±0 .002 
(4b) 
pAcLacEMA 35,100 43,500 1.24 0.060 ±0 .002 
(10) 
pGlcEMA 23,000 60,000 2.61 0.131 
(5a-A) 
pGalEMA 461,000 1,019,000 2.21 0.140 
(5b-A) 
pLacEMA 296,000 669,200 2.26 0.150 
(11-A) 
pGlcEMA 5,932 10,410 1.75 0.126 
(5a-B) 
pGalEMA 2,984 6,410 2.15 0.146 
(5b-B) 
pLacEMA 15,380 21,840 1.42 0.142 
(11-B) 
4a, 4b and 10: SEC performed in THF; dn/dc, determined in THF at 30 °C using a calibrated light 
scattering signal, working at known concentrations and with a He-Ne laser (wavelength 670 nm) as 
the light source. 
5a-A,B, 5b-A,B and 11-A,B: SEC in aqueous solution; dn/dc determined by means of a differential 
refi-actometer, at 25 °C, working in the same experimental conditions used for the SEC 
measurements. 
Absolute molecular weight values were obtained using the previously estimated 
refractive index increments, dn/dc, which were determined in THF at 30 °C using a 
calibrated light scattering signal, working at known concentrations and with a He-Ne 
laser (wavelength 670 nm) as the light source. Values of 0.058 ml g"', 0.071 ml g"' 
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and 0.060 ml g"' for pAcGlcEMA, pAcGalEMA and pAcLacEMA, respectively, were 
obtained. These values were consistent for three batches of the same polymer. Since 
the experimental conditions were the same for all polymer solutions, this interesting 
difference could possibly be explained by different conformations of the three 
polymers in solution perhaps induced by the different side chain stereochemistries. 
The deprotected polymers, pGlcEMA (5a), pGalEMA (5b) and pLacEMA 
(11) were obtained following the two different procedures reported in Schemes 3 and 
4. In route A, the deprotected monomers 3a, 3b and 9 were polymerised with 
potassium persulfate in a 4:1 mixture of water and methanol at 65 "C for 48 h. In route 
B, the protected polymers 4a, 4b and 10 were deacetylated with sodium methoxide in 
a 1:1 mixture of chloroform and methanol. In both cases, 5a, 5b and 11 were obtained 
as highly hygroscopic white solids. The three polymers sjTithesised by polymerisation 
of the deprotected monomers are denoted by (A); polymers obtained by deacetylating 
the protected polymers are denoted by (B). pGlcEMA, pGalEMA and pLacEMA were 
characterised by IR and NMR spectroscopy, optical activity measurements and 
elemental analysis. All six deprotected polymers synthesised were soluble only in 
water and the resulting aqueous solutions tended to foam on agitation, indicating 
surface activity. As will be shown in chapter 4, dynamic light scattering 
measurements revealed that pGlcEMA and pGalEMA tended to aggregate in aqueous 
media. 
The ' H-NMR spectra of the pol3Tners prepared by each route showed 
noticeable differences, as reported in Figures 4-6. It can be seen that despite 
exhaustive deprotecting conditions, signals due to methyl protons of the protecting 
acetyl groups can still be seen in the range 5 2.0-2.2 ppm in the spectra of polymers 
obtained by route B, while no trace of these signals is present in the spectra of 5a-A, 
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5b-A and 11-A. As expected, the observed difference was more pronounced for the 
polymer containing t he d isaccharide residue. T he p resence in polymers-B of s ome 
residual protecting groups was also shown in the ' ^ C - N M R specfra by peaks in the 
range 5 22.0-24.0 ppm (see Figure 7 for ' ^C -NMR specfra of pGalEMA-A and 
pGalEMA-B). Moreover, microanalyses of these polymers typically gave a higher 
carbon percentage than expected (Table 2). In only one case was the result in 
agreement with the calculated composition. It should be noted that deprotection could 
not be continued to completion due to precipitation of the partially deprotected 
polymers from solution. Moreover, cleavage of the methacrylate ester bonds could 
occur during the deacetylation of the pAcGlcEMA, pAcGalEMA and pAcLacEMA, 
leading to polymers containing methyl ester and/or acid functionalities in the side 
chains. While there is no clear evidence to support this, the ' H - N M R specfra of 
polymers prepared by route B generally contain many more weak signals just above 
the baseline indicating more impurities than in the corresponding compounds 
S3mthesised by polymerisation of the deprotected monomers (Figures 4-6). Some of 
these resonances are in regions where the -OMe signals of methyl methacrylate units 
would be expected (6-3.5 ppm). 
Absolute molecular weights of the deprotected polymers were determined by 
SEC in aqueous solution and the obtained values are reported in Table 3. The 
refractive index increments, dn/dc, were determined by means of a differential 
refractometer, working in the same experimental conditions used for the SEC 
measurements. Values of 0.131 ml g"', 0.140 ml g'', 0.150 ml g"', 0.126 ml g"', 0.146 
ml g ' and 0.142 ml g"' for pGlcEMA-A, pGalEMA-A, pLacEMA-A, pGlcEMA-B, 
pGalEMA-B and pLacEMA-B, respectively, were obtained. 
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The average molar mass values of 5b-A are much higher than those of 5a-A, 
which may be indicative of a tendency of the former to aggregate more sfrongly in 
aqueous solution (it was noticed that aqueous solutions of the deprotected polymers 
had a tendency to froth). However, more surprising is the difference in average molar 
mass values of deprotected polymers prepared by route B compared to their parent 
polymers (compare 5a-B with 4a, 5b-B with 4b and 11-B with 10). While a 
reduction in molecular weight is expected due to removal of four acetyl groups per 
sugar residue, this alone cannot account for the differences observed in Mn and 
between 5-B and 4 or 11-B and 10. Scission of polymer chain C-C bonds during 
deprotection is an unlikely explanation. The average molar mass values for 5-B and 
11-B polymers may in fact be artefacts of the polymer deprotection procedure. 
During the deprotection, a white polymeric precipitate is produced, which is collected 
as the product. Since the chains become less soluble in the reaction medium as the 
extent of deprotection of each chain increases, precipitation of shorter chains is likely 
to occur before longer chains. Therefore, we may have inadvertentiy fractionated our 
polymer samples during deprotection, leaving the longer chains in solution. This 
serves to highlight the differences between the glycopolymer preparation routes and 
reinforces our belief in the unreliability of the polymer d eprotection route B. It is 
worth noting that "route B" is the generally adopted synthetic procedure: most of the 
glycopolymers reported in the literature have been prepared by deprotection of the 
corresponding polymers. 
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2 . 3 E X P E R I M E N T A L 
2.3.1 G E N E R A L 
2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl bromide (95+%o) and 2,3,4,6-tetra-
(9-acetyl-ar-D-galactopyranosyl bromide (-95%) were purchased from Sigma and 
Fluka, respectively. Lactose was purchased from Sigma (95+%). 2-Hydroxyethyl 
methacrylate (HEMA, 99+%), silver trifluoromethanesulfonate (99+%), acetic 
anhydride (99+%), potassium persulfate (99+%), pyridine (99.8%), methanol (99.8%) 
and cation-exchange resin DOWEX 50Wx2-200 were purchased from Aldrich. 2,2'-
Azoisobutyronitrile (AIBN, 97%)) was obtained from BDH Laboratory Supplies. 
HEMA was purified by distillation under vacuum; dichloromethane (DCM) was 
distilled from calcium hydride under N2; all other chemicals were used without further 
purification. 
NMR-spectra were recorded with a Varian Inova 500 spectrometer, operating 
at 499.78 ( 'H ) and at 125.67 MHz ('^C); results of HETCOR and COSY correlation 
studies have been used in order to assign the observed signals to the hydrogen and 
carbon atoms of the compound. Infrared spectra were obtained with a Perkin Elmer 
1600 Series FTIR spectrometer. Mass spectra were obtained with a Micromass 
Platform spectrometer and with a Micromass LCT specfrometer, ionisation modes 
ES+ or ES-. Size exclusion chromatography (SEC) of pAcGlcEMA, pAcGalEMA and 
pAcLacEMA was performed with a Viscotel 200 + light scattering, in THF, using a 
Plgel 10 \JL MIXED-B column and working with a flow rate of 1.000 ml min' and an 
injection volume of 100 }x\. Absolute molecular weights of pGlcEMA-A,B, 
pGalEMA-A,B and pLacEMA-A,B were determined by aqueous size exclusion 
chromatography coupled to a Water 410 RI detector and a Wyatt DAWN DSP 
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MALLS, using a TSK GMPW column (30 cm x 7.8 mm id). The mobile phase 
consisted of 80 % HPLC grade water, 20 % methanol, 0.05 M NaNOa and 2.5 ml 1"' 
I.O M NaOH at a flow rate of 0.8 ml min"'. The MALLS detectors were normalized 
using 50K pullulan purchased from Gearing Scientific. A l l polymer samples were 
prepared as 0.2 - 0.6 wt% solutions and filtered through 0.2 i^m filters. Molecular 
weight averages and polydispersity were calculated using Astra 32 software. The 
dn/dc values used were previously determined using a model BP-2000-V Brice-
Phoenix Visual Laboratory Type Differential Refractometer, Phoenix Precision 
Instrument Company, Pennsylvania (USA); four solutions o f concentration ranging 
between ca. 4% and 15% in 20% methanol, 80% 0.05 M NaNOs and 2.5 ml 1"' 1.0 M 
NaOH solution were prepared for each polymer and the measurements carried out at 
25 °C. Optical Rotations were estimated using a P-1020 Series Polarimeter, JASCO 
(UK) Ltd. Elemental Analyses were obtained with an Exeter Analytical Inc. CE-440 
Elemental Analyzer. Products were freeze-dried using a Christ ALPHA-1-4 freeze-
dryer with controller L D C - I M . 
2.3.2 X - R A Y C R Y S T A L L O G R A P H Y 
The diffraction experiment (nominally covering ful l sphere of the reciprocal 
space) was carried out at 7 = 100 K on a SMART 3-circle diffractometer with a I K 
CCD area detector,^ using graphite monochromated Mo-Ka radiation {X = 0.71073 A) 
and a Cryostream (Oxford Cryosystems) open-flow N2 gas cryostat. 
Crystal data. C20H28O12, f w. 460.42, orthorombic, space group P2i2i2i (No. 
19), a = 8.442(2), b = 12.466(4), c = 21.904(7) A, F = 2305(1) A^ Z = 4, D^ = 1.33 g 
^ SMART and SAINT, Area detector control and integration software. Version 6.0. Bruker AXS, 
Madison, Wisconsin, U.S.A., 1999. 
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ml"', ^ = 0.11 mm"'. 28 228 reflections were measured (29 < 58°), of these 3451 were 
independent and 2631 were Friedel equivalents thereof [5679 and 2430 respectively 
with / > 2o(T)]. The structure was solved by direct methods and refined by full-matrix 
least squares against of all data, using SHELXTL software.^ A l l non-hydrogen 
atoms were refined in anisotropic approximation, the H atoms at C(12) isotropically, 
methyl groups as rigid bodies (with a common refined U for three H atoms); other H 
atoms were treated in 'riding' model. Final R = 0.037 for data with / > 2o(/), wR(I^) 
= 0.097 for all data. The absolute configuration could not be determined and was 
assigned from the known one of the starting material. Full data (excluding structure 
factors) have been deposited at the Cambridge Crystallographic Data Centre. CCDC 
reference no. 207/171437. 
2.3.3 M O N O M E R AND P O L Y M E R SYNTHESIS 
2-(2',3',4',6'-Tetra-0-acetyl-/ff-D-glucosyloxy)ethyl methacrylate, 
AcGlcEMA (la) 
To a stirred solution of 2,3,4,6-tetra-O-acetyl-a-D-glucopyranosyl bromide (10 
g, 24.3 mmol) and an excess of HEMA (9.5 g, 72.8 mmol) in dry DCM at - 40 °C 
under N2 containing 3 A powdered molecular sieves (12 g), an excess of silver 
trifluoromethanesulfonate (7.5 g, 29.2 mmol) was added and the reaction mixture 
stirred in the same conditions for 48 h. After this time the mixture was gradually 
allowed to reach room temperature and then filtered through celite. After evaporation 
of the solvent, the residue (10.9 g) was dissolved in a mixture of pyridine (250 ml) 
and acetic anhydride (100 ml ) and stirred under N2 overnight in order to acetylate 
* SHELXTL, an integrated system for solving, refining and displaying crystal structures from 
diffraction data. Version 5.10. Bruker AXS, Madison, Wisconsin, USA, 1997. 
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unreacted HEMA and so aid purification. After evaporation of the solvent the residue 
was dissolved in DCM (250 ml), washed with a solution of hydrochloric acid (0.25 
M , aliquots of 100 ml), a saturated solution of NaHCOa (aliquots of 100 ml), brine 
(100 ml) and dried over Na2S04. The solvent was removed and the residue was then 
purified by flash chromatography (ethylacetate:hexane, 3:7) to afford the product la 
(8.3 g, 72%) as colourless plate-like crystals suitable for X-ray analysis; mp 77-79 °C 
(litP^^ 77.5 °C); [a]D^^ -12.8 (c 0.14 in C H C I 3 ) (ZrY.'^ '^ [a]J^ -12.7 , 0.015 mol dm"^  in 
C H C I 3 ) ; (Found: C, 52.11; H , 6.19. C20H28O12 requires C, 52.17; H , 6.13%); IR (KBr 
disc) v/cm"' 1758 (C=0 of 0-acetyl groups), 1718 (C=0 of HEMA moiety), 1635, 
1321, 1299 (C=C); 5H^ (500 MHz; C D C I 3 ) 1.99 (3H, s, 3 x H-3), 2.00, 2.01, 2.03, 
2.07 (3H X 4, s X 4, Ac X 4), 3.68 ( IH , ddd, 74',5' 10.5 Hz, /j'.ea' 2.5 Hz, J5,6b'4.5 Hz, H -
5'), 3.81 ( I H , ddd, 76a,6b 11.5 Hz, y5a,6a7.0Hz, 75b,6a3.5 Hz, H-6a), 4.04 ( IH , ddd, 76a,6b 
11.5 Hz, /5a,6b = i5b,6b 5.0 Hz, H-6b) 4.12 ( IH , dd, 76a',6b 12.2 Hz, 75',6a' 2.5 Hz, H-6'a), 
4.25 ( I H , dd, 76a'.6b 12.2 Hz, 75',6b 4.5 Hz, H-6'b), 4.23-4.32 (2H, m, 2 x H-5a.b), 4.56 
( I H , d, Jr,2- 7.9 Hz, H-1'), 4.99 ( I H , dd, Jy,2 7.7 Hz, J2;y 9.7 Hz, H-2'), 5.07 ( IH , t, J 
9.7 Hz, H-4'), 5.18 ( I H , t, J 9.5 Hz, H-3'), 5.57-5.59 ( IH , m, H -1 Z to CH3-C=C), 
6.10-6.12 ( I H , m, H - 1 E to CH3-C=C), NOESY correlation studies allowed the 
differentiation between H - I (Z) and }i-l(E) due to the long range coupling of H - l (Z) 
with 3 X H -3 ; NOESY also allowed the differentiation between 2 x H - 5 and 2 x H-6 
due to the long range coupling of H-6 with H - l ' ; 5c (125.67 MHz, decoupled ' H 500 
MHz; C D C I 3 ) 18.2 (C-3); 20.5, 20.6 ( H 3 C C O O - x 4), 61.8 (C-6'), 63.3 (C-5), 67.4 (C-
6), 68.2 (C-4'), 71.0 (C-2'), 71.8 (C-5'), 72.6 (C-3'), 100.7 (C-1'), 125.8 (C-1), 135.9 
(C-2), 167.1 (C-4), 169.2, 169.3, 1 70.2, 1 70.6 ( H 3 C C O O - x 4 ) ; L R M S m/z (ES+): 
found 483.5 (M-i-Na)^ 100%. 
See Scheme 3 for numbering. 
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2-(2',3',4',6'-Tetra-0-acetyl-y(?-D-galactosyloxy)ethyl methacrylate, 
AcGalEMA (lb) 
2,3,4,6-Tetra-O-acetyl-cir-D-galactopyranosyl bromide (10 g, 24.3 mmol) and 
an excess of HEMA (9.5 g, 72.8 mmol) were allowed to react and the resulting 
product purified as described for la , to afford product lb (8.9 g, 80%) as a viscous 
colourless oil; [ajn^^-5.5 (c 0.25 in C H C I 3 ) ; (Found: C, 51.94; H , 6.03. C20H28O12 
requires C, 52.17; H , 6.13%); IR (nujol) v/cm"' 1756 (C=0 of acetate groups), 1724 
(C=0 of HEMA moiety), 1632, 1320, 1295 (C=C); 5H (500 MHz; C D C I 3 ) 1.96 (3H, 
s, 3 X H-3), 1.99, 2.02, 2.03, 2.13 (3H x 4, s x 4, Ac x 4), 3.82 ( I H , ddd, J^^^h 11-5 
Hz, J5a,6a 7.5 Hz, Jjb.ea 4.0 Hz, H-6a), 3.90 ( I H , td, J, = Js'.ea' = Js\6\s 6.5 Hz, Ji = Jv,5' 
1.1 Hz, H-5'), 4.04 ( I H , ddd, J6a.6b 11-5 Hz, y5a.6b = Jsb,(,h 5.0 Hz, H-6b), 4.10 ( IH , dd, 
y6a',6b' 10.3 Hz, Js'.ea' 6.7 Hz, H-6'a), 4.14 ( I H , dd, Jga'.eb' 10.9 Hz, Jy,(>v 6.5 Hz, H-6'b), 
4.26 ( I H , ddd, J5a,5b 12.0 Hz, J5a,6a 7.5 Hz, J5a,6b 4.5 Hz, H-5a), 4.31 ( I H , ddd, J5a,5b 
12.5 Hz, /5b,6a = /5b,6b 5.0 Hz, H-5b), 4.52 ( I H , d, Jr.r 8.0 Hz, H-1'), 4.98 ( I H , dd, Jr,y 
10.5 Hz, J3',4' 3.5 Hz , H-3'), 5.19 ( I H , dd, Jvj' 8.0 Hz, /2',3' 10.5 Hz, H-2'), 5.36 ( IH , 
dd, J3',4' 3.5 Hz, Jv,y 1.0 Hz, H-4'), 5.57-5.58 ( IH , m, H -1 Z to CH3-C=C), 6.10-6.11 
( I H , m, H-1 E to CH3-C=C); 5c (125.67 MHz, decouple ' H 500 MHz; C D C I 3 ) 18.2 
(C-3), 20.5 20.6 ( H 3 C C O O - X 4), 61.2 (C-6'), 63.4 (C-5), 66.9 (C-4'), 67.3 (C-6), 68.5 
(C-2'), 70.6 (C-3'), 70.8 (C-5'), 101.2 (C-1'), 125.8 (C-1), 136.0 (C-2), 167.0 (C-4), 
169.3 170.1 170.2 170.3 ( H 3 C C O O - x 4); LRMS m/z (ES+): 483.3 (M+Na)^, 100%. 
2-(0-acetyl)ethyl methacrylate, AcEMA (2) 
Colourless oil; 5H (200 MHz; CDC13) 1.92-1.93 (3H, m, CH3-C=C), 2.05 (3H, 
s, CH3 -C=0) , 4.26-4.36 (4H, m, - C H 2 - C H 2 - ) , 5 .56-5.58 ( I H , m, vinyl proton Z 10 
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CH3-C=C), 6.10 ( I H , m, vinyl proton E to CH3-C=C); LRMS m/z (ES+): found 195 
(M+Na)^ 100%, 211 (M+K)^ 10%. 
2-(/?-D-GlucosyIoxy)ethyl methacrylate, GlcEMA (3a) 
l a (2 g, 4.3 mmol) was dissolved in 10 ml of dry methanol and the obtained 
solution was stirred for 15 min at room temperature under N2. Then, 1 ml of freshly 
prepared 0.03 M solution of sodium methoxide in methanol was added. The solution 
was stirred at room temperature and continuously monitored by TLC 
(acetonitrile:water, 9:1). The reacfion was stopped after 40 min when the formation of 
the product resulting from the cleavage of the ester bond of HEMA moiety was 
observed (Rf = 0.2). Cation-exchange resin (DOWEX 50Wx2-200) was added in 
order to bring the pH to neutral and to remove Na^ cations. The solution was stirred 
for 15 min before filtering the resin. After evaporation of the solvent, the residue was 
purified by flash chromatography (chloroform:methanol, 8:2) to afford 3a as a viscous 
colourless oil that gave a strongly hygroscopic amorphous colourless solid after 
freeze-drying (1 g, 80%); [a]^^^ - 22.5 (c 0.20 in CH3OH); (Found: C, 48.99; H 7.01. 
C12H20O8 requires C, 49.31; H 6.90%); IR (KBr disc) v/cm"' 3364 (OH), 1715 (C=0 
of HEMA moiety), 1635, 1320, 1298 (C=C); 5H** (500 MHz; CD3OD) 1.93 (3H, m, 3 
x H-3), 3.17 ( I H , dd, JV,T 8.0 Hz, /2'.3' 9.5 Hz, H-2'), 3.25-3.35 (3H, m, H-3', H-4', H-
5'), 3.65 ( I H , dd, Jgaw 12.0 Hz, Jj'.ea' 5.5 Hz, H-6'a), 3.83 ( I H , ddd, Jga.eb 11.5 Hz, 
/5a,6a 6.0 Hz, J5b,6a 3.5 Hz, H-6a), 3.84 ( I H , dd, /6a'.6b- 11.7 Hz, Jy,6V 1-7 Hz, H-6'b), 
4.09 ( I H , ddd, y6a,6b 11.5 Hz, y5a.6b 4.0 Hz, J5b,6b 6.0 Hz, H-6b), 4.29 ( I H , ddd, J5a,5b 
12.0 Hz, y5a,6a 5.5 Hz, Jja.eb 3.5 Hz, H-5a), 4.30 ( I H , d, Jy^r 8.0 Hz, H-1'), 4.34 ( IH, 
ddd, J5a,5b 12.0 Hz, y5b,6a 3.5 Hz, J5b,6b 6.0 Hz, H-5b), 5.61-5.62 ( I H , m, H-1 Zto CH3-
' See Scheme 3 for numbering. 
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C=C), 6.11-6.12 ( I H , m, H-1 E to CH3-C=C); 5c (125.67 MHz, decoupled ' H 500 
MHz; C D 3 O D ) 18.4 (C-3), 62.7 (C-6'), 65.3 (C-5), 68.6 (C-6), 71.6 (C-3' or C-4' orC-
5'), 75.0 (C-2'), 78.0 ( 2 C , C-3' or C-4' or C-5'), 104.6 (C-1'), 126.4 (C-1), 137.6 (C-2), 
168.9 (C-4); HRMS m/z (ES+): found 3 15.1049 [(M+Na)*. C 12H20O8 requires m/z, 
315.1056] . 
2-(/S-D-Galactosyloxy)ethyl methacrylate, GalEMA (3b) 
lb (2 g, 4.3 mmol) was treated using an identical procedure to that described 
in the preparation of 3a, to afford 3b as a viscous colourless oil that gave a strongly 
hygroscopic amorphous colourless solid after freeze-drying (0.95 g, 75%); [a]^^ - 5.5 
(c 0.20 in C H 3 O H ) ; [Found: C, 48.34; H, 6.96. (C12H20O8 + 0.3 mol H2O) requires C, 
48.42; H, 6.97%]; IR (KBr disc) v/cm"' 3384 (OH), 1712 (C=0 of HEMA moiety), 
1636, 1320, 1298 (C=C); 5H^^  (500 MHz; C D 3 O D ) 1.93 ( 3 H , m, 3 x H-3), 3.45 ( I H , 
dd, JT,y 9.7 Hz, y3',4' 3.3 Hz, H-3'), 3.50 ( I H , td, 7, = Js'.ea' = J^'fiv 5.5 Hz, Jd = JA\i' 1.0 
Hz, H-5'), 3.52 ( I H , dd, Jv,2' 7.5 Hz, J2;y 10.0 Hz, H-2'), 3.71 ( I H , dd, Jea'.eb' H-O Hz, 
Js'.ea' 5.5 Hz, H-6'a), 3.74 ( I H , dd, Jga'.eb' H.O Hz, Jy,6h' 7.0 Hz, H-6'b), 3.82 ( I H , dd, 
Jy,A^ 3.3 Hz, J4'.5' 0.7 Hz, H-4'), 3.84 ( I H , ddd, y6a,6b 12.0 Hz, Jja.ea 6.0 Hz, Jjb.ea 4.0 
Hz, H-6a), 4.10 ( I H , ddd, y6a,6b 12.0 Hz, /5a.6b 3.7 Hz, J5b,6b 6.0 Hz, H-6b), 4.26 ( IH , d, 
Jvj' 7.5 Hz, H-1'), 4.31 ( I H , ddd, y5a.5b 12.0 Hz, y5a,6a 6.0 Hz, y5a,6b 3.5 Hz, H-5a), 4.35 
( I H , ddd, J5a,5b 12.0 Hz, Jsb.ea 3.5 Hz, /jb.eb 6.0 Hz, H-5b), 5.61-5.62 ( I H , m, H-1 Z to 
CH3-C=C), 6.12 ( I H , m, H-1 E to CH3-C=C); 5c (125.67 MHz, decoupled ' H 500 
MHz; C D 3 O D ) 18.4 (C-3), 62.5 (C-6'), 65.3 (C-5), 68.5 (C-6), 70.3 (C-4'), 72.4 (C-2'), 
74.9 (C-3'), 76.7 (C-5'), 105.3 (C-1'), 126.4 (C-1), 1 3 7 . 7 ( 0 - 2 ) , 168.8 (C-4); HRMS 
m/z (ES+): found 315.1065 [(M+Na)^ C12H20O8 requires m/z, 315.1056] . 
See Scheme 3 for numbering. 
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Poly[2-(2',3',4',6'-tetra-0-acetyl-/?-D-glucosyloxy)ethyl methacrylate], 
pAcGlcEMA (4a) 
A solution of l a (2 g, 4.3 mmol) and AIBN (20 mg, 1 wt%) in chloroform was 
degassed by bubbling N2 through for 15 min at room temperature. Then, the flask was 
sealed and the polymerisation c arried out at 65 "C for 48 h . The resulting viscous 
solution was poured in to an excess of diethyl ether (10:1) in order to precipitate the 
polymer. The product was then purified by re-precipitation from chloroform in diethyl 
ether to obtain 4a (1.9 g, 95%) as a white solid; [a]^^ -11.7 (c 0.11 in CHCI3) (Ut.^^^^ 
-10.3, 0.015 mol r' in benzene); [Found: C, 52.03; H, 6.17. (C2oH280i2)m requires C, 
52.17; H 6.13%]; IR (KBr disc) v/cm"' 2960 (-CH2-), 1756 (C=0 of 0-acetyl groups); 
5H (500 MHz; CDCI3) 0.75-1.15 (3H, br m, CH3-C), 1.60-2.27 (2H, br, -CH2-), 2.01, 
2.03, 2.06, 2.10 (12H, s x 4, Ac x 4), 3.70-3.88, 3.95-4.07, 4.10-4.25, 4.99-5.03, 5.08-
5.18, 5.20-5.28 (lOH, protons of the carbohydrate residue and the methylene groups 
of the side chains), 4.66 ( I H , br, anomeric proton); 8c (125.67 MHz, decoupled ' H 
500 MHz; CDCI3) 16.5 18.2 (IC, br, CH3-C, racemic-racemic (rr) and me^o-racemic 
(mr) triads, respectively), 20.6, 20.7, 20.8 (4C, H3CCOO- x 4), 45.2 (IC, -CH2-), 
52.2-55.6 ( IC, br, CH3-C-), 61.1 (IC, carbohydrate residue of the side chains), 63.6 
(IC, -CH2-0-carbohydrate residue), 66.6 (IC, -CH2-OCO), 67.3, 69.1, 70.6, 70.8 (4C, 
carbohydrate residue of the side chain), 100.5 (IC, anomeric carbon), 169.3, 170.0, 
170.3 (4C, H3CCOO- x 4), 176.5, 176.9-177.8 (IC, br, -CCOO-, meso-racemic (mr) 
and racemic-racemic (rr) triads, respectively). 
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PoIy[2-(2',3',4',6'-tetra-0-acetyI-;5-D-galactosyloxy)ethyl methacrylate], 
pAcGalEMA (4b) 
lb (2 g, 4.3 mmol) was polymerised in an identical procedure to that described 
for 4a, to obtain 4b (1.86 g, 93%) as a white solid; [a]D^^-12.2 (c 0.11 in C H C I 3 ) ; 
[Found: C, 51.92; H, 6.26. (C2oH280i2)m requires C, 52.17; H 6.13%]; IR (KBr disc) 
v/cm'' 2960(-CH2-), 1752 (C=0 of 0-acetyl groups); 5H (500 MHz; C D C I 3 ) 0.78-1.16 
(3H, br m, CH3 -C) , 1.63-2.20 (2H, br, - C H 2 - ) , 1.98, 2.05, 2.06, 2.16 (12H, s x 4, Ac x 
4), 3.71-3.83, 3.95-4.09, 4.10-4.24, 5.05-5.21, 5.37-5.43 (lOH, protons of the 
carbohydrate residue and the methylene groups of the side chains), 4.62 ( I H , br, 
anomeric proton); 5c (125.67 MHz, decoupled ' H 500 MHz; C D C I 3 ) 17.4, 18.9 (IC, 
br, CH3 -C , racemic-racemic (rr) and me^o-racemic (mr) triads, respectively), 20.8, 
20.9, 21.0 (4C, H 3 C C O O - X 4), 45.2 (IC, - C H 2 - ) , 52.5-56.1 (IC, br, CH3-C-) , 61.3 
(IC, carbohydrate residue of the side chains), 63.6 (IC, -CH2-0-carbohydrate 
residue), 66.6 ( IC, -CH2-OCO), 67.3, 68.9, 70.9, 71.0 (4C, carbohydrate residue of 
the side chain), 101.1 (IC, anomeric carbon), 169.5, 170.2, 170.5 (4C, H 3 C C O O - x 
4), 176.5, 177.1-177.8 ( IC, br, -CCOO-, meso-racemic (mr) and racemic-racemic (rr) 
triads, respectively). 
Poly[2-(/?-D-glucosyloxy)ethyi methacrylate], pGlcEMA (5a) 
Synthesis A 
A solution of 3a (1 g, 3.4 mmol) and K2S2O8 (25 mg, 2.5 wt%) in a mixture of 
high purity water:methanol (4:1) was degassed by bubbling N2 through for 15 min at 
room temperature. Then, the flask was sealed and the polymerisation was carried out 
at 65 °C for 48 h. The resulting solution was freeze-dried and the recovered polymer 
was then purified by dialysis against water (Dialysis Tubing-Visking, Size 20 Inf 
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Dia. 18/32" - 14.3 mm : 30 M , MWCO -12-14,000 Daltons) for 1 week. The solution 
was fireeze-dried to afford 5a (0.82 g, S2%) as a white hygroscopic solid; [a]o^^ -15.2 
(c 0.12 in H2O) ; {Found: C, 48.82; H 6.92. [(Ci2H2o08)m + 0.1 mol H2O] requires C, 
49.01; H 6.92%}; IR (KBr disc) v/cm"' 3446 (OH), 1718 (C=0 of HEMA moiety); 5H 
(500 MHz; D 2 O ) 0.73-1.22 (3H, br m, CH3-C), 1.78-2.22 (2H, br, -CH2-), 3.25-3.53, 
3.67-3.76, 3.86-398, 4.08-4.32 (lOH, protons of the carbohydrate residue and of the 
methylene groups of the side chains), 4.47 ( I H , d, J 7.5 Hz, anomeric proton); 6c 
(125.67 MHz, decoupled ' H 500 MHz; D 2 O ) 17.2, 18.8, 21.2 (IC, br, CH3-C, 
racemic-racemic (rr), me^o-racemic (mr) and meso-meso (mm) triads, respectively), 
45.0 ( IC, -CH2-), 51.0-53.7 (IC, br, CH3-C-), 61.1 (IC, carbohydrate residue of the 
side chains), 6 5.1 ( I C , -CH2-0-carbohydrate residue), 67.3 (IC, -CH2-OCO), 69.9, 
73.3, 76.0, 76.1 (4C, carbohydrate residue of the side chain), 102.7 (IC, anomeric 
carbon), 178.9, 179.7-180.0 ( IC, br, -CCOO-, meso-racemxc (mr) and racemic-
racemic (rr) triads, respectively). 
Synthesis B 
A solution of 4a (2 g) in CHCl3:CH30H (1:1, 8 ml) was stirred at room 
temperature under N2 for 15 min. Then, 1 ml of a freshly prepared 1 M solution of 
sodium methoxide in methanol was added and the formation of a white precipitate 
was observed after around 30 s. After stirring at room temperature under N2 for Ih, 
the solid was filtered, dissolved in water and a cation-exchange resin (DOWEX 
50Wx2-200) was added in order remove Na^ cations. The solution was stirred for 15 
min before filtering the resin. After purification by dialysis against water, the solution 
was freeze-dried to afford 5a (0.80 g, 63%) as a white hygroscopic solid; [Found: C, 
51.26; H 6.69. (Ci2H2o08)m requires C, 49.31; H 6.90%. Assuming that two 0-acetyl 
groups were still present after the deprotection: (Ci6H240io)m would require C, 51.06; 
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H 6.43%. Found: as before]; IR (KBr disc) v/cm'' 3423 (OH), 1718 (C=0 of HEMA 
moiety); 5H (500 MHz; D 2 O ) 0.75-1.18 ( 3 H , br m, CH3-C), 1.72-2.22 (2H, br, -CH2- ) , 
2.06, 2.17, 2.20 (methyl protons of C?-acetyl groups still present after the 
deprotection), 3.31-3.52, 3.72, 3.92, 4.05-4.36 (lOH, protons of the carbohydrate 
residue and of the methylene groups of the side chains), 4.48 ( I H , d, 7 7 Hz, anomeric 
proton); 5c (125.67 MHz, decoupled ' H 500 MHz; D2O) 17.3, 18.9 (IC, br, CH3-C, 
racemic-racemic (rr) and me^o-racemic (mr) triads, respectively), 45.0 (IC, -CH2- ) , 
51.0-53.8 ( IC, br, CH3 -C-) , 61.1 (IC, carbohydrate residue of the side chains), 65.1 
(IC, -CH2-0-carbohydrate residue), 67.3 (IC, -CH2-OCO), 69.9, 73.3, 76.0, 76.1 ( 4 C , 
carbohydrate residue of the side chain), 102.7 (IC, anomeric carbon), 178.8, 179.8-
180.0 (IC, br, -CCOO-, me^o-racemic (mr) and racemic-racemic (rr) triads, 
respectively). 
Poly[2-(y5-D-galactosyloxy)ethyl methacrylate], pGalEMA (5b) 
Synthesis A 
3b (1 g, 3.4 mmol) was polymerised and the resulting polymer purified 
according to the procedure described in the synthesis of 5a to afford 5b (0.86 g, 86%) 
as a white hygroscopic solid; [a]^^ + 8.0 (c 0.10 in H2O); {Found: C, 48.82; H 6.92. 
[(Ci2H2o08)m + O.l mol H 2 O ] requires C, 49 .01; H 6.92%}; IR (KBr disc) v/cm'' 3447 
(OH), 1718 (C=0 of H E M A moiety); 5H (500 M H Z ; D 2 O ) 0.82-1.20 ( 3 H , br m, C H 3 -
C), 1.78-2.35 ( 2 H , b r , - C H 2 - ) , 3.52-3.59, 3.62-3.72, 3.72-3.85, 3.89-4.02 4.06-4.35 
(lOH, protons of the carbohydrate residue and of the methylene groups of the side 
chains), 4.43 ( I H , d, J 6.5 Hz, anomeric proton); 5c (125.67 MHz, decoupled ' H 500 
MHz; D 2 O ) 17.2, 18.9 ( IC, br, CH3 -C, racemic-racemic (rr) and we^o-racemic (mr) 
triads, respectively), 45.0 (IC, - C H 2 - ) , 52.0-53.8 (IC, br, CH3-C-) , 61.1 (IC, 
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carbohydrate residue of the side chains), 65.0 (IC, -CH2-0-carbohydrate residue), 
67.1 ( IC, -CH2-OCO), 68.8, 70.9, 73.0, 75.3 (4C, carbohydrate residue of the side 
chain), 103.2 (IC, anomeric carbon), 178.9, 179.8-180.0 (IC, br, -CCOO-, meso-
racemic (mr) and racemic-racemic (rr) triads, respectively). 
Synthesis B 
4b (2 g) was deprotected and the resulting polymer purified as for 4a to afford 
5b (0.83 g, 65%) as a white hygroscopic solid; [Found: C, 51.20; H 6.75. (Ci2H2o08)m 
requires C, 49.31; H, 6.90%. Assuming that two 0-acetyl groups were still present 
after the deprotection (Ci6H240io)m would require C, 51.06; H 6.43. Found as before]; 
IR (KBr disc) v/cm"' 3445 (OH), 1718 (C=0 of HEMA moiety); 5H (500 MHz; D2O) 
0.76-1.16 (3H, br m, CH3-C), 1.76-2.24 (2H, br, -CH2-), 2.07, 2.14, 2.20 (methyl 
protons of O-acetyl groups still present after the deprotection), 3.56, 3.61-4.00, 4.12-
4.32 (lOH, protons of the carbohydrate residue and of the methylene groups of the 
side chains), 4.43 ( I H , d, J6.5 Hz, anomeric proton); 5c (125.67 MHz, decoupled ' H 
500 MHz; D2O) 17.2, 18.8, 20.3 (IC, br, CH3-C, racemic-racemic (rr), me^o-racemic 
(mr) and meso-meso (mm) triads, respectively), 23.8 (methyl carbon of 0-acetyl 
groups still present after the deprotecfion), 45.0 (IC, -CH2-), 51.4-53.7 (IC, br, CH3-
C-), 61.1 ( I C , carbohydrate residue of the side chains), 65.1 (IC, -CH2-O-
carbohydrate residue), 67.1 (IC, -CH2-OCO), 68.7, 70.9, 73.0, 75.3 (4C, carbohydrate 
residue of the side chain), 103.2 (IC, anomeric carbon), 178.9, 179.7-180.0 (IC, br, -
CCOO-, wew-racemic (mr) and racemic-racemic (rr) triads, respectively), 1 82.1 (-
COOH due to cleavage of the ester bond of the side chains). 
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2',3',4',6'-Tetra-O-acetyl-y0-D-galactopyranosyl(l'^4)-2,3,6-tri-(?-acetyI-
y3-D-glucopyranose (6) 
A suspension of anhydrous sodium acetate (20 g, 0.24 mol) in acetic 
anhydride (140 ml, 1.48 mol) was warmed until it was gently refluxing. After having 
turned off the heat source D-lactose (20 g, 55.5 mmol) was added portion by portion at 
a rate that maintained the boiling without external heating. The reaction mixture was 
refluxed for 2 h, then cooled and poured into ice-water (300 ml). The yellow oil was 
extracted by D C M (400 ml) and the organic layer washed with a saturated solution of 
NaHCOs (aliquots of 200 ml) and dried over MgS04. The solvent was removed under 
vacuum to afford 6 (87% as |3 anomer) as a crystalline white soHd (37.7 g, 100%); 
C28H38O19; mp 96-98 °C; 5 H " (500 MHz; C D C I 3 ) 1.95, 2.02, 2.03, 2.04 (3H x 8, s x 
8, Ac X 8), 3.75 ( I H , ddd, 74.5 10 Hz, 75,6a 4.5 Hz, 75,6b 2 Hz, H-5), 3.81-3.88 (2H, m, 
H-4, H-5'), 4.06 ( I H , dd, 76a,6b' H-O Hz, 75',6a' 7.0 Hz, H-6'a), 4.09-4.14 (2H, m, H-6'b, 
H-6a), 4.43-4.48 ( I H , m, H-6b), 4.46 ( IH , d, 7r,2' 8.0 Hz, H-1'), 4.93 ( I H , dd, 72',3' 10.5 
Hz, 73',4' 3.5 Hz, H-3'), 5.03 ( I H , dd, 7i,2 8.5 Hz, 72,3 9.5 Hz, H-2), 5.09 ( IH , dd, 7r.2' 
8.0 Hz, 72,3' 10.5 Hz, H-2'), 5.23 ( I H , t, 7 9.0 Hz, H-3), 5.34 ( I H , d, 73',4' 3.5 Hz, H-4'), 
5.66 ( I H , d, 7i,2 8.0 Hz, H-1); 5c (125.70 MHz, decoupled ' H 500 MHz; C D C I 3 ) 20.7, 
20.8, 20.9, 21.0, 21.1 ( H 3 C C O O - x 8), 61.0 (C-6'), 61.9 (C-6), 66.8 (C-4'), 69.2 (C-2'), 
70.7 (C-2), 70.9 (C-5'), 71.2 (C-3'), 72.8 (C-3), 73.7 (C-5), 75.6 (C-4), 91.5 (C-1), 
100.9 (C-1'), 169.1, 169.3, 169.8, 169.9, 170.3, 170.4, 170.5, 170.6 ( H 3 C C O O - x 8); 
LRMS m/z (ES+): found 701.1 (M+Na)^, 100%. 
See Scheme 4 for numbering. The discussed peaks are the ones for the highly predominant P anomer. 
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2',3',4',6'-Tetra-0-acetyl-y^D-galactopyranosyl(l'^4)-2,3,6-tri-0-acetyl-
a-D-glucopyranosyl bromide (7) 
6 (20 g, 29.5 mmol) was dissolved in dry DCM 125 ml containing 3 A 
powdered molecular sieves (10 g). A ready-made solution of HBr in CH3COOH 
(30%, 40 ml) was added and the mixture stirred under N2 overnight. The mixture was 
then poured in ice-water (200 ml) and the oil extracted by DCM (100 ml). The 
organic layer was washed with a saturated solution of NaHCOs (aliquots of 50 ml) 
and dried o ver MgS04. The solvent was removed and the residue was purified by 
flash chromatography (ethylacetate:dichloromethane, 1:9) to afford the product 7 
(14.9 g, 72%) as a white solid; C26H35BrOi7; mp 136-138 °C; 5H^^  (500 MHz; C D C I 3 ) 
1.96, 2.03, 2.05, 2.06, 2:09, 2.13, 2.15 (3H x 7, s x 7, Ac x 7), 3.85 ( IH , t, J 8.75 Hz, 
H-4), 3.88 ( I H , td, /t 6.0 Hz, 7d 1.5 Hz, H-5'), 4.05-4.21 (4H, m, H-6'a, H-6'b, H-6a, H-
5), 4.47-4.52 ( I H , m, H-6b), 4.50 ( I H , d, Jy^r 8.0 Hz, H-1'), 4.75 ( IH , dd, 7,,2 4.0 Hz, 
72,3 10.0 Hz, H-2), 4.95 ( I H , dd, 72',3' 10.5 Hz, 73'.4' 3.5 Hz, H-3'), 5.12 ( IH , dd, JV,T: 
8.0 Hz, 72',3' 10.5 Hz, H-2'), 5.35 ( I H , dd, /3'.4' 3.5 Hz, /4',5' 1.2 Hz, H-4'), 5.55 ( IH , t, J 
9.5 Hz, H-3), 6.25 ( I H , d, / i ,2 4.0 Hz, H-1); 5c (125.70 MHz, decoupled ' H 500 MHz; 
CDCI3) 20.5, 20.6, 20.8 (H3CCOO- x 7), 60.8 (C-6'), 61.0 (C-6), 66.5 (C-4'), 69.0 (C-
2'), 69.5 (C-3), 70.7 (C-2), 70.8 (C-5'), 71.0 (C-3'), 72.9 (C-5), 74.9 (C-4), 86.6 (C-1), 
100.8 (C-r), 168.9, 169.2, 170.0, 170.1, 170.2, 170.2, 170.6 (H3CCOO- x 7); LRMS 
m/z (ES+y. found 720.7, 722.7 (M+Na)^, 100%, 98.86%, respectively. 
See Scheme 4 for numbering. 
115 
2-[2",3",4",6"-Tetra-0-acetyl-/?-D-galactopyranosyl(l"->4')-2',3',6'-tri-0-
acetyl-y^D-glucosyloxy] ethyl methacrylate, AcLacEMA (8) 
7 (20 g, 28.6 mmol) and an excess of HEMA (11.1 g, 85.3 mmol) were 
allowed to react as described for la. After removal of the solvent, the residue was 
purified by flash chromatography (dichloromethane:ethylacetate, 9:1) to afford 
product 8 (7.9 g, 37%) as a white, amorphous solid; mp 50-52 °C; [ a ]D" -16.9 (c 0.10 
in CHCI3); [Found: C, 50.82; H, 5.96. (C32H44O20 + 0.25 mol H2O) C, 51.03; H, 
5.96%]; IR (KBr disc) v/cm'' 1753 (C=0 of O-acetyl groups + C=0 of HEMA 
moiety), 1636, 1321, 1298 (C=C); 6H*" (500 MHz; C D C I 3 ) 1.94 (3H, s, 3 x H-3), 
1.96, 2.00, 2.04, 2.04, 2.06, 2.12, 2.15 (3H x 7, s x 7, Ac x 7), 3.59 ( I H , ddd, J4',5' 
10.0 Hz, y5',6a' 2.0 Hz, J5',6b'5.0 Hz, H-5'), 3.76-3.81 (2H, m, H-4', H-6a), 3.86 ( I H , t, J 
7.0 Hz, H-5") 4.05 ( I H , ddd, /sa.eb 5.0 Hz, 75b,6b 3.5 Hz, J6a,6b 11.5 Hz H-6b), 4.05-4.14 
(3H, m, H-6'a, H-6'b, H-6"a), 4.23-4.31 (2H, m, 2 x H-5a,b), 4-46-4.49 ( I H , m, H-6"b), 
4.47 ( I H , d, Jr,2" 8.0 Hz, H-1"), 4.52 ( I H , d, Jr.r 8.0 Hz, H-1'), 4.90 ( I H , dd, J,.2. 7.5 
Hz, 72',3' 9.5 Hz, H-2'), 4.95 ( I H , dd, Jr,y 10.5 Hz, Jj-.r 3.5 Hz, H-3"), 5.10 ( IH , dd, 
7i",2" 8.0 Hz, 72',3" 10.5 Hz, H-2"), 5.18 ( I H , t, 7 9.5, H-3'), 5.34 ( I H , d, 73-,4" 3.4 Hz, 
H-4"), 5.58-5.59 ( I H , m, H-1 Zto CH3-C=C), 6.11 ( I H , s, broad, H-1 EXo CH3-C=C); 
NOESY allowed the differentiation between H - l ' and H-1" due to the long range 
coupling of H-6 with H - l ' ; 5c (125.70 MHz, decoupled ' H 500 MHz; C D C I 3 ) 18.5 (C-
3); 20.8, 20.9, 21.0, 21.1 (H3CCOO- x 7), 61.0 (C-6'), 62.2 (C-6"), 63.6 (C-5), 66.8 
(C-4'), 67.7 (C-6), 69.3 (C-2"), 70.9 (C-5"), 71.2 (C-3"), 71.7 (C-2'), 72.9 (C-5'), 73.0 
(C-3'), 76.5 (C-4"), 100.8 (C-l ') , 102.4 (C-1"), 126.2 (C-1), 136.3 (C-2), 167.4 (C-4), 
169.3, 169.8, 170.0, 170.3, 170.4, 170.6, 170.7 (H3CCOO- x 7); HRMS m/z (ES+): 
found 771.2324 [(M+Na)*. C12H20O8 requires 771.2324]. 
*" See Scheme 4 for numbering. 
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2-[;5-D-Galactopyranosyl(l"^4')-/?-D-glucosyloxy]ethyl methacrylate, 
L a c E M A (9) 
8 (1 g, 1.3 mmol) was treated using an identical procedure to that described in 
the preparation of 3a. After evaporation of the solvent, the residue was purified by 
flash chromatography (dichloromethane:methanol:acetic acid:water, 70:20:1:2) and 
the solvent removed under vacuum first and by freeze-drying after to afford 9 (0.25 g, 
41%) as a strongly hygroscopic amorphous white solid; [ajo^'^ - 7.6 (c 0.10 in H2O); 
(Found: C, 47.31; H, 6.46. C18H30O13 requires C, 47.58; H, 6.65%); IR (KBr disc) 
v/cm"' 3 376 (OH), 1718 (C=0 of H E M A moiety), 1 636, 1 320, 1 299 (C=C); 5H^^ ^ 
(500 MHz; CD3OD) 1.92 (3H, m, 3 x H-3), 3.31 ( I H , t, J,=Jv,T = Ji\y 8.2 Hz, H-2'), 
3.52 ( I H , dd, J2',y 8.0 Hz, J3',4' 10.0 Hz, H-3'), 3.63-3.66 (2H, m, H-5", H-6"a), 3.67-
3.72 (2H, m, H-4', H-6"b), 3.73-3.81 (2H, m, H-5', H-6'a), 3.76 ( I H , t, J, = J r . r = Jxw 
8.2 Hz, H-2"), 3.79 ( I H , dd, /2",3" 11.5 Hz, /3",4" 3.5 Hz, H-3"), 3.91 ( I H , d, y3",4" 
3.50Hz, H-4"), 3.94 ( I H , dd, Js'ea' 2.0 Hz, h^^v 12.5 Hz, H-6'b), 3.98 ( I H , ddd, y^ a.eb 
11.5 Hz, /5a,6a 7.5 Hz, Jjb.ea 3.0 Hz, H-6a), 4.15 ( I H , ddd, y6a,6b 11.5 Hz, y5a.6b 8.5 Hz, 
J5b,6b 2.5 Hz, H-6b), 4.35-4.39 (2H, m, 2 x H-5), ), 4.43 ( I H , d, Jv,r 8.0 Hz, H-1"), 
4.53 ( I H , d, Jr,2' 8.0 Hz, H-1'), 5.72 ( I H , m, H-1 Zto CH3-C=C), 6.16 ( I H , m, H-1 E 
to CH3-C=C); 5c (125.67 MHz, decoupled ' H 500 MHz; CD3OD) 17.5 (C-3), 60.1 
(C-4"), 64.3 (C-5), 66.1 (C-6'), 68.2 (C-5"), 68.7 (C-6), 70.6 (C-3'), 71.8 (C-3"), 72.7 
(C-5'), 72.8 (C-2"), 74.4 (C-4'), 75.5 (C-6"), 78.3 (C-2'), 102.5 (C-1'), 103.0 (C-1"), 
127.2 (C-1), 135.9 (C-2), 169.8 (C-4); HRMS m/z (ES+): found 477.1589 [(M+Na)^ 
C18H30O13 requires m/z, 477.1584]. 
See Scheme 4 for numbering. 
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Poly{2-[2",3",4",6"-tetra-0-acetyl-/?-D-galactopyranosyl(l"->4')-2',3',6'-
tri-0-acetyl->^D-glucosyloxy]ethyl methacrylate}, pAcLacEMA (10) 
8 (1 g, 1.3 mmol) was polymerised in an identical procedure to that described 
for 4a, to obtain 10 (0.72 g, 72%) as a white solid; [ a ]D" -31.0 (c 0.12 in CHCI3); 
{Found: C , 50.71; H , 5.90. [(C32H4402o)m + 0.5 mol H 2 O ] requires C , 50.73; H 
5.99%}; I R (KBr disc) v/cm'' 2960 ( -CH2-) , 1753 (C=0 of acetate groups); 5H (500 
MHz; C D C I 3 ) 0.75-1.10 (3H, br m, CH3-C), 1.70-2.25 (2H, br, - C H 2 - ) , 1.94, 1.96, 
1.99, 2.00, 2.05, 2.12, 2.15 (21H, s x 7, Ac x 7), 3.70, 3:88-3.96, 4.09-4.12, 4.48-4.62, 
4.88, 5.07, 5.18, 5.35 (16H, protons of the carbohydrate residue and the methylene 
groups of the side chains), 4.52 ( I H , br, anomeric proton), 5.02 ( I H , broad, anomeric 
proton); 5c (125.67 MHz, decoupled ' H 500 MHz; C D C I 3 ) 16.5 18.2 (IC, br, CH3-C, 
racemic-racemic (rr) and we^o-racemic (mr) triads, respectively), 20.5, 20.6, 20.8 
(7C, H3CCOO- X 7), 45.0 (IC, - C H 2 - ) , 52.5-55.5 (IC, br, CH3-C-), 60.8 (IC, 
carbohydrate residue of the side chains), 62.5 (IC, -CH2-0-carbohydrate residue), 
63.2 ( IC, -CH2-OCO), 66.8, 67.3, 69.4, 70.7, 71.2, 71.7, 73.0, 73.2 (9C, carbohydrate 
residue of the side chain), 100.3, 101.0 (2C, anomeric carbons), 169.2, 169.5, 169.8, 
170.0, 170.2 (7C, H3CCOO- X 7), 176.5-178.2 (IC, br, -CCOO-). 
Poly{2-[/?-D-galactopyranosyl(l"->4')->S-D-glucosyloxy]ethyl 
methacrylate}, pLacEMA (11) 
Synthesis A 
9 (1 g, 3.4 mmol) was polymerised and the resulting polymer purified 
according to the procedure described in the synthesis of 5a to afford 11 (0.36 g, 59%) 
as a white hygroscopic solid; [a]D^^ - 12.7 (c 0.11 in H2O); {Found: C , 46.79; H 6.82. 
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[(Ci8H3oOi3)m+ 0.3 molHzO] requires C, 47.02; H 6.71%}; IR (KBr disc) v/cm"' 
3417 (OH), 1719 (C=0 of HEMA moiety); 5H (500 MHz; D2O) 0.72-1.16 (3H, br m, 
CH3-C), 1.78-2.25 (2H, br, -CH2-), 3.22, 3.36, 3.44-3.57, 3.62, 3.64-3.69, 3.82-3.85, 
3.99-4.22 (16H, protons of the carbohydrate residue and of the methylene groups of 
the side chains), 4.33 ( I H , br, anomeric proton), 4.40 ( I H , br, anomeric proton); 5c 
(125.67 MHz, decoupled ' H 500 M H Z ; D2O) 16.8, 1 7.9 ( I C , br, CH3-C, racemic-
racemic (rr) and /we^o-racemic (mr) triads, respectively), 45.0 (IC, -CH2-), 53.0-54.1 
(IC, br, CH3-C-), 60.2, 61.3 (2C, carbohydrate residue of the side chains), 65.2 (IC, -
CH2-0-carbohydrate residue), 67.1 (IC, -CH2-OCO), 68.8, 70.9, 72.9, 73.0, 74.5, 
75.3, 75.6, 78.8 (IOC, carbohydrate residue of the side chain), 102.2 (IC, anomeric 
carbon), 103.2 (IC, anomeric carbon), 175.1, 177.8-180.0 (IC, br, -CCOO-, i?teso-
racemic (mr) and racemic-racemic (rr) triads, respectively). 
Synthesis B 
10 (0.40 g) was deprotected and the resulting polymer purified as for 4a to 
afford 11 (0.18 g, 76%) as a white hygroscopic solid; [a]^^ - 6.5 (c 0.10 in H2O); 
[Found: C, 54.31; H 6.38. (CigHjoOu)™ requires C, 47.58; H, 6.65%]; IR (KBr disc) 
v/cm-' 3423 (OH), 1752 (C=0 of residual O-acetyl groups), 1718 (C=0 of HEMA 
moiety); 5H (500 MHz; D2O) 0.75-1.14 (3H, br m, CH3-C), 1.73-2.18 (2H, br, -CH2-), 
1.96, 2.02, 2.08 (methyl protons of 0-acetyl groups still present after the 
deprotection), 3.24, 3.33, 3.43-3.52, 3.60-3.67, 3.79-3.86, 3.99-4.5 (16H, protons of 
the carbohydrate residue and of the methylene groups of the side chains), 4.31 ( IH , 
br, anomeric proton), 4.38 ( I H , br, anomeric proton); 5c (125.67 MHz, decoupled ' H 
500 MHz; D2O) 16.7, 18.0 (IC, br, CH3-C, racemic-racemic (rr) and me^o-racemic 
(mr) triads, respectively), 20.7 (methyl carbon of 0-acetyl groups still present after 
the deprotection), 44.9 (IC, -CH2-), 53.4-54.4 (IC, br, CH3-C-), 60.3, 61.1 (2C, 
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carbohydrate residue of the side chains), 65.0 (IC, -CH2-0-carbohydrate residue), 
67.3 (IC, -CH2-OCO), 68.7, 71.1, 72.7, 72.9, 74.6, 75.0, 75.5, 78.7 (IOC, 
carbohydrate residue of the side chain), 102.5 (IC, anomeric carbon), 103.1 (IC, 
anomeric carbon), 174.5-179.9 ( IC, br, -CCOO-). 
2.4 CONCLUSIONS 
Monomeric and polymeric methacrylate derivatives bearing P-D-
glucopyranoside, /?-D-galactopyranoside and y9-D-lactoside residues have been 
successfully synthesised in an efficient stereo-controlled manner and, for the 
compounds containing the monosaccharide units, in high yields. A l l products have 
been fully characterised. Critically, it has been shown that deprotection of the 
polymers according to the methods used for all previous syntheses of 
poly(glycoacrylates) and -methacrylates'^^'^^'^''^ results in an incomplete deacetylation 
and yields products of ill-defined composition. Instead, fully deacetylated, well-
defined and pure materials can be obtained by the novel me'thod of pol)Tnerisation of 
the deprotected monomers. Absolute number- and weight-average molecular weights 
have been determined for all the polymers synthesised. 
The thorough comparison of all functional properties of these glycopolymers, 
including binding of the deprotected glycopolymers to specific receptor proteins 
(lectins) to assess their feasibility for biomedical applications, are reported in the next 
chapters. 
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SURFACE ACTIVITY OF PROTECTED 
GLYCOPOLYMERS 
3.1 INTRODUCTION: NUCLEATION B E N E A T H 
LANGMUIR F I L M S 
Langmuir monolayers have attracted and continue to attract wide interest as 
model systems for biological membranes and for the understanding of the early stages 
of molecular self-assembly'^'l 
Recently, the research on Langmuir-Blodgett (LB) films has rapidly increased 
due to their potential applications in the field of non-linear optics, electronic devices, 
sensors and so on. In particular, poly(methyl methacrylate) (PMMA) LB films have 
been significantly studied because of their use in nanolithography and non-linear 
optics^^'^l Transfer characteristics onto silicon substrates of several 
polymethacrylates' films, including poly(ethyl methacrylate) (PEMA) and poly[(2-
hydroxypropyl)methacrylate] (PHPMA), have been investigated. A l l the monolayers 
showed qualitatively similar transfer properties, gradually passing from an initial Z-
type transfer to a Y-type transfer with increasing the transfer surface pressure^''l 
On the other hand, the oriented growth of crystalline solids in biological 
systems, called biomineralisation'^^, has inspired numerous studies of crystallisation 
induced by surfactant films. In Nature, in fact, organic systems, such as aggregates of 
proteins or phospholipids, are found to promote the growth of one particular 
polymorph or morphology related to a particular biological function. Langmuir 
monolayers have been thus shown to act efficiently as matrixes beneath which 
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heterogeneous, nucleation and growth preferentially occur'^l This nucleation is often 
highly specific, opening important applicative possibilities in the fields of crystal 
morphological engineering^^^ and biomineralisation^^l 
In order for a f i l m to work effectively as a preferential nucleation site, the 
interfacial tension between itself and the nucleating species must be low. Moreover, 
the crystallising material must be adsorbed significantiy onto the monolayer and the 
resultant arrangement of the adsorbed molecules must be able to induce nucleation of 
the bulk crystal'^^l I f these conditions are satisfied, epitaxial growth of the crystalline 
material beneath the film can be achieved, with transfer of structural information from 
the 2D monolayer to the 3D crystal. Certainly, i f the surfactant is chosen so that the 
film headgroups mimic perfectiy or at least closely the molecular array of a particular 
plane of the crystallising species, the monolayer wil l act as a highly efficient a nd 
specific nucleator, leading to nucleation bounded by this plane^'^l This template-
directed mechanism, based on the exact or close match between the lattice structures 
of the film and the to-be-grown crystal, has been extensively investigated and 
employedf""''*l Landau et a/.'"''^^ were the first to demonstiate that Langmuir films 
can promote the oriented nucleation of both organic and inorganic crystalline solids. 
For example, glycine crystals were grown with their {010} faces attached to a 
monolayer constituted by resolved amino acid surfactants. The ability of the film to 
induce nucleation was directly related to the degree of lattice match between the 
{010} glycine faces and the film structure. However, epitaxial growth beneath 
monolayers has been shown to occur also in the absence of such a strong lattice 
correspondence'^''I Electrostatic interactions between an ionic film headgroups and an 
ionic nucleating species may result in an arrangement of ions relative to a particular 
crystal face^'^l Despite the different mechanism through which epitaxial growth can 
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occur, most crystallisation experiments have shovwi that optimal conditions are 
achieved when the monolayer is compressed at high surface pressures, i.e. in a 
condensed, close-packed and fully ordered s t a t e ' " ( F i g u r e 1). 
Figure 1 
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compression. 
Thus, it has been long believed that a close-packed fi lm is a necessary requirement for 
maximising the nucleation rate. The observed slower oriented growth beneath 
partially compressed or uncompressed monolayers has been so explained by assuming 
the existence in the expanded film o f close-packed islands still able to act as 
nucleation p r o m o t e r s ' T h e presence o f such ordered clusters has been in some 
cases demonstrated'^''. However, in monolayers with aliphatic chains, close-packed 
film islands are not generally observed at room temperature and low surface 
pressures. Moreover, fikns at lower surface pressure may also possess a certain degree 
o f order, even in the absence o f cluster formation. In 1996, Ahn and co-workers'^^' 
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showed that calcite could crystallise beneath monolayers at a surface pressure equal to 
10 mN m"', due to the capability of the organic template to reorganise itself in order to 
optimise the geometric and stereochemical match with the growing crystal face. In 
1997, Cooper et alP' showed for the first time that partially compressed or 
uncompressed films can work as preferential nucleation catalysts compared to their 
fully ordered counterparts. dl-Aspartic acid and d,l-asparagine were found to nucleate 
preferentially beneath monolayers at low to medium surface pressures (< 25 mN m''). 
Since the corresponding close-packed films were ineffective at inducing nucleation, 
the oriented growth observed at lower surface pressures was unlikely to be promoted 
by ordered clusters present in the film. Instead, the increased compressibility of these 
monolayers would allow them to reorganise to form arrangements which more closely 
resemble planes in the bulk crystals. For systems where there is not an exact match 
between the film and the nucleating species lattice structures, nucleation can be 
expected to be biased toward low to medium pressure, as the condensed films are 
more rigid and, consequently, less able to accommodate the existing mismatch than 
the corresponding partially compressed or uncompressed ones. 
In this work, preliminary studies of the nucleation of dl-aspartic acid beneath 
monolayers constituted of the two protected glycopolymers, pAcGlcEMA and 
pAcGalEMA, were performed. Both films were found to act as efficient nucleation 
promoters, in a qualitatively and quantitatively similar manner. 
Based on the knowledge that the nucleating ability of a film is paralleled with 
the capability of its soluble analogue to inhibit the growth of the same crystal face'^''^ 
the deprotected pol3miers, pGlcEMA and pGalEMA, were tested as dl-aspartic acid 
growth inhibitors. Glycoproteins are known to act as antifreeze in the serum of deep-
sea fish, allowing them to survive at temperatures as low as -2 °C. Their property to 
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lower the fireezing point seems not to be related to any colligative effect; on the 
contrary it is thought to arise fi-om a mechanism that inhibits ice nucleation and 
growtht"""^ Synthetic glycopeptide analogues have been prepared and shown to 
[28 291 
exhibit significant antifreeze properties'^  • . 
3.2 R E S U L T S AND DISCUSSION 
3.2.1 11-^ ISOTHERMS 
Tl-A isotherms for t he p rotected pol3Tners, p AcGlcEMA (4a), pAcGalEMA 
(4b) and pAcLacEMA (10), over aqueous solutions were recorded. Comparison o f 
curves obtained for the same film over water and over a saturated d 1-aspartic acid 
solution shows whether the amino acid adsorbs onto the film, an essential requirement 
for its heterogeneous nucleation beneath the monolayer. 
Initially, measurements using octadecanoic acid, a film material of well-
known n - ^ behaviour, were carried out, in order to test the suitability of the apparatus 
used. Measurements were repeated changing different parameters until the curve 
obtained showed good agreement with the isotherm reported in the literature^^"^ and 
good reproducibility. Figure 2 shows that stable isotherms could be obtained. The 
limiting area per molecule was found to be ^ 19.5 A^, in good agreement with the 
value of 20 reported in the literature for isotherms recorded at 25 °C. It has to be 
noted that all the isotherms determined in this study were recorded at 20 ± 0.1 "C, 
unless differently stated, and with an accuracy of ± 1 mN m"' and ± 1 A^. At H = 0, 
the area per molecule of the film was ~ 31 A^. 
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Figure 2 U-A curve of octadecanoic acid on pure water at 20 °C. 
The isotherms determined for all glycopolymers over pure water at neutral pH 
are reported in Figure 3. 
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Figure 3 U-A curves of pAcGlcEMA, pAcGalEMA and pAcLacEMA over pure water at neutral 
pH and at 20 °C. The number-average molecular weights of the polymers are indicated 
in the legend. 
A l l glycopolymers were highly soluble in chloroform so that all solutions were easily 
spread on the subphase, as observed by eye and confirmed by optical microscopy. As 
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expected for polymer monolayers'^'\ the 11-^ 4 curves were smooth, without marked 
discontinuities indicating phase transitions. Limiting areas per monomeric unit at high 
surface pressure were « 32 A^ for pAcGlcEMA, ^ 33 A^ for pAcGalEMA and ~ 60 
A^ for pAcLacEMA. Limiting areas per repeating unit at 11 = 0 were !^7l for 4a, 
~ 72 A^ for 4b and 100 A^ for 10, as determined fi-om experiments performed 
spreading a lower amount of material. Glycopolymers carrying monosaccharide 
residues (4a and 4b) showed approximately the same limiting area (at high surface 
pressure) of 30 A^, despite the different structure of the peracetylated carbohydrate 
constituting the polar headgroup. For pAcLacEMA, instead, the limiting area per 
monomeric unit was double that determined for pAcGlcEMA and pAcGalEMA. In 
order to determine whether this result was related to the larger (double) dimension of 
the disaccharide residue or to the lower (half) molecular weight of the polymer, 
additional measurements were carried out using a different batch of pAcLacEMA 
having an average-molecular weight of 325,200 gmol"' . Unfortunately, it was not 
possible to obtain 10 with Mn ~ 60,000 g mol' ' . However, measurements performed 
using a polymer possessing a much larger molecular weight should indicate whether 
the increase of polymer dimension results in a condensation of the spreading film. The 
isotherms determined using the two different batches of pAcLacEMA are reported in 
Figure 4. Interestingly, the 11-^ curve obtained for 10 having the highest molecular 
weight was slightiy more expanded than that for the same polymer with the lowest 
Mn. Limiting areas per monomeric unit at high surface pressure varied fi-om « 60 A^ 
to « 70 A^ with increasing the molecular weight of approximately 10-fold. Therefore, 
it could be concluded that the double limiting area per monomer unit obtained for 
pAcLacEMA, compared to the glycopolymers containing the monosaccharide 
residues, could be related to the double dimensions of the lactose residues, which 
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probably dispose themselves at the interface with the two sugar rings parallel to the 
surface. 
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Figure 4 U-A curves of pAcLacEMA over pure water at neutral pH and at 20 "C. The number-
average molecular weights of the polymers are indicated in the legend. 
Studies utilising polymer fractions of different average molecular weight as 
film materials have been reported'^and the area occupied per monomer unit at 
surface pressures above 1 mN m' ' was generally found to be independent from the 
molecular weight. 
In this study, further investigations of the effect of the molecular weight were 
carried out using two different batches of pAcGalEMA possessing different molecular 
weights. The isotherms so obtained are reported in Figure 5. In this case the results 
were rather different and the limiting area per monomeric unit increased with 
decreasing the molecular w eight of the polymer. In particular, when the molecular 
weight roughly halved, the limiting area at high surface pressure increased from « 33 
A ^ o » 4 2 A\ 
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After spreading and evaporation of the solvent, the freshly formed monolayer 
is usually not in a condition of absolutely stable equilibrium. Various processes 
producing film loss from the surface can then occur in order to reach this equilibrium 
{e.g. evaporation, solution, collapse or fracture)'^^"^'*l Therefore, the loss of material 
can be considered an index of the film stability. The 11-^ curves of unstable films wil l 
progressively shift toward lower areas per molecule with repeating Yl-A runs. I f the 
presence of the interface provides a lower free energy than does the presence of an 
additional b ulk p hase, an e xtremely h igh i nsolubility and non-volatility of the film 
material can ensure that non-significant loss from the surface wil l take place. The 
monolayer state can so correspond to the minimum free energy of the system. 
However, even i f the monolayer state does not represent the minimum of free energy, 
the film can still remain in its metastable state throughout the experiment, due to the 
slow rates of the processes producing material loss. Films of highly insoluble 
polymers are expected to be stable on the time-scale of the measurement, volatility 
not being a problem with macromolecules. Due to the decreased stability of the first 
formed aggregates of the nucleating species^ ^^^ in the absence of any suitable particles 
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on which the f i lm can nucleate, many monolayers can be compressed to pressures 
considerably higher than their equilibrium spreading pressure - the pressure o f the 
monolayer in equilibriimi with its bulk phase - without collapse occurring. 
Eventually, however, there wi l l be a surface pressure - collapse pressure, Flc'^ ^^ -
above which molecules wi l l be forced out o f the monolayer to form agglomerates o f a 
new adjacent bulk phase. Either the area o f the f i lm wi l l decrease rapidly at constant 
pressure or the pressure wi l l drop i f the f i lm is maintained at constant area. 
A l l glycopolymers formed highly stable films with considerably high collapse 
pressure: « 40-50 mN m' ' . Moreover, in all cases repeated consecutive runs with 
increasing final surface pressure showed that the films could be compressed up to n « 
35 m N m' ' before a shift o f the U-A curves toward lower areas per monomeric unit 
could be detected. A l l films were compressed at surface pressures 10-50 mN m' ' . The 
decrease o f surface pressures after the films were held at n values between 25 and 35 
m N m"' can be attributed to reversible reorganisation o f the monolayers. The repeated 
runs recorded for pAcGlcEMA are reported in Figure 6. 
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surface pressure, on pure water, at neutral pH, at 20 °C. The values of the final FT for 
each run are reported in the legend. 
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Saturated dl-aspartic acid solutions have pH « 3. U-A curves over these 
solutions should therefore be compared with the corresponding curves over water at 
the same pH, to negate any effect due to pH alone. Yl-A curves over water at pH 3 
were so determined. As expected, the isotherms using water at neutral pH and water at 
pH » 3 as subphases did not show relevant differences. The curves obtained for 
pAcGlcEMA and pAcGalEMA are reported in Figure 7. 
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Figure 7 U-A curves of pAcGlcEMA and pAcGalEMA on pure water at neutral pH and pH = 3, 
at 20 °C. 
The presence of solute may have a profound effect on the film behaviour'"'^^l 
Its adsorption onto the film can occur when film-solute and water-water interactions 
exceed film-water and solute-water interactions. Thus, i f the film-solute interactions 
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are sufficiently strong and the adsorption does not significantly reduce the favourable 
film-film interactions, the solute wi l l strongly adsorb onto the film. As a consequence, 
the limiting area per molecule wi l l be larger than the corresponding one in the absence 
of the solute, reflecting the cross-section of the film headgroup and the attached solute 
molecule, and the Tl-A curve wi l l shift toward the right^^^'. The U-A curves of 
pAcGlcEMA and pAcGalEMA on saturated dl-aspartic acid solution at 20 "C are 
reported in Figure 8. 
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Figure 8 Yl-A curves of pAcGlcEMA and pAcGalEMA on pure water and on saturated dl-
aspartic acid solution at pH » 3 and at 20 °C. 
In both cases, adsorption of amino acid molecules between the film headgroups 
occurred at all surface pressures higher than approximately 15 mN m"', causing the 
observed slight expansion of the curves above this 11 value. Adsorption was also 
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retained at high surface pressure, leading, for pAcGlcEMA, to a significant 
stabilisation of the film, as shown by the increase of the collapse pressure. Tl-A curves 
above saturated dl-aspartic acid solutions were d etermined only for g lycopolymers 
carrying the monosaccharide residues, since only these materials were then tested as 
nucleation promoters. As already mentioned in Section 3.1, adsorption at the surface 
of the nucleating species is the first requirement for its film induced epitaxial growth. 
3.2.2 N U C L E A T I O N O F D L - A S P A R T I C A C I D B E N E A T H 
G L Y C O P O L Y M E R LANGMUIR F I L M S 
The effect of pAcGlcEMA and pAcGalEMA films on dl-aspartic acid 
nucleation was investigated, using subphase amino acid solutions with different 
percentage supersaturation, o%, and working at different surface pressures, i.e. at 
different degrees of film compression. Supersaturated solutions of the amino acid 
were prepared using the equation and data reported in Appendix I I . 
Initially, pAcGalEMA (Mn = 63,000 g mol"') was chosen as the film material 
and a dl-aspartic acid solution with a% = 120% as the subphase. The crystallisation 
experiments were carried out at 10 °C, in order to minimise the water evaporation 
from the trough throughout the experiment (24 h). In the first experiment the film was 
compressed at a surface pressure of 25 mN m'' and the temperature kept at 10 + 0.1 
°C by means of a water bath connected to the trough. The temperature of the subphase 
surface was checked by means of a thermometer equipped with a surface probe. A 
temperature gradient of 3 degrees was observed between the solution surface and the 
PTFE base of the trough, with the temperature of the latter being 7 °C. This caused an 
increase of the supersaturation of the solution in the proximity of the trough base, in 
turn responsible for the observed significant nucleation and growth of crystals on 
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scratches present on the bottom of the apparatus. Figure 9 reports a picture taken from 
the base of the trough. It can be seen that the crystals showed the morphology 
characteristic o f crystals grown homogeneously from aqueous solutions, with a 
prismatic crystal habit, dominated by low energy {110} faces, edged by two {111} 
and two {2 02} faces (see Appendix III) . A l l faces were smooth. 
Figure 9 Typical crystal habit of dl-aspartic acid nucleated homogeneously from aqueous 
solution. The picture was taken from the bottom of the trough after 24 h (magnify xlOO). 
Pictures o f the crystals observed at the surface are reported in Fgure 10. 
Crystals grown beneath the pAcGalEMA monolayer film presented a different crystal 
habit with respect to those grown on the base of the trough, with an enlargement of 
the face grown attached to the monolayer. Crystallisation beneath monolayer films 
occurs, after adsorption of the nucleating species, by crystal nucleation at the surface 
followed, after attainment of the nuclei critical size, by mainly diffusion limited 
crystal growth. Diffusion of crystallising material to the attached faces wil l be reduced 
compared to that toward the faces in solution, decreasing their growth rate and so 
resulting in their enlargement (see Figure 21). Moreover, faces grown attached to the 
film showed numerous surface irregularities, whilst all other faces appeared smooth. 
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A large number of surface structure effects is typical of epitaxial growth, due to either 
coalescence o f growing nuclei or to lattice mismatch between the film and the 
nucleating crystal face. Since the nucleation rate wil l cause less than 1% of the surface 
to be covered by crystals, in the present system irregularities can be assumed to result 
predominantly from misfit dislocations due to the inherent lattice mismatch between 
the film and the nucleating species. 
m 
(a) (b) 
Figure 10 dl-Aspartic acid crystals grown after 24 h beneath pAcGalEMA film at n = 25 mN m' 
from a 120% supersaturated solution at 10 °C (magnify xlOO). a), Faces {111} and 
{110} grown attached to the film; b), {110} and probably {200} faces grown bounded 
to the film. 
In order to avoid the previously mentioned gradient of temperature, critical for 
this kind of investigation, it was decided to carry out the experiments at 20 °C. 
Nucleation on the base and sides of the PTFE trough, resulting in a lowering of the 
supersaturation level throughout the experiment, should, in fact, be avoided. The 
temperature was recorded for the initial and final instant of the experiments and it was 
found to remain constantly equal to 20 °C. However, water evaporation from the 
trough during the 24 h, with subsequent increasing of the dl-aspartic acid solution 
supersaturation, was found causing the loss of the solution up to ca. 30% of the total 
volume. This undesired phenomenon was afterwards reduced by placing two 2 litres 
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beakers of water (kept at 70 °C throughout the experiment) under the sheet covering 
the trough. The loss of solution for each experiment was then ca. 15% of the total 
volume. The evaporation of the water from the trough also causes an error in the value 
of the surface pressure measured. Due to the decrease of the depth of immersion of 
the Wilhelmy plate during the experiment, the value of n wi l l decrease with time. 
However, the magnitude of this effect was found to be negligible compared to 
lowering in the surface pressure due to reorganisation, dissolution, fracture and 
collapse of the film. Despite the fact that a supersaturation of 120% is well below the 
reported value of 284 + 5%^^ ' as the critical supersaturation limit for homogeneous 
nucleation of dl-aspartic acid, again crystallisation upon scratches present on the base 
of the trough was found to invalidate the measurements. It was, therefore, decided to 
reduce the a% of the subphase to 43%. pAcGalEMA (Mn = 63,000 g mol"') was again 
used as the film material. Two experiments were carried out, at 10.5 mN m"' and 20 
mN m"', respectively. As expected practically no crystals were observed in the first 
case, due to negligible adsorption of amino acid molecules onto the film at this low 
surface pressure (see Figure 8). However, crystallisation was poor also for the highest 
surface pressure, where the isotherm reveals that adsorption of the nucleating species 
is occurring. Pictures of crystals grown at the surface inside the barriers in these 
conditions are reported in Figure 11. It is worth noting that at this low supersaturation, 
nucleation of dl-aspartic acid onto the base of the trough was negligible and the few 
crystals observed (grown onto the trough base) showed the typical habit of crystals 
nucleated homogeneously (see Figure 9). The film was stable throughout the 
experiment, the value of the surface pressure recorded after 24 h being equal to 17 
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mN m' ' . Crystal faces nucleated attached to the monolayer appeared to be mainly 
{110} and {111}*. 
t- • 
Figure 11 
I r •«.-tj 
(a) (b) 
dl-Aspartic acid crystals grown after 24 h beneath pAcGalEMA film at n = 
from a 43% supersaturated solution at 20 °C (magnify xlOO). a), Small 
clump. 
= 20mN 
crystals; b), 
In order to determine whether the scarce crystallisation was due to the low 
supersaturation of the solution used as the subphase or to an inherent poor capability 
of the film to act as a nucleation catalyst, further experiments were carried out using 
dl-aspartic acid solution with a% equal to 100%. pAcGalEMA (Mn = 63,000 g mol"') 
was again employed as the film material and the monolayer compressed at 15 mN m"', 
the limit at which the amino acid was shown to adsorb onto the film. After 24 h, the 
number of crystals observed at the surface between the barriers was significantly 
increased compared to the previous experiments, but the crystals were still generally 
small. No crystals were observed at the surface outside the barriers and in the 
supersaturated solution kept as a control. Very few crystals were detected on the base 
of the trough. Again these latter crystals presented the habit typical of homogeneous 
nucleation reported in Figure 9. Hence, any difference in the morphology of crystals 
* See Appendix III for the assignment of the crystal faces. 
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grown heterogeneously under the monolayer could be attributed to the film and not to 
any supersaturation effect. The film was found to be rather stable during the 
experiment, with a final surface pressure equal to 7 mN m"'. Pictures of crystals 
grown in these conditions are reported in Figures 12 and 13. 
^ ^ ^ ^ ^ 
(b) 
(a) 
Figure 12 a-b), dl-Aspartic acid crystals grown after 24 h beneath pAcGalEMA film at O - 15 mN 
m"' from a 100% supersaturated solution at 20 °C (magnify x 100). 
(a) 
(b) 
Figure 13 dl-Aspartic acid crystals grown after 24 h beneath pAcGalEMA film at n - 15 mN m" 
from a 100% supersaturated solution at 20 °C (magnify x500). a), { 1 11} Face grown 
attached to the film; b), {110} face grown bounded to the film. 
Faces grown attached to the film were typically enlarged compared to their usual size 
in crystals grown from aqueous solution. These faces were mainly {110} and {111}. 
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They showed a high density of surface irregularities, with growth appearing to occur 
outwards in all directions from a site of initial nucleation ("hopper" growth''"'^ Figure 
13b). A l l other faces present in the crystals were those commonly seen in aqueous 
solution, although the large size of the faces attached to the film would sometimes 
mask the formation of the adjacent crystal faces. 
The experiment was left over the weekend and the crystals at the surface were 
observed again after two days (that is after three days from the beginning of the 
experiment). The size was significantly increased and numerous aggregates of large 
crystals could be observed, as reported in Figure 14. 
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Figure 14 
(a) (b) 
dl-Aspartic acid crystals grown after 72 h beneath pAcGalEMA film at n =^ 15 mN m" 
from a 100% supersaturated solution at 20 °C (magnify xlOO). a), Face {111} grown 
attached to the film; b), aggregate. 
The 100% supersaturated solution was used as the subphase for subsequent 
experiments, where pAcGlcEMA (Mn = 61,600 g mol'') and pAcGalEMA (Mn = 
63,000 g mol' ') were used as film materials and the monolayers compressed at 20 mN 
m' ' . In both cases the monolayers showed good stability throughout the experiments, 
with final surface pressures equal to 13 and 11 mN m'' for pAcGlcEMA and 
pAcGalEMA, respectively. The evaporation of the solution was approximately 15% 
of the total volume. Both glycopolymer films were found to be effective dl-aspartic 
143 
acid nucleators. Numerous large crystals were well visible to the naked eye after 24 h, 
forming aggregates covering almost all the surface between the barriers. In both 
experiments no crystals were detected at the surface outside the barriers and in the 
supersaturated solution kept as a control. Some of the crystals nucleated 
heterogeneously were collected and kept for X-ray investigations that could be 
performed in the near future. Pictures of crystals obtained in these conditions are 
reported in Figures 15, 16 and 17. 
(a) (b) 
Figure 15 dl-Aspartic acid crystals grown after 24 h beneath pAcGlcEMA film at n - 20 mN m"' 
from a 100% supersaturated solution at 20 °C (magnify xlOO). a-b), Aggregates with 
{T 11}, {110} and { 2 02} as attached faces. 
1 ^ . 
(a) (b) 
Figure 16 dl-Aspartic acid crystals grown after 24 h beneath pAcGalEMA film at f l = 20 mN m' 
from a 100% supersaturated solution at 20 °C (magnify xlOO). a-b). Aggregates with 
{T11}, {110} and { 2 02} as attached faces. 
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(a) 
(d) 
Figure 17 dl-Aspartic acid crystals grown after 24 h beneath pAcGlcEMA and pAcGalEMA films 
at n = 20 mN m"' from a 100% supersaturated solution at 20 °C (magnify x500). a), 
{111} Attached face (pAcGalEMA film); b), {110}_attached face (pAcGlcEMA film); 
c), { 2 02} attached face (pAcGlcEMA film); d), { 2 02} attached face (pAcGalEMA 
film). 
It can be seen that the crystal faces that grew attached to pAcGlcEMA and 
pAcGalEMA films in these conditions were namely {111} and {110}, with a smaller 
proportion of { 2 0 2 } . In both cases, the largest crystals seemed to grow with faces 
{111} bound to the films. Again the attached faces could be recognized by the high 
density of surface structure effects. The typical "hopper" growth, occurring outwards 
in all directions from a focal region, was also evident (Figure 17). 
Further crystallisation experiments were carried out using the 100% 
supersaturated solution of dl-aspartic acid as the subphase and pAcGalEMA (Mn = 
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33,200 g mol"') as the film material. The limiting area per monomeric unit at high 
surface pressure for this polymer of lower molecular weight was ~ 42 A^. The 
monolayer was compressed at 20 mN m'' . Interesfingly, the film was still found to act 
as a nucleation promoter, but its effectiveness was lower than that of the 
corresponding polymer with higher molecular weight with a limiting area per 
monomeric unit o f ~ 30 A^. Pictures of the crystals observed at the surface between 
the barriers are reported in Figure 18. 
Figure 18 
(C) 
^ 1 i ^ . ^ ^ • 
if. 
(d) 
dl-Aspartic acid crystals grown after 24 h beneath pAcGalEMA (M„ - 33,200 j 
film at n = 20 mN m'' from a_100% supersaturated solution at 20 °C (magnify x 
b), Aggregates; c-d), namely {111} faces grown attached to the film. 
I mol"') 
100). a-
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The crystals observed on the surface between the barriers after 24 h showed a 
morphology analogous to that determined from the previous experiments, with the 
{ 1 11}, {110} and, in small quantity, { 2 02} faces grown attached to the film. Again, 
the largest crystals seemed to grow bounded through the { 1 11} faces. However, the 
number of crystals was significantiy smaller than that reported for pAcGlcEMA (Mn = 
61,600 g mol"') and pAcGalEMA (Mn = 63,000 g mol"'), with few aggregates visible. 
Moreover, the crystals appeared to be larger and slightiy more uniform in size than 
those showed in Figures 15-17. This suggests that once the crystal nuclei were 
formed, subsequent crystal growth occurred on these nuclei at the expense of fresh 
nucleation^'^l Isotherms recorded for this polymer over aqueous and saturated dl-
aspartic acid solution (Figure 1 9) showed that the extent of amino acid adsorption 
onto the film at 20 mN m'' was comparable to that determined for pAcGlcEMA (Mn = 
61,600 g mol' ') and pAcGalEMA (Mn = 63,000 g mof") at the same surface pressure. 
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Figure 19 U-A curves of pAcGalEMA (M„ = 33,200g mol') on pure water and on saturated dl-
aspartic acid solution at pH « 3 and at 20 °C. 
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Since, as has already been pointed out, nucleation beneath monolayers relies 
on a degree of molecular recognition between the film and the nucleating species, the 
structural/geometric correlation must be lower for pAcGalEMA (Mn = 33,200 g mol'') 
than for pAcGlcEMA (Mn = 61,600 g mol"') and for pAcGalEMA (Mn = 63,000 g 
mol' '). In other words, the larger area per monomeric unit of the former Langmuir 
monolayer may result in a greater mismatch between the film and the growing crystal 
lattice structures; increased mismatch that could not be fizlly accommodated by the 
very likely higher compressibility of this film compared to that of pAcGlcEMA and 
of pAcGalEMA with the highest molecular weight. Thus, whilst a significant 
adsorption of the nucleating species could still take place onto this more expanded 
film, the resultant arrangement of dl-aspartic acid molecules was less suitable to 
induce crystallisation of the bulk phase, decreasing the density of crystals obtained. 
More experiments would be required in order to assign rigorously the 
mechanism through which these glycopolymer films induce epitaxial growth of dl-
aspartic acid. Experiments at higher surface pressures would reveal i f nucleation 
would be favoured by increasing the order of the organic template. Most importantly, 
investigations dedicated to the determination of the structure of the polymeric films 
would be essential. Polymers, in fact, behave rather differentiy from monomeric 
surfactants. It is already difficult to decide whether or not polymers are forming true 
monolayer films. Thus, for example, it is generally assumed that the polymer disposes 
itself at the surface so that each monomer segment is constrained to remain anchored 
at the interface throughout the experiment. However, it is easily possible that each 
polymer molecule has only a few of its polar headgroups anchored to the surface, 
while the rest actually extends into the adjacent bulk phase'^ '^l It is also possible that 
the polymer maintains at the surface its solution structural organisation (i.e. coils), as 
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has been found for some proteins for which the film is viewed as formed from intact 
a-helices'^'"l 
Nevertheless, keeping in mind that there is no straightforward relation between 
the results obtained for monomeric surfactants and polymeric materials, a latter aspect 
of the results obtained in the present study may be underlined. It has been found that 
when epitaxial growth occurs under a partially compressed or uncompressed film, 
thanks to the capability o f the latter to reorganise itself in order to optimise the 
geometric and stereochmical match with the to-be-grown crystal, crystallisation is less 
specific, leading to more than one crystal morphology. The film is able to reorganise 
into more arrangements that m imic planes in the bulk crystal a nd different c rystal 
faces can nucleate at the same surface pressure^^l This behaviour was observed in this 
study, where crystals were found to grow with faces {111} , {110} and, in small 
quantity, {202} attached to the films. This would, therefore, suggest that 
pAcGIcEMA and pAcGalEMA films possess a certain degree of compressibility 
which allow them to accommodate eventual mismatches with the nucleating species, 
leading to arrangements of the adsorbed dl-aspartic acid molecules compatible with 
the { T i l } , {110} and {202} faces. 
3.2.3 INHIBITION O F D L - A S P A R T I C A C I D G R O W T H BY 
G L Y C O P O L Y M E R S 
Preliminary studies of the crystal growth inhibition activity of the deprotected 
analogues, pGlcEMA (5a) and pGalEMA (5b), were performed. Crystals were grown 
at room temperature in a 100%) supersaturated dl-aspartic acid solution at 20 °C, 
containing pGlcEMA or pGalEMA (Figure 20b-f). The habit of the crystals obtained 
was compared with that of crystals grown in supersaturated solution only (Figure 
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20a). The presence of the polymers in solution seemed to affect the morphology of the 
resulting crystals. 
(a) 
1 
Ih) (c) 
(d) (e) (f) 
Figure 20 a), dl-Aspartic acid crystals grown in homogeneous conditions in supersaturated solution 
only; b-c), dl-aspartic acid crystals grown in 100% supersaturated solution containing 10 
mg ml"' of pGalEMA; d-0, dl-aspartic acid crystals grown in 100% supersaturated 
solution containing 10 mgml"' of pGlcEMA. 
Factors governing nucleation promotion and crystal growth inhibition are the 
same: both phenomena depend on the extent to which a foreign matrix can produce 
adsorption 0 f , or adsorb onto, respectively, a particular crystal face. In the case of 
crystal growth inhibition the foreign material adsorbs onto a crystal face exposing its 
hydrocarbon "tails" at the surface and so reducing subsequent growth upon that face 
(Figure 21). Therefore, this face, having the lowest rate of growth, wi l l dominate the 
resultant crystal morphology. 
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Comparison o f the morphologies o f the obtained crystals with those predicted 
by computational modelling^, revealed that pGalEMA seemed to affect dl-aspartic 
acid growth by adsorbing onto faces { 1 1 1 } (Figure 22) and {110}. pGlcEMA 
appeared to behave similarly and the majority o f crystals obtained seemed to have 
{110} as the dominant face (Figure 23). 
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(a) (b) 
Figure 22 a), di-Aspartic acid grown in 100% supersaturated solution containing 10 mg ml"' of 
pGalEMA; b), crystal morphology as predicted by computational modelling with 
Cerius^, showing a dominant { 1 1 1 } face and compatible w i th the morphology 
experimentally obtained. 
^ Cerius^ program using a Bravais Friedel Donnay Barker (BFDH) method. The comparison was 
carried out by measurement o f the face angles. 
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(a) 
(b) 
Figure 23 dl-Aspartic acid grown in 100% supersaturated solution containing 10 mg ml ' of 
pGlcEMA; b), crystal morphology as predicted by computational modelling with 
Cerius-, showing a dominant {110} face and compatible with the morphology 
experimentally obtained. 
Although further investigations are absolutely required in order to assess 
whether these glycopolymers can actually work as crystal growth inhibitors, it is 
interesting to note that the pGlcEMA and pGalEMA appeared to inhibit the growth o f 
faces { 1 1 1 } and {110}, which are exactly those that predominantly nucleated 
beneath films o f the protected, insoluble analogues. This correspondence suggests the 
reliability o f the results obtained for pGlcEMA and pGalEMA. 
3 . 3 E X P E R I M E N T A L 
3.3.1 G E N E R A L 
dl-Aspartic acid was purchased in its purest available form, 99%, from Sigma. 
The polymers used were prepared according to the procedures reported in Section 
2.3.3. The octadecanoic acid used in the preliminary U-A runs was 99% pure, 
supplied by Aldrich. Ultra-pure Mill i -Q water with a resistivity o f 18 M Q m was used 
throughout the experiments, both in preparing the dl-aspartic acid solutions and in all 
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the Yl-A runs. Each f i lm material was spread from a 99.9% HPLC grade chloroform 
solution, purchased from Aldrich. 
3.3.2 T R O U G H C L E A N I N G P R O C E D U R E 
Purity and protection from contamination are of utmost importance in 
monolayer experiments. Due to the very small amount of material used - typically 
properties of a f i lm containing « 1 mole have to be measured - , any contaminant 
present can cause serious effects. Therefore, great care has to be taken to ensure that 
the troughs and the barriers are clean and the chemicals used are as pure as possible. 
A scmpulous trough cleaning p rocedure was adopted: before each e xperiment, the 
trough and the barriers were first rinsed with ultra-pure Mill i-Q water. Then, they 
were cleaned with a special surfactant-free tissue soaked in chloroform and again 
rinsed with ultra-pure Mill i -Q water. During all the procedure disposable powder-free 
plastic gloves were worn to prevent grease contamination from the hands. 
3.3.3 C R I T E R I A F O R A C L E A N SUBPHASE S U R F A C E 
Before spreading of the f i l m on the subphase, the surface o f the latter was 
checked for any surface impurities. The trough was filled with the subphase solution 
with the barriers at their maximum area position. The surface pressure of the subphase 
was taken as zero. The barriers were then moved inwards until their minimum area 
position. When the balance reading did not increase by more than 0.5 mN m"' during 
the compression, the subphase solution was considered suitably free from surface 
active contaminants. Any surface impurity present could be removed from the surface 
using a clean pipette attached to a water pump until a clean surface was obtained. 
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3.3.4 F I L M SPREADING 
Ultra-pure chloroform was chosen as a suitable solvent for the spreading of the 
f i lm materials. The films were added drop-wise to the subphase from « I mg ml"' 
solutions, using a micro-syringe, which could measure 1 | i l quantities of the film 
solution. The syringe was held no further away than 1 cm from the surface to prevent 
any film solution sinking to the trough bottom. The solvent was allowed to evaporate 
between each addition by waiting 10 seconds before the next drop was added. 
3.3.5 U-A I S O T H E R M S 
A l l n-^ isotherms were recorded using an automated Langmuir trough (NIMA 
Technology Ltd.), type 601A (30 x 20 x 0.5 cm^), containing w 350 cm^ when filled 
so that a convex meniscus formed (Figure 24). 
Figure 24 Langmuir trough (type 601 A) used for U-A curves determination. 
The Wilhelmy plate was made of a piece of filter paper connected, via a light 
metal hook, to a microbalance. I f it is assumed that the contact angle, 9, between the 
Wilhelmy plate and the liquid phase in the trough is zero, i.e. complete wetting of the 
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plate occurs, then it is possible to relate the weight measured by the microbalance to 
the surface pressure. A fresh plate was used for each experiment. 
Typically, 50 yd of film solution of approximately 1 mg m f ' were added to the 
surface. The film solution concentrations used were 1.00 mg m f ' for octadecanoic 
acid, 1.04 mg ml"' for pAcGlcEMA, 1.08 mg ml"' for pAcGalMEA and 1.05 mg mf ' 
for pAcLacEMA. After the spreading, the chloroform was allowed to evaporate 
waiting 3 minutes before the initial surface pressure reading was taken. The fi lms 
were spread on pure water (neufral and acidic pH) and on saturated dl-aspartic acid 
solution. The barriers were then moved under computer confrol, changing the surface 
pressure (IT) and the area per repeating unit (A) of the films. n-/i isotherms were 
recorded protecting the frough with its fransparent cover to avoid contamination of the 
surface. 
3.3.6 P R E P A R A T I O N O F SUPERSATURATED SOLUTIONS 
The required amount (see Appendix II) of dl-aspartic acid was added to 500 
ml of Mil l i -Q water and heated until all the crystalline material had dissolved. The 
solution was then filtered in a conical flask using the pre-heated filtering apparatus 
shown in Figure 25. The filtration was conducted under atmospheric pressure, since 
raising the pressure beyond this could cause the tearing of the 0.22 ^m filters through 
which the solution flowed. Filters of this pore size removed any dust particles 
possibly present within the solution. After the filfration, the solution was kept, 
covered, at a temperature of at least 10 °C above its saturation temperature for two 
hours, in order to dissolve any microscopic crystal nuclei that could have passed 
through the filter. Then, the solution was left at room temperature ovemight. The next 
day it was used for the nucleation studies, unless it contained crystalline material. The 
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remainder of the solution was kept covered throughout the experiment as a control, to 
check that no crystals would nucleate in the supersaturated solution alone. 
Figure 25 Filtering apparatus. 
3.3.7 N U C L E A T I O N E X P E R I M E N T S 
Nucleation experiments were carried out by means of an automated Langmuir 
trough (NIMA Technology Ltd.), type 601M (15 x 7 x 0.5 cm^), containing 70 cm'' 
when filled so that a convex meniscus formed. The sapphire window present on the 
base of the trough made it ideal for the analysis in situ of crystal growth and shape. 
The apparatus was fitted with an optical microscope, which was in turn connected to a 
digital camera and to a TV screen. The formed crystals could so be visualised and 
photographed. The equipment is shown in Figure 26. 
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Figure 26 Langmuir trough (type 601M) fitted with the optical microscope connected to the digital 
camera and to the TV screen. 
To avoid crystallisation upon the Wilhelmy plate, it was decide to use a thin 
platinum strip of set width. Before each experiment the plate was cleaned by dipping 
it into a concentrated hydrochloric acid solution and subsequent fiaming. 
7 |j.l of the film solution were added to the surface and, after evaporation of the 
chloroform, the film was compressed to the desired surface pressure. For all 
experiments it was decided to work with an initial surface pressure larger than zero. 
This was unavoidable, since any reduction in the amount of film material used would 
have required a compression of the film at too small areas in order to attain the 
desired n. Nucleation under films at a small area would obviously have been 
disadvantageous. Moreover, the surface pressure was not maintained constant during 
the experiment because the continued movement of the barriers required to 
recompress the monolayer at the set n could have disrupted the orientation of any 
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small crystal nuclei under the film and would have increased the loss of material from 
the surface. 
The frough was covered throughout the 24 h of experiment with a plastic sheet 
to reduce the possibility of any impurity entering the system. Water evaporation from 
the trough during the experiment, which increased the dl-aspartic acid solution 
supersaturation and which was found to cause the loss of the solution up to 30%, was 
reduced by placing two 2 lifres beakers of water kept at 70 °C under the sheet 
covering the frough. 
3.4 C O N C L U S I O N S 
Glycopolymers carrying peracetylated mono- and disaccharide residues, 
pAcGlcEMA, pAcGalMEA and pAcLacEMA, were found to form stable spreading 
Langmuir films on pure water at neufral and acidic pH. As expected for polymer 
films, 11-^ curves were in all cases smooth. The glycopolymers bearing the 
monosaccharide residues gave monolayers characterised by limiting area per 
monomeric unit at high surface pressures approximately equal to 30 A^, whereas the 
same parameters was approximately double for the film formed by the polymer 
containing peracetylated lactose units in the side chains. 
pAcGlcEMAand pAcGalEMA of approximately number-average molecular 
weight of 60,000 gmof ' Langmuir films were found to act as efficient dl-aspartic acid 
nucleation promoters. In both cases crystals were obtained in high density and 
appeared to grow mainly bounded through the { 1 11} and {110} faces and, in a 
smaller proportion, through the {202} face. The faces grown attached to the films 
showed the numerous surface stmcture effects typical of epitaxial growth. They 
appeared enlarged compared to the corresponding faces of crystals grown 
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homogeneously from solution, as expected for the case of a diffusion limited growth. 
These faces also showed "hopper" growth, with the growing process proceeding 
outwards in all directions from an initial site of nucleation. pAcGalEMA with 
number-average molecular weight of approximately 30,000 g mof ' also showed 
activity as a dl-aspartic acid nucleation catalyst, although with a lower efficiency 
compared to the analogue with higher molecular weight. The crystals nucleated 
beneath its Langmuir film appeared again to grow with faces {111} and {110} and, 
in a smaller proportion, {202} attached to the monolayer. Crystals were less 
numerous but larger and more uniform in size relative to those grown beneath films of 
pAcGlcEMA and pAcGalEMA with Mn « 60,000 g mof". 
As expected from the parallelism between n ucleation promotion a ctivity of 
surfactants and crystal growth inhibition properties of the corresponding soluble 
analogues, the deprotected glycopolymers, pGlcEMA and pGalEMA, appeared to 
inhibit dl-aspartic acid growth. In particular the growth rate of faces {111} and 
{110} seemed to be reduced by the presence of the polymers in solution, resulting in 
crystals having morphologies dominated by these faces. Although only few crystal 
growth inhibition studies were carried out, the finding that the faces that grew 
attached to the monolayers of the protected polymers were the same as those whose 
growth was inhibited by the deprotected analogues suggests that pGlcEMA and 
pGalEMA may actually possess a certain crystal growth inhibition activity. Further 
crystal inhibition studies wi l l enlighten this latter aspect. 
Nucleation experiments carried out at different surface pressures, together 
with a detailed investigation of the stmctural properties of the films, could certainly 
provide information about the mechanism through which the monolayers induce the 
observed epitaxial growth. With regard to this, experiments where pAcLacEMAis 
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used as the film material (with the film possessing a limiting area per monomeric unit 
at high surface pressure double relative to pAcGlcEMA and pAcGalEMA films) 
would also give important additional data. 
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PROPERTIES OF DEPROTECTED 
GLYCOPOLYMERS 
4.1 I N T R O D U C T I O N 
Protein-carbohydrate interactions are involved in a mjoiad of human 
biological processes, including the initiation of several kinds of infections and 
diseases, trafficking and clearance of glycoproteins, immune defence, fertilisation, 
recruitment of leukocytes to inflammatory sites, malignancy and metastasis''"^'. 
Synthetic saccharides would therefore find wide employment in the invesrigation of 
biochemical phenomena proceeding through cellular recognition and in the design of 
new dmg systems. Non-cytotoxic pharmaceuticals could be developed, consisting of 
molecules able to inhibit the initial pathogenic carbohydrate-mediated adhesion to the 
host cell. Alternatively, efficient macromolecular dmg carriers designed to deliver the 
dmg exclusively to those cell types which require the treatment, so minimising 
adverse side effects and reducing the cost of the therapy, could be produced. 
However, attempts to synthesise high-affinity specific compounds have been 
frustrated by the low intrinsic affinity of the protein-carbohydrate interaction. Typical 
binding constants of monovalent mono- and oligosaccharide ligands to specific lectins 
are in the range 10^-10^ M'^'^^l Nature has overcome the intrinsic weakness of binding 
through multivalency: lectins typically exist as oligomeric stmctures in physiological 
conditions. Therefore, the preparation of multivalent compounds able to bind to 
multivalent targets seems a promising strategy in the search for high-affinity protein 
ligands. The activity enhancement of a multivalent ligand compared to the 
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corresponding monovalent saccharide on a valency-corrected basis, defined as the 
"cluster glycoside e f f ec f is nowadays generally accepted. However, the physical 
origin of the phenomenon is still not well understood'^ '^ .^ It has been repeatedly 
pointed out that both structural and energetic aspects of the lectin-carbohydrate 
interaction have to be elucidated, i f a deep understanding of the process is to be 
a c h i e v e d ' ^ ' F r o m an energetic point of view, the delicate balance between 
enthalpy and entropy needs to be revealed. Most techniques currently in use for the 
determination of the thermodynamic parameters of protein-ligand association directly 
provide only K values, which give little information about the forces involved in the 
complexation process. A / / and ISS are derived only indirectly by means of the van't 
Hof f equation and the assumptions required for the use of this equation question the 
accuracy of the values obtained. Isothermal tifration microcalorimetiy, ITM, is the 
only technique . which allows the determination of the thermodynamic binding 
parameters K, AG, A// , A5 and n (stoichiometry of binding, carbohydrate:protein) in a 
single experiment. 
Few calorimetric studies of multivalent carbohydrate-protein 
interactions'"''^''^"^'' (indeed few for any multivalent ligand^^ '^'^ ^ )^ have been reported 
so far. Moreover, I T M has been limited to small or dendritic glycoconjugates 
possessing a maximum number of carbohydrate residues equal to six. Despite 
hemagglutination inhibition studies (HIA), enzyme-linked lectin assays (ELLA), 
enzyme-linked immunosorbent assays (ELISA) and surface plasmon resonance (SPR) 
having shown the great potential of glycopolymers as high-affinity polyvalent ligands, 
calorimetrically derived thermodynamic data of their association with lectins have 
never been reported. The reasons may reside in the complexity of the system and the 
difficulties associated with the exact knowledge of the ligand composition and 
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structural features. Thus, high pure and strictly well-defined polymers are absolutely 
needed for a true understanding of the results obtained. Furthermore, polyvalent 
ligand-lectin interactions often proceed through an aggregative mechanism in which 
each ligand cross-links distinct protein molecules. This phenomenon may result in the 
precipitation of the aggregates, which, in turn, may hamper the I T M experiment. 
Thermodynamic parameters are, in fact, state functions and the enthalpy recorded is 
the sum of all processes occurring in the reaction cell. 
In this study, for the first time the interaction of polymeric glycoconjugates 
with a lectin was investigated by isothermal titration microcalorimetry. In particular, 
the binding properties of the glycopolymer carrying the galactose unit to peanut 
agglutinin (PNA, lectin from Arachis Hypogaea) were determined. As discussed in 
Chapter 2, deprotected polymers were obtained following two routes (designated A 
and B); polymerisation o f the deprotected glycomonomers (route A) and deprotection 
of the corresponding polymers (route B). A thorough investigation of the materials' 
properties revealed that the procedure of preparation strongly affected the polymer 
composition. Whilst the deprotecfion of the polymers (route B) resulted in an 
incomplete deacetylation and yielded products of ill-defined compostion, fully 
deacetylated, well-defined and pure materials could be obtained by polymerisation of 
the corresponding deprotected glycomonomers (route A). It was therefore interesting 
to test whether the polymer composition affected its binding properties. 
Prior to proceeding with the evaluation of the thermodynamic binding 
parameters, the behaviour of the deprotected polymers in aqueous solutions was 
investigated by dynamic light scattering (DLS). pGlcEMA-A,B and pGalEMA-A,B 
were found to self-assemble in water and buffer solutions. The aggregates formed 
were analysed by transmission electron microscopy (TEM) and environmental 
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scanning electron microscopy (ESEM). Considering that the enthalpy determined by 
I T M is the sum of all processes which take place in the sample cell, it is fundamental 
to assess all the phenomena that can contribute to the recorded heat value. 
The carbohydrate-protein interaction was probed in two ways. Initially, 
qualitative information was obtained by ultraviolet-difference spectroscopy. Due to 
the presence of tyrosine residues in the binding site'^ '* ,^ PNA develops a strong 
ultraviolet-difference spectrum on ligand binding'^^'^^l The presence of UV-
difference spectra indicated that all ligands bound to the lectin. 
Subsequently, calorimetric quantitative determinations of the thermodynamics 
of binding of D-galactose, GalEMA and pGalEMA-A,B for peanut agglutinin were 
performed. 
4.1.1 G E N E R A L A S P E C T S O F I S O T H E R M A L T I T R A T I O N 
M I C R O C A L O R I M E T R Y , I T M 
Isothermal titration microcalorimetry (ITM) allows the measurement of the heat 
flow in chemical, physical and biological processes and, therefore, their relative 
thermodynamic binding parameters'^^l 
I T M has been applied to a wide range of areas, including biological research and 
chemical and pharmaceutical industry^^°\ in order to determine the binding affinity of 
numerous types of interactions, such as nucleic acid-protein'^'\ protein-protein'^^'^''^ 
antigen-antibodyt^^""^ and protein-carbohydrate'"''^''^•^"•^^'^^l 
A schematic representation of a titration microcalorimeter is reported in Figure 
1. 
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Figure 1 Titration microcalorimeter showing reference cell and sample cell; the latter is fitted 
with a stirred syringe for injecting aliquots of a solution into the solution held in the 
sample cell. 
The sample and reference cells are brought to thermal equilibrium and then heated at 
a constant rate. Addition of the ligand to the sample cell perturbs this equilibrium in 
such a way depending on the enthalpy of the interaction. The resulting difference in 
temperature is detected by highly sensitive thermopiles (usually capable, as in the 
present experiment, to respond to temperature gradients of less than one millionth of a 
degree Celsius). As a result, a voltage proportional to the rate of heat energy transfer 
across the thermopiles is generated and the reference and sample cells are brought 
back to equilibrium. The reference cell is placed in parallel to the sample cell and it is 
also connected to the thermopiles. It contains the same volume as the sample cell. 
Therefore, any disturbances from the surroundings wi l l affect both sample and 
reference cells to the same extent and they wil l be subtracted from the total heat 
output. 
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Typically, for lectin-carbohydrate interactions, the lectin is placed in the 
sample cell and the ligand is added in a series of injections.. 
Raw data are in units o f power versus time. Integration with respect to time 
provides the binding isotherm, relating the heat to the ligand concentration. Assuming 
a model, the enthalpy (MI), the binding constant (AT) and the stoichiometry (;;) of the 
process are determined by non-linear least-squares analysis of the binding isotherm. 
The free energy of complex formation (AG) is then calculated from AG = -RTlnK 
and the entropy of binding determined as TAS = AH - AG. 
4.1.2 P E A N U T A G G L U T I N I N , L E C T I N F R O M ARACHIS 
HYPOGAEA 
Peanut agglutinin is a homotetrameric, non-glycosylated leguminous lectin. It 
is terminal D-galactosyl residue specific, with a particularly high affinity for the 
tumour-associated T-antigenic disaccharide [DGal/^1^3)DGalNAc, Thomsen-
Friedenreich antigen]. Each subunit, 27,000 ± 1,500 Da'''^', contains 236 amino 
acid residues and presents the well-known jelly roll tertiary structural fold, 
characteristic of all legume lectins'"*'' (Figure 2b). The tertiary structure is constituted 
by a six-stranded nearly flat sheet (sheet 1), a curved seven-stranded sheet (sheet 2), a 
small five-stranded sheet (sheet 3) which plays an important role in connecting the 
two larger sheets, and a number of loops which make up 54% o f the polypeptide 
chain. The arrangement of the loops gives rise to a second hydrophobic core between 
sheet 2 and the loops in addition to that between sheets 1 and 2'^ '^*' (Figure 3). 
Differences between the tertiary structures of peanut agglutinin and other legume 
lectins are largely confined to loops and chain terminii'^'l The two metal ions, Ca^ ^ 
and Mn^"^, are located at the same positions as in other legume lectins. 
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Figure 2 
(a) 
(b) 
a). Schematic representation o f the main-chain to main-chain hydrogen bonds present in 
all subunits. A hydrogen bond which connects Gly l03 N and Gly210 0 is not shown in 
the Figure; b), ribbon drawing o f a subunit in peanut lectin. The red and blue circles 
represent manganese and calcium ions, respectively. 
Figure 3 Stereo view of the buried hydrophobic residues (red) in the subunit with the main-chain 
shown in yellow. 
Despite having the same tertiary structure at the monomeric level, legume 
lectins exhibit considerable variation in their quaternary arrangement arising from 
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small changes in their sequence. Different modes o f dimerisation are possible, 
resulting in the formation o f the canonical dimer* observed in concanavalin A, pea 
lectin, favin and L. ochrus or o f the GS4 dimer characteristic o f G. simplicifoUa and 
E. corallodendroii^^^. Further association o f the dimers into tetramers is also 
observed, for instance in concanavalin A and peanut agglutinin. Unlike all the other 
well-characterised tetrameric proteins constituted by identical subunits, PNA has 
neither 222 {Dj) nor 4-fold (C4) symmetry. Instead, it exhibits the unusual "open'" 
assembly reported in Figure 4^^'^ 
Figure 4 Quaternary structure o f PNA complexed with lactose. Blue and white circles represent 
manganese and calcium ions, respectively. 
* See Chapter 1, Section 1.1.1.1. 
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Despite the lack of Di symmetry, it has been shown that peanut lectin tetramer 
is a dimer of a dimer'^''\ where the two dimers, 1-4 and 2-3, are constituted from two 
GS4 arrangements. The open quaternary association is stabilised mainly by 
hydrophobic, hydrogen-bonded and water-mediated interactions. While the 
dimerisation process results in the burial of 1920 surface area of which 71% is 
non-polar, the percentage of hydrophobic surface area buried during the further 
formation of the tetramer is relatively low. The dimers interact in such a way that 
monomers 1 and 2 associate in a canonical fashion except that the sheets do not 
interact directly, but by means of six water bridges. As a result, the 1-2 interface is 
intrinsically less stable than the analogous interface in Con PP^^. As with most plant 
lectins, the quaternary structure of PNA depends on the pH. The lectin is a tetramer at 
physiological pH'^^^, which dissociates reversibly into dimers at pH below 5.1. Below 
pH 3.4 the lectin is totally dimeric'^'*^ 
The protein in association with lactose was first crystallised at neutral pH in an 
orthorhombic form'^^^ and then at acidic pH in two monoclinic forms and one triclinic 
form'^^'. Subsequently, crystal stmctures of the complexes of the protein with methyl-
/?-galactose (MeGal)'^^^, the T-antigenic disaccharide (Tant)'^^"''^, A^-acetyllactosamine 
(LacNAc)'^^^ and lactose (Lac)'^"^ were reported (Figure 5). Residues in four loops -
75 to 83, 91 to 106, 125 to 135 and 211 to 216 - make up the carbohydrate binding 
pocket toward the top right of the subunits in legume lectins''*^^ A triad of amino acid 
residues is involved in the interaction with ligahds in almost all legume lectins: 
Asp83, Glyl04 (present in all legume lectins with the exception of Con A) and 
Asnl27 (in the PNA numbering scheme). Another invariant feature of the sugar-
binding sites is the presence o f an aromatic residue'^corresponding to Tyrl25 in 
PNA, which stacks against the sugar ring. These invariant features belong to the first 
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three loops mentioned, while interactions involving amino acid residues in loop 211-
216 appear to be primarily responsible for the sugar specificity o f each legume lectin. 
In fact, this loop is highly variable in terms o f length, sequence and conformation. 
AspW) 
GlyKM 
A M I 1:7 
r.iui:') 
AspXI l C:iy21-1 
6 
.•\5p8.1 
G]yl04 
(,1c 0 1 
(c) 
Figure 5 a), Stereo diagram of PNA-MeGal complex. The sugar is represented in red. The 
interacting residues (yellow-orange) are numbered in pink. Hydrogen bonds are 
represented by pink dotted lines. The water molecules (green spheres) are numbered in 
orange; b), crystal structure o f PNA-Tant complex. Water molecules are represented by 
violet spehers; c), stereo diagram of PNA-LacNAc complex. Colours as for 5a; d), 
crystal structure o f PNA-Lac complex. Colours as for 5b. 
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The four invariant hydrogen bonds Asp83 ODl-Gal 03, Asp83 0D2-Gal 04, Glyl04 
N-Gal 03 and Asnl27 ND2-Gal 03 can be seen in Figures 5a-d. The stacking 
interaction with the aromatic side chain of Tyrl25 is also shown in the stereo 
diagrams of PNA-MeGal and PNA-LacNAc complexes. The hydrogen bond between 
Asp80 0D2 and Gal 06 can also be observed in all four complexes. Further hydrogen 
bonds involve Ser211 OG, which belongs to the fourth loop (211-216). Water bridges 
involving W l and W2 occur in all four complexes: Gal 02 is connected to Glul29 
0E2 through W l and to Glyl04 N through W2. Gal 01 is connected to Ser211 OG 
and to Gly213 N through W8 in PNA-MeGal. The residues within 4 A from the 
sugars in PNA-MeGal, PNA-LacNAc and PNA-Lac complexes are listed in Table 1, 
together with the formed hydrogen bonds. Moreover, about 40 van der Waals contacts 
between these residues and the galactose moiety are m ade in each c omplex. A s a 
result, the position of the galactose ring is approximately the same in all cases 
examined. The number of residues within 4 A from the carbohydrate increases by one 
when the second sugar is added, with the number of van der Waals contacts raising to 
60. PNA binds the T-antigen 20 times more strongly than it binds lactose. As already 
said, the interactions between the galactose moiety and the protein are similar in all 
four complexes. As can be seen from Figure 5, the conformation of the disaccharides 
is such that 04 of the second ring of the T-antigen occupies the same position as 03 
of the glucose moiety in PNA-Lac. 04 is therefore hydrogen bonded to Ser211 OG 
and Gly213 N instead of 03 as in the other two disaccharides. The major additional 
interactions between the T-antigen and PNA, compared to the other disaccharides, 
occur through two water molecules involving the carbonyl O atom of the acetamido 
group: W3 connects the O atom to IlelOl O, while W4 connects it to Asn41 ND2 and 
to Leu212 N . These two water molecules also exist in the other complexes, but in 
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these cases they interact only with the protein, due to the lack of sugar atoms in their 
immediate vicinity. Therefore, the high specificity of PNA for the T-antigenic 
disaccharide appears to be generated by two water bridges, which illustrates the 
critical importance of water-mediated interactions in protein-carbohydrate binding. 
Table 1 Protein-sugars interactions. 
Protein atom Sugar atom Distance (A) in subunit 
1 2 3 4 
Metyl-^galactose 
Hydrogen bonds 
Asp83 O D l Gal 03 2.6 2.7 2.7 2.6 
G l y l 0 4 N Gal 03 3.2 3.0 2.9 2.9 
Asn l27ND2 Gal 03 2.S 2.9 2.9 2.8 
Asp83 0 D 2 Gal 0 4 2.7 2.7 2.8 2.7 
Ser211 OG Gal 0 4 2.8 2.7 2.8 2.7 
Ser211 OG Gal 05 3.2 3.5 3.6 3.3 
Asp80 0 D 2 Gal 0 6 3.0 3.2 3.3 3.0 
Residues within 4 A from the sugar 
AspSO, Ala82, Asp83, Glyl03, Glyl04, Tyrl25, Asnl27, Ser211 and Gly213 
A'-acetyllactosamine 
Hydrogen bonds 
Asp83 O D l Gal 03 2.6 2.5 2.8 2.8 
G l y l 0 4 N Gal 03 3.2 3.4 3.0 2.0 
Asnl27 ND2 Gal 03 2.9 2.S 2.8 2.7 
Asp83 0 D 2 Gal 0 4 2.7 2.8 3.0 2.8 
Ser211 OG Gal 0 4 2.7 2.8 2.9 3.0 
Ser211 OG Gal 05 3.0 3.3 3.6 3.3 
AspSO 0 D 2 Gal 06 3.2 3.5 3.3 3.4 
Ser211 OG GlcNAc 03 3.1 3.3 3.6 3.2 
Gly213 N GlcNAc 03 2.7 2.9 3.3 2.7 
Residues within 4 A from the sugar 
AspSO, Ala82, Asp83, Glyl03, Glyl04, Tyrl25, Asnl27, Ser211, Leu212 and Gly213. 
Lactose 
Hydrogen bonds 
AspS3 O D l Gal 03 2.67 2.43 2.58 2.49 
G l y l 0 4 N Gal 03 3.08 2.92 3.07 2.81 
Asnl27 ND2 Gal 03 2.S6 3.00 3.12 3.02 
Asp83 0 D 2 Gal 0 4 2.59 2.68 2.64 2.55 
Ser211 OG Gal 0 4 2.62 2.82 2.66 2.76 
Ser211 OG Gal 05 3.12 3.34 3.09 3.16 
AspSO 0 D 2 Gal 0 6 3.33 3.39 3.36 2.98 
Ser211 OG Glc 03 3.34 3.31 3.58 2.98 
G l y 2 1 3 N GIc 03 2.92 2.98 3.29 3.28 
Residues within 4 A from the sugar 
AspSO, Ala82, Asp83, Glyl03, Glyl04, Tyrl25, Asnl27, Ser211, Leu212 and Gly213. 
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A detailed study o f the water molecules in the combining sites o f the four 
complexes has been carried out'^^'. The 16 subunits o f the complexes, along with the 
hydration shells, were superimposed. A l l the water molecules within 5 A from any 
carbohydrate atom were considered to belong to the binding site. Such 
superimposition is reported in Figure 6. 
Figure 6 Stereo diagrams o f the water clusters (green), numbered in orange, in the binding site 
after superimposition o f the 16 subunits in the four complexes o f PNA. The numbering 
in green is for the T-antigenic disaccharide (pink) . The A'-acetyllactosamine is coloured 
in red. The surrounding peptide stretches (yellow-orange) are numbered in pink. 
Hydrogen bonds are represented by pink dotted lines. 
Most water molecules appeared in clusters, indicating their relative invariance in the 
binding sites. A cluster was defined as a set o f water molecules from different 
subunits in which all water O atoms are within a sphere o f 1.5 A radius with the 
average position as the centre. Water clusters W1-W6 are not displaced by sugar 
molecules in any o f the four complexes. The acetamido group displaces W7 in the T-
antigen complex. W8 and W9 are displaced by the second ring and they occur only in 
PNA-MeGal. W l , W2 and W5 form a network which bridges galactose and PNA at 
the primary binding site. W3 and W4 are also hydrogen bonded to the protein: W3 to 
I le lOl O and W4 to Asn41 ND2 and Leu 212 N . In PNA-Tant both hydrogen bond to 
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GalNAc 07, giving rise to the two bridges responsible for the high specificity of the 
lectin for this disaccharide. W6 is hydrogen bonded to W4, but not to any protein or 
sugar atom. Interestingly, as already reported for other carbohydrate-binding 
proteins'^^\ ordered water molecules can be found in the unligated form at positions 
corresponding to hydroxyl groups in the ligated form (for instance, a water molecule 
occupies the postion of GalNAc 07 of the T-antigen). In general, water molecules in 
the carbohydrate-binding region mimic the ligand to a substantial extent not only at 
the primary site, but also in the regions adjacent to it. Molecular dynamics simulations 
carried out for PNA-Tant and PNA-Lac complexes showed that the number of 
alternative binding modes is higher for the former than for the latter, resulting in the 
"breaking" of enthalpy-entropy compensation characteristic of the binding of 
monovalent sugars to lectins'^^l Moreover, mutational analysis at Leu212'^ ^^ and 
Asn4l'^'*' proved the critical role of these two amino acid residues in the binding of 
the T-antigenic disaccharide, strengthening the theory that non primary contacts, 
generally made through water molecules, are involved in imparting extraordinary 
specificity. 
The interaction of mono- and disaccharides with peanut agglutinin has been 
investigated by hemagglutination inhibition studies, fluorimetry, ultraviolet-difference 
spectroscopy, C-13 NMR, circular dichroism ( C D ) and molecular dynamics 
calculations (MD)'""^*'^ '^^ '^^ °'*^"^^1 The results reported from different groups showed 
good agreement. As already mentioned, the highest affinity was determined for the 
tumour-associated T-antigenic disaccharide, while the higher affinity for 
methylgalactopyranosides compared to galactose was attributed to the binding of 
sugars in the pyranose form''*^^ Between the galactosides, a slight preference for the 
a-anomers was detected, as the a-linkage is more sterically acceptable'^'l The 
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affinity increased with decreasing the temperature, especially for disaccharides. PNA 
in dimeric form (low pH) binds sugars with the same stoichiometry as the tetramer 
(one binding site per protomer) but with an association constant one order of 
magnitude lower than that for the tetramer'^^'^'*l Thermodynamic parameters 
determined by means of UV-difference spectroscopy, fluorimetry and isothermal 
titration microcalorimetry are reported in Table 2. In all cases, the interaction is 
enthalpically driven, as a result of the formation of direct and water-mediated 
hydrogen bonds and van der Waals interactions, and shows the typical enthalpy-
entropy compensation'^*''^ 
Table 2 Thermodynamic binding parameters of PNA-monovalent ligand interactions. 
Ligand 10"' X K AG AH AS 
m' kJ mo!"' kJ mol"' J mol ' K ' 
Methyl-a-D-Gal 1.8" -17.6" 
1.810.1 ' ' -18.510.1 '' -42 1 2 ' ' -79 + 6' ' 
3.08410.127' ' 
Methyl-^D-Gal 1.4" -17.2" 
1.010.1 -17.110.1 "' -43 1 3' ' - 8 7 1 9 ' ' 
1.87010.078'' 
D-Galactose 1.2" -16.7" 
Lactose 1.5" -17.2" 
1.310.1 
2 .0 ' -18.8 = -40.6' -73 ' 
Methyl-yS-D-Lac 1.410.1 -17.910.1 " -65 1 4 *" -1561 H*" 
/?-D-Gal(1^3)-D- 2 8 1 2 ' ' -25.410.2' ' -78 1 5 '' -1771 16" 
GalNAc 
T-antigen 20.6 ' -24.7' -59.0 •= -115' 
Mellmb-a-D-Gal 1.710.3 ' -18.4' 
Me\Jmb-/3-D- 3314'= -25.5 ' 
Gal(1^3)-D-GalNAc 
1 c . — 1-Jul 
Phosphate buffer, containing 200 m M NaCl, 10 °C, determined by UV-difference spectroscop/ . 
PBS, pH 7.2, 25 "C (for Methyl-a-D-Gal, Methyl->3-D-Gal and Lactose)^^^^; 10 m M phosphate buffer, 
containing 150 mM NaCl, pH 7.2, 25 °C [for Methyl-,5-D-Lac and y9-D-Gal(l->3)-D-GalNAc], 
determined by UV-difference spectroscopy^^^l " 50 mM Tris-HCl buffer, containing 500 mM MgCl2, 
1 m M CaCl2, 1 mM MnCh, pH 6.9, determined by f l u o r i m e t r / " l Phosphate buffer, pH 7.4, 25 °C, 
determined by ITM^'^^l ^ PBS, pH 7.4, 297.0 K for lactose and 297.9 K for T-antigen, determined by 
ITM^^"] 
^ See Chapter 1, Section 1.3.2.1. 
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4.2 R E S U L T S AND DISCUSSION 
4.2.1 S E L F - A S S O C I A T I O N O F D E P R O T E C T E D 
G L Y C O P O L Y M E R S IN AQUEOUS M E D I A 
pGlcEMA-A,B (5a-A,B) and pGalEMA-A,B (5b-A,B) tended to form 
aggregates in aqueous media. The aggregation of polymers was investigated by 
dynamic light scattering (DLS) and the critical aggregation concentration (CAC) 
determined. Curves of scattering intensity versus polymer concentration are reported 
in Figure 7. 
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Figure 7 Scattering intensity versus polymer concentration as determined by DLS. 
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It can be noted that the curves for deprotected polymers obtained by route A 
(polymerisation of the corresponding deprotected monomers) exhibited the typical 
behaviour of surfactants aggregating in aqueous media with a starting plateau and an 
increase of the scattering intensity corresponding to the critical aggregation 
concentration. CACs of pGlcEMA-A and pGalEMA-A were both ca. 1x10'^ mg ml' ' . 
On the contiary, the behaviour found for pGlcEMA-B and pGalEMA-B could be 
explained considering the presence of partially protected poljoners that did not form 
mixed aggregates with the frilly deprotected ones. As previously reported the 
deprotection of the polymers (route B) was not quantitative. 
The morphology and the size distribution of the aggregates were investigated 
by transmission election microscopy, TEM (Figure 8) and DLS (Figure 9), 
respectively. In all cases, the aggregates showed a spherical morphology and a core-
shell architecture, with size varying on a broad range - 15-500 nm - , as a result of the 
polydispersity of the polymers (Table 3). It can be noted that in general polymers with 
the highest molecular weights formed the largest aggregates. 
Table 3 Number- and weight-average molecular weights, dn/dc and effective aggregate diameter 
of deprotected polymers*. 
Polymer M„ 
g mol"' 
M„ 
g mol"' 
M„ IVI„ dn/dc 
m l g ' 
d (aggregates) 
nm 
pGlcEMA-A 23,000 60,000 2.61 0.131 21.5 
pGalEMA-A 461,000 1,019,000 2.21 0.140 42.4 
pGIcEMA-B 5,932 10,410 1.75 0.126 20.7 
pGalEMA-B 2,984 6,416 2.15 0.146 9.4 
The larger aggregates size observed by TEM compared to DLS was expected, 
considering that TEM measurements were carried out using solutions 10 times more 
concentrated than those employed for DLS. Nevertheless, the size and morphology 
* For the details of molecular weight measurements, see Chapter 2. 
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determined by TEM could be affected by the drying process required for the 
preparation of the samples: flattening of the particles could alter their real features. 
(a) pGIcEMA-A (b) pGalEMA-A 
(c) pGlcEMA-B (d) pGalEMA-B 
(e) CORE-SHELL ARCHITECTURE 
Figure 8 a-d), TEM micrographs obtained using 10 mg ml-' aqueous solutions (bars 800 nm); e), 
TEM micrograph showing the core-shell structure observed for all aggregates (bar 300 
nm). 
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The observed core-shell architecture is hardly understandable considering the 
structure o f the polymers. Moreover, fluorescence studies carried out using pyrene as 
hydrophobic probe showed no variations in the emission spectrum o f pyrene in the 
presence o f the polymers. In principle, the emission spectrum of pyrene changes 
depending on the polarity o f the environment. For surfactants forming micelle-like 
assemblies, on formation o f aggregates pyrene is encapsulated into the hydrophobic 
core o f the aggregates, with subsequent increase o f the intensity o f band 111 (X\u = 384 
nm) and decrease o f the band 1/band 111 ratio (A-i = 373 nm). Pyrene is largely used for 
the determination o f the critical micelle concentration (CMC) of surfactants. The 
aggregation o f pGlcEMA and its CAC in aqueous solution has been already 
determined by fluorimetry^^'l However, measurements carried out here did not show 
any variation o f the pyrene emission spectrum, indicating that the probe environment 
did not change when polymer aggregates were present in solution (Figure 10). 
water 
1 mg ml"" pGalEMA-A aq. solution 
1.0x10"H 
8.0x10N 
S 6.0x10 
~ 4.0x10' 
2.0x10' 
300 350 400 450 500 550 
Wavelength, XI nm 
Figure 10 Emission spectra o f pyrene in water and in pGa lEMA-A aqueous solution. A^xdi - 334 
nm. 
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Measurements were performed following several procedures for the sample 
preparation, including that reported for pGlcEMA, but results did not show any 
entrapment of pyrene into hydrophobic regions. Therefore, pGlcEMA and pGalEMA 
particles might be better envisaged as loose aggregates, as a result of inter- and 
intramolecular direct and water-mediated hydrogen bonds. Such aggregates have been 
reported and extensively studied for polyethylene oxide, PEO^^ '^ (Figure 11). 
T 
f&0-H«=>^C) 
H,0--H,0 
PEO--HP 
Figure 11 Schematic representation of hydrogen bonding between water and PEO, including 
water-water hydrogen bonds, and the corresponding chain conformation of 
poiy(ethylene oxide) (PEO) in aqueous solutions at high (a) and low (b) temperatures. 
ESEM studies were performed in order to investigate whether the drying 
process affected the aggregates' morphology (Figures 12-15). 
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Figure 12 ESEM micrograph obtained using 5x10"^ mg m l ' aqueous solution of pGalEMA-A, 
working at 3.0 Torr (wet mode). 
• '3 0Tofr 
Figure 13 ESEM micrograph obtained using 5x10"^ mg ml" aqueous solution of pGalEMA-A, 
working at 3.0 Torr (wet mode). 
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3.0 Torr 
Figure 14 ESEM micrograph obtained using 5x10"^ mg ml aqueous solution of pGalEMA-A, 
working at 3.0 Torr (wet mode). 
Acc.V Spot Magn Det WD Exp 
10.0 kV 3.0 48047X G S E 8.7 1 3,0 Torr 
500 nm 
Figure 15 ESEM micrograph obtained using 5x10'^ mg ml" aqueous solution of pGalEMA-A, 
working at 3.0 Torr (wet mode). 
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A large amount o f aggregates could be detected in solution, with diameter varying 
from approximately 50 to 500-600 nm, in good agreement with values determined by 
T E M . Unfortunately, it was not possible to obtain perfectly focused images of the 
particles in the wet mode and no conclusions could be drawn on the variation o f the 
aggregates' morphology upon drying. Nevertheless, as reported in Figure 15, the 
results seemed supporting the hypothesis o f loose aggregates. 
4 .2 .2 L E C T I N - L I G A N D I N T E R A C T I O N 
4.2.2.1 U L T R A V I O L E T - D I F F E R E N C E SPECTROSCOPY 
The interaction o f peanut agglutinin (PNA) with D-galactose, D-lactose. 
GalEMA and pGalEMA-A was qualitatively investigated by ultraviolet-difference 
spectroscopy. The spectra obtained are reported in Figure 16. 
0.06-
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< i 
-0.02-j 
-0.04-
-0.06 
GalEMA 
pGalEMA 
Lactose 
Galactose 
"270 280 290 300 310 320^ 
Wavelength, 11 nm 
Figure 16 UV-difference spectra o f peanut agglutinin with D-galactose, D-lactose, Ga lEMA and 
p G a l E M A - A . [PNA] = 8x10"' M , [ligands] = 2x10"'' M . The solutions were in 10 m M 
PBS at pH 7.4. 
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The presence of UV-difference spectra indicated that all ligands bound to the lectin. 
Interestingly, the intensity of the UV-difference spectrum increased in the order: D-
galactose, GalEMA, D-lactose, pGalEMA-A. Moreover, the addition of GalEMA and 
pGalEMA to the lectin solution generated a UV-difference spectrum showing a 
maximum at approximately the same wavelength. GalEMA and pGalEMA contain 
the same yS-D-galactosyl residue, whose position in the lectin binding site in PNA-
GalEMA and PNA-pGalEMA c omplexes m ay be assumed to b e s imilar. Although 
there is no demonstrated linear correlation between the intensity of the UV-difference 
spectrum and the ligand affinity, we were pleased to see broad agreement between the 
spectroscopic and calorimetric measurements {vide infra). 
4.2.2.2 ISOTHERMAL TITRATION MICROCALORIMETRY 
Once the binding was assessed by UV-difference spectroscopy, we proceeded 
to a quantitative determination of the thermodynamics by isothermal titration 
microcalorimetry. Calorimetric determinations of the binding affinity of D-galactose, 
GalEMA and pGalEMA-A,B for peanut agglutinin were performed. Reactant 
solutions were prepared in citrate buffer. Despite the limited solubility of PNA in this 
medium, citrate buffer was used in order to remove any possible contribution of 
buffer protonation effects to the enthalpic term. Citrate buffer, in fact, exhibits AHion = 
0 kJ mor' ' ' '^l As already mentioned, thermodjTiamic parameters are state functions 
and protein-ligand complexation, changes in protonation state and coupled equilibria 
are all reported as a single enthalpy value. Thermodynamic parameters were 
determined by non-linear least-squares analysis of the binding isotherms. Typical 
outputs of the raw microcalorimetry data, the binding isotherms and the best curve 
fittings determined for PNA-D-galactose and PNA-pGalEMA-A interactions are 
shown in Figures 17 and 18, respectively. 
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(b) 
Figure 17 a), Experimental calorimetric d ata f or t he i sothermal t itration a t 2 9 8 K o f D -galactose 
into PNA. [PNA] = 3 mg ml"', [Ligand] = 0.55 mg ml"'. The solutions were in 20 mM 
citrate buffer containing 150 mM NaCl, pH 7.4; b), corresponding binding isotherm and 
best fit curve to the data. 
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Figure 18 a), Experimental calorimetric data for the isothermal titration at 298 K of pGalEMA-A 
into PNA. [PNA] = 3 mg ml"', [Ligand] = 0.55 mgml"'. The solutions were in 20 mM 
citrate buffer containing 150 mM NaCl, pH 7.4; b), corresponding binding isotherm and 
best fit curve to the data. 
The model used in this study for the non-linear least-squares analyses was 
firstly designed for the determination of the thermodynamics of the interaction of 
DNA with cationic polymers^ '^*^ Its employment here was due to its unique property 
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of considering possible precipitation processes concomitant with or following the 
protein-ligand interaction. The nature of the model is critical for calorimetric analyses. 
In a l l cases the experimental data could not be fitted by curves generated by non-
linear least-squared deconvolutions carried out using a generally utilised model for a 
1:1 non-cooperative interaction where possible precipitation was not taken into 
account. The employment of the chosen model for the investigation of our protein-
carbohydrate systems was supported not only by the good agreement between the 
experimental data and the curve fittings, but also by dynamic light scattering 
measurements. Moreover, we were pleased to see good agreement of the 
thermodynamic binding parameters determined for D-galactose with those reported in 
the literature for the same ligand'^^l 
For all ligands, DLS measurements showed an increase of the intensity of the 
scattered light throughout the titrations (Figures 19 and 20), indicating a precipitation 
process accompanying the protein-sugar interaction. For D-galactose and the 
monomeric ligand, GalEMA, no significant increase of scattering intensity was 
observed until sugar:lectin monomer ratios of ca. 1 (for both ligands when [PNA] = 
1.5 mg ml ' ' , in citrate buffer) and ca. 1.5-2 (for D-gal, [PNA] = 3 mg ml"', in saline 
citrate buffer) were reached. These values agreed with the interaction stoichiometry 
determined by I T M {vide infra). The results indicated that there was no significant 
precipitation at low ligand:lectin ratios; as the ratio increased and the interaction 
reached completion, precipitation occurred, probably due to a decrease of the already 
limited lectin solubility upon ligand binding. Indeed, the solutions, clear at the 
beginning o f the experiments, became cloudy during the titrations. 
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Figure 19 Scattering intensity measurement for PNA-ligand complexes' formation. [PNA] = 1.5 
m g m l " ' . Each point represents the addition o f aliquots o f ligand solution, reproducing 
the titration experiments carried out by I T M . D-galactose was injected into buffer 
without lectin and buffer was injected into PNA as control. The experiments were 
carried out in 20 m M citrate buffer, pH 7.4 at 25 °C. 
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Figure 20 Scattering intensity measurement for PNA-ligand complexes' formation, a), Each point 
represents the addition o f aliquots o f ligand solution to PNA solution, reproducing the 
titration experiments carried out by I T M , [PNA] = 3 mg ml" ' ; b), each point represents 
the addition o f aliquots o f ligand solution to buffer without lectin; the error bars are 
within the symbols. The experiments were carried out in 20 m M citrate buffer, 
containing 150 m M NaCl , pH 7.4 at 25 °C. 
When pGalEMA-A was used as titrant, a significant increase o f the intensity o f 
scattered light was detected already after the first addition. The magnitude o f the 
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increase was much larger than that recorded for the monovalent ligands. These results, 
combined with what has just been reported for the monomer, GalEMA, and with the 
thermodynamic binding parameters determined by I T M (vide infra), would suggest 
the formation of large, cross-linked PNA-poljmier complexes, which phase-separate 
during the experiments. Formation of a precipitate was also observed by the naked 
eye. An intramolecular mechanism of protein-ligand interaction would result in the 
formation of a complex where intersite regions of the receptor surface are covered by 
polymer segments rich in hydrophilic groups, which would not be expected to lower 
the lectin solubility. Moreover, pGalEMA is highly soluble in aqueous media. 
Therefore, as a first approximation, the effect of pGalEMA chelation upon PNA 
solubility could be expected to be analogous to that determined for GalEMA i f an 
intramolecular mechanism was operating, i.e. a lower increment of scattered light 
would be recorded. Again DLS measurements showed good agreement with 
calorimetric results: a plateau was reached at the same addition/injection for 
analogous experiments. 
Calorimetrically determined thermodynamic binding parameters are reported 
in Table 4^ As expected monovalent ligands gave rise to enthalpically driven protein-
ligand interactions, exhibiting enthalpy-entropy compensation'''''''''^ The favourable 
enthalpic contribution arises from the formation of direct and water-mediated 
hydrogen bonds and van der Waals interactions, while the negative entropic term may 
be mainly attributed to the loss of degrees of freedom of the ligand upon binding'^^'l 
The values of K and n for D-galactose were approximately 1x10'^ M ' ' and 1, 
respectively, and showed good agreement with those previously reported'^^l 
^ Data presented here are the mean of a minimum of three replicate titrations for each experiment. 
Since molar concentrations of the reactants rather than their activities were used, the subscript "obs" 
was affixed to the calculated binding parameters. 
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GalEMA exhibited a 5-fold enhanced binding affinity compared to D-galactose, due 
to an increase of -Aff** uncompensated by -ASf. This result is in agreement with the 
previously reported specificity of PNA for sugars in the pyranose form^''^'. 
Significantly different thermodynamics were determined for polymeric ligands. On a 
valency-corrected basis, pGalEMA-A exhibited a 50-fold affinity gain compared to D-
galactose and a 10-fold enhancement with respect to the corresponding monovalent 
ligand, GalEMA. A significant diminution of enthalpy was determined: -Aff 
decreased fi'om ca. -23 kJ mol"' for D-galactose to ca. -6 kJ mof ' for pGalEMA-A. 
On the contrary, the entropic contribution became favourable, varying fi-om negative 
for the monovalent ligands to positive for the polymer. In particular, for pGalEMA-A 
approximately 75% of ACf arose fi-om the favourable entropy term. 
It is interesting to compare the results obtained for the two polymeric ligands 
pGalEMA-A and pGalEMA-B^^ An affinity enhancement was still detected for 
pGalEMA-B compared to D-galactose and GalEMA: approximately 1 0-fold and 2-
fold, respectively. With respect to the monovalent compounds, the polymer 
interaction was still characterised by a decrease of -A / / ' and a favourable AS". 
However, its affinity for the protein was much lower than that of pGalEMA-A. The 
binding constant diminished by approximately 5-fold, due to the reduction of the 
favourable entropic term, TA^", fi^om ca. 20 kJ mol"' for pGalEMA-A to ca. 3 kJ mof 
' for pGalEMA-B. - A l f , instead, raised to ca. -20 kJ mol"', giving a more favourable 
contribution than that reported for pGalEMA-A. The stoichiometrics observed for the 
*' Mfu A l f j , n and n, are all model parameters. The results are discussed in terms of A//*i and n. t j f i 
was less significant and mostly invariant regardless the ligand type. Furthermore, A / / ' , and A//*, are 
mutually related by model assumption; therefore, changes in M f i are reflected in A//", values, n, was 
approximately equal to n for all experiments. 
" pGalEMA-A: M„ = 461,000 g mol"' with M„/M„ = 2.21; pGalEMA-B: M„ = 2,984 g mol" with 
M„/M„ = 2.15. 
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protein-carbohydrate interactions were also intriguingly different, being 1.5 and 11 for 
pGalEMA-A and pGalEMA-B, respectively. As mentioned above, the polymer 
deprotective step involved in the synthesis of pGalEMA-B is non-quantitative, 
resulting in a polymeric material of ill-defined composition, where partially or fiilly 
protected sugar residues, unable to bind (efficiently) to the lectin, are still present. 
Thus, the lower affinity of pGalEMA-B relative to pGalEMA-A and the higher 
number of carbohydrate residues per lectin monomer required for the interaction can 
easily be understood, considering that not all the sugar residues can, in principle, be 
recognised by the protein. This confirmed our expectations that fully deprotected 
polymers and partially acetylated ones would possess different functional properties. 
Importantly, it unambiguously shows how strongly the polymer binding properties are 
affected by its composition, leading again to the indispensability of highly pure and 
strictiy well-defined materials. 
According to Toone and co-workers'"''^', a decrease of the binding enthalpy 
(in absolute value) can be considered as the thermodynamic signature of an 
endothermic intermolecular aggregative process superimposed on an exothermic 
ligand binding event, which is assumed to proceed with thermodynamic parameters 
equivalent to those of the corresponding monovalent saccharide''^'. Therefore, the 
thermodynamic parameters evaluated for polymeric ligands in this study, and 
especially those for pGalEMA-A, can be related to an affinity enhancement mainly 
achieved through the formation of cross-linked ligand-protein complexes''^''^''*', 
which phase separate during the titration. A significant amount of precipitate was 
always observed in the cell at the end of the calorimetric measurements. In analogy 
with the hydrophobic effect responsible for the micellisation of surfactants in aqueous 
media, the significant favourable entropic contribution might then be explained by the 
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release of structurally ordered water molecules from the hydration shells of protein 
tetramers brought close to one another by the aggregation (each peanut agglutinin 
tetramer is surrounded by 518 molecules of water'^"'). This hjqjothesis was also 
supported by dynamic light scattering measurements. 
At least two phenomena have to be taken into account in the search for a 
justification of the determined protein-pGalEMA-A binding stoichiometry of 
approximately 1.5. First of all, the proximity of carbohydrate residues to each other 
within the polymer might prevent the interaction of all the sugars, due to steric 
hindrance. Secondly, the observed precipitation of the cross-linked aggregates would 
decrease the number o f binding sites available in solution. Lectin-carbohydrate cross-
linked complexes have been found to generally occur during protein-multivalent 
ligand interactions''^"'*'''''^'. Their formation was found to depend on several factors, 
including the valencies of the two interacting molecules, the structural arrangement of 
the ligand epitopes, the binding sites and the subunits of the lectin. When both 
valencies are greater than two, 2- and 3-dimensinal cross-linking was reported, giving 
rise to highly ordered complexes. 
Rao et a/.'^ '^^ '^ recently measured the thermodynamics of the interaction of a 
trivalent derivative of D A D A (D-Ala-D-Ala) and of Lac-R'd-Lac with a trivalent and a 
divalent derivative of vancomycin, respectively. The observed affinity enhancements 
compared to the monovalent analogues were in both cases certainly reached by means 
of an intramolecular mechanism. Both -AH and -AS were found to scale 
proportionally to the number o f epitopes, behaviour not observed in this study. 
Despite glycopolymers possessing a carbohydrate residue per monomeric unit 
have been shown to bind lectins through a chelation mechanism'"', the 
thermodynamic data, the stoichiometry of the interaction, DLS measurements and the 
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lack in the polymeric structure of portions resembling the protein surface, which could 
lead to favourable interactions in a chelation process, indicate that the polymers 
analysed in this study are likely to act mainly by aggregating distinct PNA 
tetramers^'^l 
Addition of salt slightly affected the interaction of D-galactose with the lectin. 
Only a small decrease of the binding constant was evaluated with a slight increase of 
the sugar:lectin subunit ratio. Binding isotherms became less steep as a result of the 
diminished affinity strength. On the contrary, the presence of NaCl critically affected 
the interactions o fGa lEMA and pGalEMA. Calorimetric studies o f PNA-GalEMA 
binding under these conditions were no longer possible, probably due to the too low 
[PNA monomerJ AT product'^^l The binding constant of pGalEMA-A decreased to ca. 
6x\0'^ M'\ approximately 7-fold lower than that determined in the absence of salt. 
The enthalpy change was not strongly affected, becoming slightly more favourable, 
while TA^ almost halved. A lower incidence of the endothermic, entropically driven, 
aggregation process would result in a more favourable enthalpic term and a decrease 
of the positive entropic contribution. A further increase in the amount o f salt still 
further reduced the binding constant of PNA-polymer interaction to ca. 1x10"^ M"', as 
shown by experiments carried out in 50 mM Tris-HCl buffer containing 500 mM 
MgCl2, 1 m M CaCl2 and 1 mM UnCh- Although Tris-HCl exhibits AHion = 46.02 kJ 
mol"' and buffer protonation effects may affect AH and AS values, favourable 
enthalpic and entropic contributions were still observed. An increase of n (which is 
not buffer dependent) up to 4 was determined. A weaker interaction would require an 
excess of polymer to reach protein binding sites' saturation. 
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It is interesting to note that blank experiments carried out injecting the 
polymer into citrate and Tris-HCl buffers gave significantly different results (Figures 
21 and 22). 
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Figure 21 a), Experimental calorimetric data for the injection of pGalEMA-A into buffer only. 
[polymer] = 0.55 mg ml"', 20 mM citrate buffer, containing 150 mM NaCl, pH 7.4, 25 
°C; b), corresponding calculated isotherms -A / / versus polymer effective concentration. 
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a), Experimental calorimetric data for the injection of pGalEMA-A into buffer only, 
[polymer] = 1 mg ml ', 50 mM Tris-HCl buffer, containing 500 mM MgCU, 1 mM 
CaClz and 1 m M MnCIa, p H 6.9, 25 ° C ; b) , corresponding calculated isotherms -A/ / 
versus polymer effective concentration. 
In both cases non-negligible heats of dilution were observed. It has been already 
discussed that DLS, TEM and ESEM measurements showed that deprotected 
glycopolymers tended to self-associate in water. DLS studies revealed that pGalEMA 
formed nanoaggregates also in citrate and Tris-HCl buffer solutions. Whilst 
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aggregates were present in the starting polymer solutions used for the I T M titrations, 
no trace of a ggregation could be detected at c oncentrations a s 1 ow a s those in the 
microcalorimeter cell after the first injection. Thus, the heats of dilution observed by 
I T M could be related to the dissociation of the aggregates under a certain critical 
concentration. Despite the fact that a ful l calorimetric study of the polymer behaviour 
in aqueous media was not carried out, it is worth noting that good agreement between 
the critical aggregation concentration values in the two buffer solutions determined by 
DLS and estimated by I T M was observed. A change of medium from water to saline 
citrate buffer seemed not to affect significantly the polymer behaviour in solution. In 
both cases CAC was close to 1x10'^ mg ml ' ' . In Tris-HCl, instead, pGalEMA-A 
aggregation appeared to occur at a higher concentration approximately equal to 4x10 
mg ml"', as determined by both techniques. In all media, the average diameter of the 
aggregates was close to 40 nm when the polymer concentration was ca. 1 mg ml"'. 
DLS measurements revealed that the aggregate dimension increased with increasing 
concentration. For experiments carried out in saline citrate buffer, this further 
association could be detected by microcalorimetry as an exothermic process (the 
intensity of the peaks reported in Figure 21a decreases until the CAC is reached, well 
above this concentration the intensity of the peaks increases due to the further 
association of the aggregates present in solution). 
It is worth noting that when the calorimetric experiments were performed in 
citrate buffer the dissociation of the polymer aggregates was exothermic, while the 
same was endothermic in Tris-HCl. Buffer protonation was therefore certainly 
involved in this deaggregation process. The exchange of protons between the buffer 
and the polymer might result i n electrostatic interactions somehow involved in the 
binding of pGalEMA to PNA. Moreover, ions resulting from the salt dissolution 
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would neutralise charges on the protein surface involved in intramolecular and 
intermolecular electrostatic interactions. Thus, a change in the quaternary structure of 
the protein could affect the chelation of different binding sites by the polymer. On the 
other hand, ptotein-protein attractive interactions, perhaps involved in the aggregation 
of tetramers cross-linked by the ligand, could be neutralised hampering the 
aggregation itself 
It is worthwhile to note that for experiments performed in citrate buffer 
thermodynamic data determined by subtracting heats of dilution (evaluated by means 
of blank titrations) from each binding heat or by subtracting the average dilution heat 
determined from the end part of the release heat titration profile^^'^ were substantially 
identical. Only a sHght decrease of A G " was observed, due to a slight decrease of the 
enthalpic term (Table 3). Therefore, the concomitancy of the polymer aggregates' 
dissociation process with the binding event did not prevent the determination of 
thermodynamic binding parameters. 
4.3 EXPERIMENTAL 
4.3.1 D Y N A M I C L I G H T S C A T T E R I N G , D L S 
Dynamic light scattering (DLS) measurements were performed using a 
Brookhaven RI 200SM goniometer and a BI-9000AT digital correlator, with a 
frequency doubled solid state Nd-YAG laser (;^ o = 532 nm) (for the determination of 
the critical aggregation concentration of pGlcEMA-A,B and pGalEMA-A,B in water 
and buffer solutions and for the determination of the aggregates' size distribution) and 
with a Malvern PCS4700 photon correlation spectroscopy assembly (Malvern 
Instruments, Marivem, UK) (for the PNA-ligand complexes' formation). Titrations 
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analogous to those carried out by I T M were performed adding aliquots of ligand 
solution to the lectin solution placed into the cell. The intensity of the scattered light 
was measured after each addition of the titrant and reported versus carbohydrate 
residues:lectin subunits ratio. Control experiments adding ligand to buffer and buffer 
to PNA were also performed. 
4.3.2 TRANSMISSION E L E C T R O N M I C R O S C O P Y , T E M 
Transmission electron microscopy (TEM) measurements were performed 
using a Philips C M 100 (compustage) transmission electron microscope operating at 
100 kV. One drop of a 10 mg'ml"' sample solution was put onto a coated copper grid 
and allowed to dry before analysis. 
4.3.3 ENVIRONMENTAL SCANNING E L E C T R O N 
M I C R O S C O P Y , E S E M 
A l l ESEM experiments a were carried out by a FEI XL-30 field emission gun 
instrument, with a Peltier sample stage and gaseous secondary electron detector 
(GSED), to produce an image. A l l samples were contained within a circular brass stub 
with a diameter of 1 cm and a depth of 0.5 cm. The temperature of the stub, and hence 
sample, was controlled using the Peltier cooling stage with a water/propanol coolant 
maintained at 283 K. A few drops of the undiluted sample were placed on the stub, 
left for a few minutes to equilibrate, before initiating pump down of the chamber from 
ambient to a few Torr. Images from the CCD camera confirmed that the sample 
remained stable, i.e. there was no 'boiling' of water during this pump-down procedure 
as t he method adopted (pumping down in steps) ensured that a high percentage of 
water vapor remained in the sample chamber/environment. In all cases, the sample 
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was cooled to ~ 275 K (2 °C) and surrounded by water vapor at a pressure of ca. 3 
Torr. Working distances were typically 8-10 mm and images were collected using an 
accelerating voltage of 5 keV. Under such conditions signal to noise ratio was 
maximized, sample dehydration minimized, and detailed high resolution images were 
obtained. Rod dimensions and their separation were subsequently determined directly 
from the images using computer software built into the ESEM. 
4.3.4 U L T R A V I O L E T - D I F F E R E N C E SPECTROSCOPY 
Ulfraviolet difference spectra were recorded on a Unicam UV2-100 
spectrometer, using masked semimicro cells of 1-cm path-length. Aliquots of 500 j^ l 
o f peanut agglutinin (PNA, Sigma, affinity-purified, salt-free lyophilised powder, 
activity < 0.1 fag ml ' ' ) solutions {ca. 2 mg ml"', ca. 80 f i M when 27,000 g mol"' was 
used as the molecular weight of PNA monomer, in PBS at pH 7.4) were added to both 
sample and reference cuvettes, and the baseline recorded. An aliquot (4 p.1) of a 
2.5x10'^ M solution of the ligand was added to the sample cell, while the reference 
received the same amount of buffer. 
4.3.5 ISOTHERIMAL TITRATION MiCROCALORIMETRY 
Isothermal titration microcalorimetry (ITM) was performed using a Thermal 
Activity Monitor (TAM 2277, Thermometric AB, Sweden) operated at 25 °C. Two 
sets of experiments were carried out preparing samples of PNA and ligands in 20 mM 
citrate buffer, containing or not 150 mM NaCl. The samples were adjusted to pH 7.4 
(±0.05) using dilute NaOH. The addition of salt allowed the doubling of the lectin 
concentration in solution. In each experiment a 2.5 ml sample of a solution of PNA 
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(1.5-3 mg ml"') was placed in a sample cell and inserted into the instrument. Once 
thermal equilibrium was reached, the titration was performed by consecutive 
injections (25 injections of 20 ^1 each) of ligand solution (0.275-0.55 mg ml"'). The 
titrant was added by means of a Hamilton microlab syringe mounted on a computer-
operated syringe driver (Lund 6100 syringe pump). The experimental method set up 
via the Digitam*^ 4 software allowed for data collection over a 15 minute period for 
the injection and a 5 minute baseline period before the next injection. This was found 
to be adequate for the interaction to proceed to completion at each injection and reach 
the baseline before the next addition. Data presented here are the mean of a minimum 
of three replicate titrations for each experiment. Heats of dilution/mixing were 
determined in blank titrations injecting aliquots of ligand solution into the appropriate 
buffer without the lectin. The signs of the released heat values were reversed for data 
analysis since the output from the instrument is from the perspective of the equipment 
and not the system under study. The equilibrium binding parameters K, Alf and n 
were determined by non-linear least-squares fitting using the routines available within 
Origin 5.0 (MicroCal Software). The integrated heats of binding were corrected for 
the enthalpy of dilution, AH^, before calculation of the binding parameters. The heat 
of dilution can be evaluated either by performing a blank titration, i.e. injection of 
ligand s olution into buffer without PNA, or from the end part of the released heat 
titration profile. In the latter case an average dilution heat is calculated and subtracted 
from the observed heat value at each data point^^l In this study both methods were 
employed. When pGalEMA was used as the titrant, c values - [PNA monomer] A: -
were > 0.9^'^l Concentrations of polymer and PNA are both expressed in terms of 
monomeric units. The free energy of complex formation (ACfobs) was calculated from 
A G l = -RTlnK^^^ and the entropy of binding determined as TAS^^ = AH^'-AG'^^. 
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4.4 CONCLUSIONS 
Deprotected glycopolymers carrying glucose and galactose residues were 
found to self-associate in aqueous media, forming nanoaggregates with dimensions 
varying over a broad range of 15-600 nm. Considering the structure of the polymers 
and the results o f fluorescence studies, it is very likely that the formed particles can be 
envisaged as loose aggregates, resulting from inter- and intramolecular direct and 
water-mediated hydrogen bonds. 
Ultraviolet-difference spectroscopy showed that the monomer and polymer 
bearing galactose units (GalEMA and pGalEMA-A,B, respectively) were efficiently 
recognised and bounded by the galactose-specific lectin peanut agglutinin. 
Quantitative evaluations of the thermodynamic binding parameters for the 
interaction of peanut agglutinin with D-galactose, GalEMA and pGalEMA-A,B were 
performed by isothermal titration microcalorimetry. Reported here is the first 
calorimetric study of the interaction of a lectin with polymeric ligands. A 50-fold 
affinity enhancement of the polymer compared to the monovalent saccharide D-
galactose was observed. The thermodynamics and DLS measurements suggested that 
the polyvalent carbohydrates bound to the lectin mainly by cross-linking distinct 
protein molecules. The polymer activity was strongly influenced by the presence of 
salt, indicating that electrostatic interactions were involved in PNA-polymer complex 
formation, either by affecting the polymer nanoparticles dissociation, and/or 
neutralising charges on the protein surface somehow involved in the 
chelate/aggregative process. Inclusion in the polymer structure of segments 
resembling the protein surface, which could give rise to favourable interactions 
between the ligands and the receptor, as well as consideration of the target structure in 
the design of the ligands, would very likely improve the affinity gain. 
207 
4.5 BIBLIOGRAPHICAL REFERENCES 
[ I ] N . Sharon, H. Lis, Science 1989, 246, 227-234. 
[2] N . Sharon, H. Lis, Lectins, Chapman and Hall, London, 1989. 
[3] M . Takeichi, Science 1991, 251, 1451-1455. 
[4] A. Varki, Glycobiology 1993, 3, 97-130. 
[5] W. J. Lees, A. Spaltenstein, W. J. E. Kingery, G. M . Whitesides, J. Med. 
Chem. 1994, 37, 3419-3433. 
[6] H. Lis, N . Sharon, Chem. Rev. 1998, 98, 637-674. 
[7] M . Mammen, S.-K. Choi, G. M . Whitesides, ^«gew. Chem., Int. Ed. Engl. 
1998, 37, 2754-2794. 
[8] D. K. Mandal, N . Kishore, C. F. Brewer, Biochemistry 1994, 33, 1149-1156. 
[9] Y. C. Lee, R. R. Townsend, M . R. Hardy, J. Lonngren, J. Amarp, M. 
Haraldsson, H. L6nn,y. Biol. Chem. 1983, 258, 199-202. 
[10] Y. C. Lee, in Neoglycoconjugates: Preparation and Applications (Eds.: Y. C. 
Lee, R. T. Lee), Academic Press, London, 1994, pp. 3-21. 
[ I I ] J. J. Lundquist, E. J. Toone, Chem. Rev. 2002, 102, 555-578. 
[12] S. M . Dimick, S. C. Powell, S. A. McMahon, D. N . Moothoo, J. H. Naismith, 
E. J. Toone, J. Am. Chem. Soc. 1999,121, 10286-10296. 
[13] G. Molema, D. K. F. Meijer, Adv. Drug Deliv. Rev. 1994, 14, 25-50. 
[14] B. G. Davis, Chem. Rev. 2002, 102, 579-601. 
[15] R. V. Weatherman, K. H. Mortell, M . Chervenak, L. L. Kiessling, E. J. Toone, 
Biochemistry 1996, 35, 3619-3624. 
[16] J. B. Corbell, J. J. Lundquist, E. J. Toone, Tetrahedron: Asymmetry 2000, 11, 
95-111. 
208 
[17] J. J. Lundquist, S. D. Debenham, E. J. Toone, J. Org. Chem. 2000, 65, 8245-
8250. 
[18] T. K. Dam, R. Roy, S. K. Das, S. Oscarson, C. F. Brewer, J. Biol. Chem. 2000, 
275, 14223-14230. 
[19] T. K. Dam, R. Roy, D. Page, C. F. Brewer, Biochemistry 2002, 41, 1351-1358. 
[20] T. K. Dam, R. Roy, D. Page, C. F. Brewer, Biochemistry 2002, 41, 1359-1363. 
[21] T. K. Dam, C. F. Brewer, Chem. Rev. 2002, 102, 387-429. 
[22] J. Rao, J. Lahiri, L. Isaacs, R. M . Weis, G. M . Whitesides, Science 1998, 280, 
708-711. 
[23] J. Rao, L . Yan, J. Lahiri, G. M . Whitesides, R. M . Weis, H. S. Warren, Chem. 
Biol. 1999, 6, 353-359. 
[24] N . M . Young, A. Z. Johnston, D. C. Watson, Eur. J. Biochem. 1991, 196, 631-
637. 
[25] W. W. Fish, L . M . Hamlin, R. L. Miller, Arch. Biochem. Biophys. 1978, 190, 
693-698. 
[26] K. J. Neurohr, N . M . Young, H. H. Mantsch, J. Biol. Chem. 1980, 255, 9205-
9209. 
[27] K. J. Neurohr, D. R. Bundle, N . M . Young, H. H, Mantsch, Eur. J. Biochem. 
1982, 723, 305-310. 
[28] M . Caron, J. Ohanessian, J. Becquart, H. Gillier-Pandraud, Biochim. Biophys. 
y4cto 1982, 777,432-438. 
[29] M . J. Blandamer, P. M . CuUis, J. B. F. N . Engberts, J. Chem. Soc. Faraday 
Trans. 1998, 94, 2261-2267. 
[30] M . Eftink, R. Biltonen, in Biological Microcalorimetry (Ed.: A. E. Beezer), 
Academic Press, London, 1980, pp. 313-412. 
209 
[31] T. Lundback, H. Hansson, S. Knapp, R. Ladenstein, T . Hard, 7. Mol. Biol. 
1998, 276, 775-786. 
[32] I . Jelesarov, H. R. Bosshard, Biochemistry 1994, 33, 13321-13327. 
[33] G. C. Kresheck, L. B. Vitello, J. E. Erman, Biochemistry 1995, 34, 8398-8405. 
[34] D. K. Srivastava, S. Wang, K. L. Peterson, Biochemistry 1997, 36, 6359-6366. 
[35] D. A. Brummell, V. P. Sharma, N . N . Anand, D. Bilous, G. Dubuc, J. 
Michniewicz, C. R. MacKenzie, J. Sadowska, B. W. Sigurskjold, B. Sinnott, 
N . M . Young, D. R. Bundle, S. A. Narang, Biochemistry 1993, 32, 1180-1187. 
[36] R. F. Kelley, M . P. O'Connell, Biochemistry 1993, 32, 6828-6835. 
[37] D. R. Bundle, B. W. Sigurskjold, Methods Enzymol. 1994, 247, 288-305. 
[38] C. Zentz, J.-P. Frenoy, R. Bourrillon, FEBS Lett. 1977, 81, 23-27. 
[39] F. P. Schwarz, K. Puri, A. Surolia, J. Biol. Chem. 1991, 266, 24344-24350. 
[40] B. A. Williams, M . C. Chervenak, E. J. Toone, J. Biol. Chem. 1992, 267, 
22907-22911. 
[41] F. P. Schwarz, K. D. Puri, R. G. Bhat, A. Surolia, J. Biol. Chem. 1993, 268, 
7668-7677. 
[42] D. K. Mandal, L. Bhattacharyya, S. H. Koenig, R. D. I . Brown, S. Oscarson, 
C. F. Brewer, Biochemistry 1994, 33, 1157-1162. 
[43] M . C. Chervenak, E. J. Toone, Biochemistry 1995, 34, 5685-5695. 
[44] D. Gupta, M . Cho, M . D. Cummings, C. F. Brewer, Biochemistry 1996, 35, 
15236-15243. 
[45] A. Surolia, N . Sharon, F. P. Schwarz, J. Biol. Chem. 1996, 277, 17697-17703. 
[46] F. P. Schwarz, H. Ahmed, M . A. Bianchet, L. M . Amzel, G. R. Vasta, 
Biochemistry 199S, 37, 5S67-5Sn. 
210 
[47] G. B. Reddy, V. R. Srinivas, N . Ahmad, A. Surolia, J. Biol. Chem. 1999, 274, 
4500-4503. 
[48] R. Lotan, E. Skutelsky, D. Danon, N . Sharon, J. Biol. Chem. 1975, 250, 8518-
8523. 
[49] N . M . Young, R. P. Oomen, J. Mol. Biol. 1992, 225, 924-934. 
[50] R. Baneijee, K. Das, R. Ravishankar, K. Suguna, A. Surolia, M . Vijayan, / 
Mol. Biol. 1996, 259, 281-296. 
[51] R. Banerjee, S. C. Mande, V. Ganesh, K. Das, V. Dhanaraj, S. K. Mahanta, K. 
Suguna, A. Surolia, M . Vijayan, Proc. Natl. Acad. Sci. USA 1994, 91, Ill-
Ill. 
[52] V. R. Srinivas, G. B . Reddy, N . Ahmad, C P . Swaminathan, N . M iti-a, A . 
Surolia, Biochim. Biophys. Acta 2001,1527, 102-111. 
[53] D. M . Salunke, M . J. Swamy, M . Islam Khan, S. C. Mande, A. Surolia, M . 
Vijayan, / Biol. Chem. 1985, 260, 13576-13579. 
[54] M . Decastel, H. De Boeck, Y. Goussault, C. K. De Bruyne, F. G. Loontiens, 
J.-P. Frenoy, Arch. Biochem. Biophys. 1985, 240, 811-819. 
[55] D. M . Salunke, M . Islam Khan, A. Surolia, M . Vijayan, J. Mol. Biol. 1982, 
154, 177-178. 
[56] D. M . Salunke, M . Islam Khan, A. Surolia, M . Vijayan, FEBS Lett. 1983,156, 
127-129. 
[57] R. Ravishankar, K. Suguna, A. Surolia, M . Vijayan, Acta Crystallogr. 1999, 
D55, 1375-1382. 
[58] R. Ravishankar, M . Ravindran, K. Suguna, A. Surolia, M . Vijayan, Curr Sci. 
1997, 72,855-861. 
211 
[59] R. Ravishankar, M . Ravindran, K. Suguna, A. Surolia, M . Vijayan, Curr. Sci. 
1999, 76, 1393-1404. 
[60] J. V. Pratap, G. M . Bradbrook, G. B. Reddy, A. Surolia, J. Raftery, J. R. 
Helliwell, M . Vijayan, Acta Crystallogr. 2001, D57, 1584-1594. 
[61] N . Sharon, TIBS 1993,18, 221-226. 
[62] S. Elgavish, B. Shaanan, J. Mol Biol 1998, 277, 917-932. 
[63] V. Sharma, M . Vijayan, A. Surolia, J. Biol Chem. 1996, 27/, 21209-21213. 
[64] P. Adhikari, K. Bachhawat-Sikder, C. J. Thomas, R. Ravishankar, A. A. 
Jeyaprakash, V. Sharma, M . Vijayan, A. Surolia, J. Biol Chem. 2001, 276, 
40734-40739. 
[65] K. J. Neurohr, N . M . Young, I . C. P. Smith, H. H. Mmisch, Biochemistry 
1981, 20, 3499-3504. 
[66] K. J. Neurohr, H. H. Mantsch, N . M . Young, D. R. Bundle, Biochemistry 
1982, 27,498-503. 
[67] M . Decastel, A.-T. Tran, J.-P. Frenoy, Biochem. Biophys. Res. Comm. 1982, 
106, 638-643. 
[68] H . De Boeck, K. L. Matta, M . Claeyssens, N . Sharon, F. G. Loontiens, Eur. J. 
Biochem. 1983 ,131 , 453-460. 
[69] M . M . Prabu, R. Sankaranarayanan, K . D . Puri, V. Sharma, A. Surolia, M. 
Vijayan, K. Suguna, J. Mol Biol 1998, 276, 787-796. 
[70] A. Cooper, Curr Opin. Chem. Biol 1999, 3, 557-563. 
[71] Y.-Z. Liang, Z.-C. L i , F.-M. L i , J. Colloid Interface Sci 2000, 224, 84-90. 
[72] E. E. Dormidontova, Macromolecules 2002, 35, 987-1001. 
[73] J. J. Christensen, H. L.D., R. M . Izatt, in Handbook of Proton Ionization Heats 
and Related Thermodynamic Quantities, John Wiley, New York, 1976. 
212 
[74] U . Rungsardthong, Doctoral Thesis, University of Nottingham, U.K., 2001. 
[75] L. R. Olsen, A. Dessen, D. Gupta, S. Sabesan, J. C. Sacchettini, C. F. Brewer, 
Biochemistry 1997, 36, 15073-15080. 
[76] J. C. Sacchettini, L . G. Baum, C. F. Brewer, Biochemistry 2001, 40, 3009-
3015. 
[77] M . Kanai, K. H. Mortell, L. L. Kiessling, J. Am. Chem. Soc. 1997, 119, 9931-
9932. 
[78] T. Wiseman, S. Williston, J. F. Brandts, L. N . Lin, Anal. Biochem. 1989, 77P, 
131-137. 
[79] T. Govender, T. Ehtezazi, S. Stolnik, L. Ilium, S. S. Davis, Pharm. Res. 1999, 
16, 1125-1131. 
213 
APPENDIX I 
T A B L E 1. C R Y S T A L D A T A 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Uni t cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
6 range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Reflections wi th I>2a( I ) 
Completeness to 9 = 29 .00° 
Absorption correction 
Refinement method 
Data / restraints / parameters 
Largest final shift/e.s.d. ratio 
Goodness-of-fit on 
Final R indices [I>2cy(I)] 
R indices (al l data) 
Absolute structure parameter 
Largest d i f f peak and hole 
AND S T R U C T U R E R E F I N E M E N T F O R A C G L C E M A (1 A ) . 
A c G l c E M A 
C20 H28 012 
460.42 
100(2) K 
0.71073 A 
Orthorhombic 
P2,2,2, (No. 19) 
a = 8.442(2) A a = 90° 
p= 90° 
Y = 90° 
i = 12.466(4) A 
c = 21.904(7) A 
2305(1) A3 
4 
1.327 g/cm^ 
0.111 m m ' 
976 
0.1 x 0 . 7 x 1.2 mm3 
1.86 to 29.0° . 
- 1 1 < h< 11 , -16< k< 1 6 , - 2 7 < / < 29 
28228 
6082 [R(int) = 0.0479] 
5679 
99.7 % 
None 
Full-matrix least-squares on 
6 0 8 2 / 0 / 3 0 7 
0.021 
1.051 
R l = 0.0365, wR2 = 0.0938 
R l =0.0404, wR2 = 0.0971 
-0.1(6) 
0.326 and-0.192 e.A-3 
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T A B L E 2. A T O M I C C O O R D I N A T E S ( xlO^) AND E Q U I V A L E N T I S O T R O P I C 
D I S P L A C E M E N T P A R A M E T E R S (A2 X1O4) F O R A C G L C E M A . U ( E Q ) IS D E F I N E D AS O N E 
T H I R D O F T H E T R A C E O F T H E O R T H O G O N A L I S E D U U T E N S O R . 
X y z U(eq) 
0(1) 66194(11) 61041(8) 24748(5) 240(2) 
0(2) 39079(11) 54306(8) 18033(4) 229(2) 
0(3) 13277(11) 46898(7) 25450(4) 212(2) 
0(4) 8428(12) 60440(8) 35890(5) 254(2) 
0(5) 51166(11) 62381(7) 33364(4) 219(2) 
0(6) 42843(13) 56365(8) 45196(5) 275(2) 
0(8) 58951(13) 78650(8) 16365(5) 266(2) 
0(9) 59057(18) 71625(15) 6945(6) 526(4) 
0(13) 51326(16) 38315(9) 17123(5) 382(3) 
0(15) 1913(12) 57142(8) 18126(5) 279(2) 
0(17) 6004(16) 46759(13) 42588(7) 486(3) 
0(19) 49410(30) 64746(13) 53805(7) 755(7) 
C(l) 50882(15) 62774(10) 26854(6) 205(2) 
C(2) 40118(14) 53788(10) 24604(6) 195(2) 
C(3) 23506(14) 55721(10) 27095(6) 187(2) 
C(4) 23827(15) 56685(10) 34018(6) 198(2) 
C(5) 36050(15) 65185(10) 35870(6) 209(2) 
C(6) 38146(18) 66582(11) 42664(7) 256(3) 
C(7) 75315(15) 70757(11) 24041(6) 228(3) 
C(8) 74808(16) 74506(12) 17498(6) 255(3) 
C(9) 52095(19) 76140(13) 10982(6) 313(3) 
•C(10) 35060(20) 79499(13) 10784(7) 329(3) 
C(l l) 28200(20) 85410(15) 16094(9) 401(4) 
C(12) 26720(30) 76867(18) 5843(9) 450(4) 
C(13) 44977(16) 45944(11) 14805(7) 255(3) 
C(14) 42500(30) 47516(16) 8088(8) 427(4) 
C(15) 2865(14) 48696(11) 20778(6) 219(2) 
C(16) -6898(18) 38952(13) 19405(7) 305(3) 
C(17) 773(17) 54798(13) 40337(6) 298(3) 
C(18) -14580(20) 60146(17) 41915(8) 404(4) 
C(19) 48230(20) 56550(14) 50942(7) 366(3) 
C(20) 52670(30) 45544(15) 53117(8) 436(4) 
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T A B L E 3. B O N D L E N G T H S [A] AND A N G L E S [°] F O R A C G L C E M A . 
0(1)-C(1) 1.3895(16) 0(15)-C(15) 1.2051(18) 
0(1)-C(7) 1.4435(16) 0(17)-C(17) 1.201(2) 
0(2)-C(13) 1.3545(17) 0(19)-C(19) 1.203(2) 
0(2)-C(2) 1.4434(16) C(l)-C(2) 1.5243(18) 
0(3)-C(15) 1.3675(16) C(2)-C(3) 1.5239(17) 
0(3)-C(3) 1.4441(15) C(3)-C(4) 1.5213(18) 
0(4)-C(17) 1.3642(18) C(4)-C(5) 1.5337(18) 
0(4)-C(4) 1.4412(16) C(5)-C(6) 1.509(2) 
0(5)-C(l) 1.4269(16) C(7)-C(8) 1.508(2) 
0(5)-C(5) 1.4325(17) C(9)-C(10) 1.498(2) 
0(6)-C(19) 1.3385(18) C(10)-C(12) 1.332(3) 
0(6)-C(6) 1.4446(18) C(10)-C(ll) 1.494(3) 
0(8)-C(9) 1.3504(18) C(13)-C(14) 1.499(2) 
0(8)-C(8) 1.4562(18) C(15)-C(16) 1.498(2) 
0(9)-C(9) 1.202(2) C(17)-C(18) 1.498(2) 
0(13)-C(13) 1.2040(19) C(19)-C(20) 1.500(2) 
C(l)-0(1)-C(7) 113.66(10) 0(6)-C(6)-C(5) 108.00(11) 
C(13)-0(2)-C(2) 117.63(10) 0(1)-C(7)-C(8) 110.29(11) 
C(15)-0(3)-C(3) 116.51(10) 0(8)-C(8)-C(7) 107.33(11) 
C(17)-0(4)-C(4) 117.58(11) 0(9)-C(9)-0(8) 122.78(16) 
C(l)-0(5)-C(5) 111.08(10) O(9)-C(9)-C(10) 125.38(15) 
C(19)-0(6)-C(6) 116.04(12) O(8)-C(9)-C(10) 111.83(14) 
C(9)-0(8)-C(8) 117.42(12) C(12)-C(10)-C(ll) 123.28(18) 
0(l)-C(l)-0(5) 108.11(10) C(12)-C(10)-C(9) 117.52(18) 
0(1)-C(1)-C(2) 109.45(10) C(ll)-C(10)-C(9) 119.19(14) 
0(5)-C(l)-C(2) 107.94(10) 0(13)-C(13)-0(2) 123.46(13) 
0(2)-C(2)-C(3) 107.10(10) 0(13)-C(13)-C(14) 125.41(14) 
0(2)-C(2)-C(l) 109.01(10) 0(2)-C(13)-C(14) 111.13(13) 
C(3)-C(2)-C(l) 108.46(10) 0(15)-C(15)-0(3) 123.14(12) 
0(3)-C(3)-C(4) 108.64(10) 0(15)-C(15)-C(16) 125.10(12) 
0(3)-C(3)-C(2) 109.91(10) 0(3)-C(15)-C(16) 111.77(12) 
C(4)-C(3)-C(2) 110.67(10) 0(17)-C(17)-0(4) 123.31(14) 
0(4)-C(4)-C(3) 107.05(10) 0(17)-C(17)-C(18) 126.49(15) 
0(4)-C(4)-C(5) 107.89(11) 0(4)-C(17)-C(18) 110.19(14) 
C(3)-C(4)-C(5) 109.29(10) 0(19)-C(19)-0(6) 122.22(16) 
0(5)-C(5)-C(6) 107.56(11) O(19)-C(19)-C(20) 126.19(15) 
0(5)-C(5)-C(4) 109.23(10) O(6)-C(19)-C(20) lli.58(14) 
C(6)-C(5)-C(4) 114.81(11) 
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T A B L E 4. A N I S O T R O P I C D I S P L A C E M E N T P A R A M E T E R S (A2 X1O3) F O R A C G L C E M A . 
T H E A N I S O T R O P I C D I S P L A C E M E N T F A C T O R E X P O N E N T T A K E S T H E F O R M : -27i4[ 
^*2uii + ... + 2HKA*B*\}M\ 
u „ U22 U33 U23 U,3 U,2 
0(1) 207(4) 177(4) 335(5) 16(4) 28(4) 4(3) 
0(2) 272(4) 216(4) 198(4) 11(4) 6(3) 54(4) 
0(3) 228(4) 185(4) 224(4) 9(3) -40(3) -32(3) 
0(4) 233(4) 268(5) 261(5) -9(4) 36(4) 0(4) 
0(5) 214(4) 209(4) 235(4) 16(3) -19(4) -1(4) 
0(6) 360(5) 239(5) 228(5) 18(4) -57(4) -18(4) 
0(8) 309(5) 243(5) 246(5) -1(4) -36(4) 11(4) 
0(9) 481(7) 846(11) 251(6) -119(6) 64(5) -101(8) 
0(13) 565(7) 230(5) 350(6) -6(4) 74(6) 122(5) 
0(15) 313(5) 275(5) 248(5) 10(4) -52(4) 48(4) 
0(17) 387(6) 606(9) 466(7) 257(7) 58(5) -39(6) 
0(19) 1473(19) 476(8) 314(7) -134(6) -309(9) 289(11) 
C(l) 202(5) 182(6) 230(6) 18(4) -4(5) 10(5) 
C(2) 210(5) 182(5) 194(5) 9(4) -4(4) 12(4) 
C(3) 205(5) 150(5) 206(5) 9(4) -15(4) -17(4) 
C(4) 211(5) 180(5) 204(5) -4(5) 0(4) 0(5) 
C(5) 230(5) 175(5) 221(6) 4(5) -13(5) -6(4) 
0(6) 319(7) 214(6) 235(6) -25(5) -24(5) -10(5) 
0(7) 205(5) 210(6) 268(6) -10(5) 3(5) -22(5) 
C(8) 259(6) 245(6) 263(6) -7(5) 37(5) -9(5) 
0(9) 369(7) 355(8) 216(6) 68(5) -9(5) -114(6) 
C(10) 369(7) 312(7) 306(8) 120(6) -64(6) -89(6) 
0(11) 371(8) 412(9) 422(9) 37(8) -98(7) 84(7) 
0(12) 485(10) 464(10) 402(9) 60(8) -136(8) -83(8) 
0(13) 270(6) 227(6) 268(6) -22(5) 49(5) -7(5) 
0(14) 622(11) 417(9) 241(7) -35(7) 45(8) 86(9) 
0(15) 188(5) 267(6) 201(6) -40(5) 0(4) 19(5) 
0(16) 284(6) 326(7) 305(7) -37(6) -43(6) -59(6) 
0(17) 255(6) 416(8) 224(6) -28(6) 5(5) -96(6) 
0(18) 270(7) 581(11) 360(9) -99(8) 74(6) -68(7) 
0(19) 517(9) 383(8) _ 198(6) -19(6) -8(6) 89(8) 
0(20) 662(12) 407(9) 238(7) 30(7) -5(7) 147(9) 
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T A B L E 5. H Y D R O G E N C O O R D I N A T E S ( xlO^) AND I S O T R O P I C D I S P L A C E M E N T 
P A R A M E T E R S ( A ^ XIO3) F O R A C G L C E M A . 
X y z U(iso) 
H(l) 4687 6989 2543 27 
H(2) 4422 4664 2594 25 
H(3) 1919 6250 2531 24 
H(4) 2632 4962 3595 26 
H(5) 3273 7223 3410 27 
H(6A) 4638 7205 4349 33 
H(6B) 2810 6900 4454 33 
H(7A) 8643 6941 2526 30 
H(7B) 7097 7641 2674 30 
H(8A) 8278 8021 1682 33 
H(8B) 7714 - 6847 1470 33 
H ( l l l ) 1688 8668 1541 54(4) 
H(112) 3367 9230 1654 54(4) 
H(113) 2961 8117 1982 54(4) 
H(121) 3190(20) 7298(17) 297(10) 34(5) 
H(122) 1560(30) 7890(20) 541(11) 51(6) 
H(141) 5103 5196 641 90(6) 
H(142) 3229 5106 739 90(6) 
H(143) 4250 4051 605 90(6) 
H(161) -1817 4082 1955 58(4) 
H(162) -465 3340 • 2245 58(4) 
H(163) -426 3625 1533 58(4) 
H(181) -2017 5588 4500 66(4) 
H(182) -2116 6074 3824 66(4) 
H(183) -1245 6733 4354 66(4) 
H(201) 5034 4491 5749 78(5) 
H(202) 6400 4436 5243 78(5) 
H(203) 4656 4017 5085 78(5) 
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T A B L E 6, T O R S I O N A N G L E S [°] F O R A C G L C E M A . 
C(7)-0(l)-C(l)-0(5) -90.14(12) 0(4 )-0(4)-0(5)-0(5) -172.38(10) 
C(7)-0(1)-C(l)-C(2) 152.53(11) 0(3) -0(4)-0(5)-0(5) -56.32(13) 
C(5)-0(5)-C(l)-0(l) 174.12(10) 0(4; -0(4)-0(5)-0(6) 66.73(14) 
C(5)-0(5)-C(l)-C(2) -67.58(12) C(3) -0(4)-0(5)-0(6) -177.21(11) 
C(13)-0(2)-C(2)-C(3) -127.07(11) C(19)-0(6)-C(6)-C(5) 167.34(13) 
C(13)-0(2)-C(2)-C(l) 115.77(12) 0(5; -0(5)-0(6)-O(6) -63.42(13) 
0(l)-C(l)-C(2)-0(2) -65.04(12) C(4) -0(5)-0(6)-0(6) 58.39(15) 
0(5)-C(l)-C(2)-0(2) 177.52(9) C(l) -0(1)-0(7)-0(8) -96.81(13) 
0(1)-C(1)-C(2)-C(3) 178.67(10) C(9) -0(8)-0(8)-0(7) -138.34(12) 
0(5)-C(l)-C(2)-C(3) 61.23(12) 0(1; -C(7)-0(8)-0(8) 71.93(13) 
C(15)-0(3)-C(3)-C(4) 135.20(11) C(8) -0(8)-0(9)-0(9) -7.5(2) 
C(15)-0(3)-C(3)-C(2) -103.57(12) 0(8) -O(8)-O(9)-O(10) 171.57(11) 
0(2)-C(2)-C(3)-0(3) 66.99(12) 0(9] -O(9)-O(10)-O(12) 3.1(3) 
C(l)-C(2)-C(3)-0(3) -175.49(10) 0(8] -O(9)-O(10)-O(12) -175.97(15) 
0(2)-C(2)-C(3)-C(4) -173.01(10) 0(9] -O(9)-O(10)-O(ll) -177.85(18) 
C(l)-C(2)-C(3)-C(4) -55.50(13) 0(8] -O(9)-O(10)-O(ll) 3.1(2) 
C(17)-0(4)-C(4)-C(3) 128.43(12) 0(2) -0(2)-0(13)-0(13) -1.9(2) 
C(17)-0(4)-C(4)-C(5) -114.05(13) 0(2) -0(2)-0(13)-0(14) 178.02(13) 
0(3)-C(3)-C(4)-0(4) -69.67(12) 0(3) -0(3)-0(15)-0(15) -0.64(18) 
C(2)-C(3)-C(4)-0(4) 169.57(10) 0(3) -0(3)-O(15)-O(16) 178.99(11) 
0(3)-C(3)-C(4)-C(5) 173.73(10) 0(4) -0(4)-0(17)-0(17) -2.4(2) 
C(2)-C(3)-C(4)-C(5) 52.98(13) 0(4) -0(4)-0(17)-0(18) 177.11(12) 
C(l)-0(5)-C(5)-C(6) -169.65(10) 0(6) -0(6)-0(19)-0(19) -1.5(3) 
C(l)-0(5)-C(5)-C(4) 65.13(13) 0(6) -O(6)-O(19)-O(20) 179.68(14) 
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APPENDIX II 
S O L U B I L I T Y DATA FOR DL-ASPARTIC A C I D 
ln(s)«-3554(1/T)+13.981 
X 
0.0038 
0.0036 
0.0034 
t : 0.0032 
0.003 
0.0028 h 
0.0026 
0 1 2 3 4 5 
ln(s), s is solubility in grams per kg water 
Solubility curve for dl-aspartic acid'. 
From the curve reported above, the percentage supersaturation of the system, a%, can 
be determined as follows: 
C^o^ = ^_j ! iELxlOO 
where: s = amount dissolved in solution 
5^a,= amount dissolved in saturated solution 
S. J. Cooper, Doctoral Thesis, University of Bristol, U.K., 1993, p. 144. 
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APPENDIX III 
C R Y S T A L H A B I T OF DL-ASPARTIC ACID^ 
C R Y S T A L L O G R A P H I C D A T A F O R H O M O G E N E O U S L Y G R O W N D L -
A S P A R T I C A C I D ^ 
Space i»roup C2/c (number 15) 
Unit cell parameters a--= I8.947A°, b = 7.4:.3A=' 
c = 9 , l84A° , P= 123.75° 
Number of molecules 
per unit cell 
8 
Reflection conditions 
hOO: h = 2n, OkO: k = 2n, 001; l = 2n, 
hOl: h, 1 = 2n, Okl; k = 2n, 
hkO: h + k = 2n. hkl; h + k - 2n 
Typical cr>'Stal habit in 
aqueous solution 
f«r.e ^ / f110) \ face 
other faces sometimes present; {200}, 
{020}, {002} and i n 1) 
Nomenclature 
Monoclinic crystal 
{hOO}, {OkO}, {001} = pinacoid faces 
(hkO) = prisms, {hOI} and (Okl) = domes 
{hkl) = pyramids 
foiTos parallel to a axis = dino 
forms parallel to b axis = ortho 
The Cerius morphology module from MSI (Molecular Simulations 
Incorporated) predicts the external morphology of the crystalline material from the 
internal crystal structure. The Bravais Friedel Donnay Harker (BFDH) method and the 
Attachment Energy (AE) method for growth morphologies are used to determine 
morphologies in vacuum, since no account is taken of the interaction of the crystal 
faces with the solvent (water). The BFDH method uses the crystal lattice dimensions 
' S. Al-IVIannai, Master Dissertation, University of Durham, U.K., 2001, 75-79. 
^ S. J. Cooper, Doctoral Thesis, University of Bristol, U.K., 1993, p. 144. 
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and symmetry to generate a list o f possible growth faces and their relative growth 
rates. The AE method relies on calculations o f the energy released when a growth 
slice is added to a growing plane. The force field COMPASS was used to calculate 
the crystal and attachment energies. Due to the consideration o f the energetics o f the 
system, the AE method gives more accurate predictions. 
Comparing the typical aqueous morphology with the predicted vacuum 
morphologies obtained by the BFDH and AE methods, it is clear that both the 
methods overestimate the importance o f the faces { 2 02}, {200} and { 3 1 1 } faces. Of 
the two, the AE method is slightly more accurate, because the { 2 0 2 } and { 3 1 1 } 
faces have smaller areas. 
A R E A S O F D L - A S P A R T I C A C I D C R Y S T A L F A C E S C A L C U L A T E D B Y B F D H M E T H O D 
C R Y S T A L F A C E CRYSTAL F A C E A R E A 
{ 1 1 1 } 7.18 
{ 1 1 0 } 6.48 
{ 2 0 2 } 4.22 
{2 0 0} 16.68 
{ 3 1 1} 0.44 
_402 20^  
311 111 
l i i , . 311 
202 402 
110 110 
402200 
4 0 
Three perpendicular views of the crystal morphology predicted for dl-aspartic acid by BFDH method. 
Black: faces in front; blue: faces under; red: faces perpendicular to the view. 
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A R E A S O F D L - A S P A R T I C A C I D C R Y S T A L F A C E S C A L C U L A T E D B Y A E M E T H O D 
C R Y S T A L F A C E CRYSTAL F A C E A R E A 
{ 1 1 1 } 4 . 7 7 
{ 1 1 0 } 7 . 7 4 
- 12.95 
{ 2 0 2 } 
{ 2 0 0 } 11 .60 
0 . 2 1 
{ 3 1 1 } 
311 
P 
111 
^00 110 
110 '00 
20i: 
202 
31 
202 202 
111 
202 
200 
To m 
202 
111 
I 110 
110 
311 
Three perpendicular views of the crystal morphology predicted for dl-aspartic acid by AE method. 
Black: faces in front; blue: faces under; red: faces perpendicular to the view. 
The following figures for crystal morphologies are produced from the Cerius^ 
software by varying the sizes o f the crystal faces present. In particular, the face 
growing beneath the monolayer film is made larger, according to the experimental 
observation. 
Three different shaped ( 1 1 1 ) cr> stal faces (yellow). 
2 2 3 
2 0 2 
Two different shaped {110} crystals faces (yellow). 
020 
Three different shaped { 2 02} crystals faces (yellow). 
2 2 4 
